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ABSTRACT.
Plasmodium falciparum  is the principal causative agent of malaria. Cells of the 
organism harbour a plastid organelle that constitutes a potential drug target. Metabolic 
functions associated with the plastid include the synthesis of isoprenoids, fatty acids and 
haem. Iron-sulphur [Fe-Sl clusters may also be assembled in the organelle. Two 
systems (ISC and SUF) are implicated in biological [Fe-S] cluster assembly in malaria. 
The ISC system probably functions in the mitochondrion while the SUF system 
operates in the plastid. The objective of this project was to investigate a gene in P. 
falciparum with marked homology to SufS, a cysteine desulphurase (EC 2.8.1.7) of the 
SUF system in Escherichia coli and Arabidopsis thaliana. P. falciparum SufS (PfSufS) 
is encoded on chromosome seven of the nuclear genome but is predicted to be trafficked 
to the plastid organelle. A number of techniques have been applied to investigate the 
function of PfSufS in this thesis. Following a general introduction in chapter 1, 
subsequent chapters describe progress with this work. In chapter 2, account is given of 
investigations into the properties of PfSufS using a combination of bioinformatic and in 
vitro techniques. Progress towards defining the intracellular targeting of PfSufS by 
transfection and immunolocalisation is described in chapter 3. Development of a simple 
colorimetric cysteine desulphurase assay is reported in chapter 4. Finally, attempts have 
been made to produce recombinant PfSufS for enzymological studies (chapter 5).
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CHAPTER 1.
GENERAL INTRODUCTION.
Apicomplexan parasites are important human and animal pathogens. One genus in the 
group, Plasmodium spp., is the aetiological agent of malaria. Cells of Plasmodium spp. 
and related organisms harbour a plastid organelle. My thesis focuses on a malarial 
sulphur mobilisation gene predicted to encode a protein involved in iron-sulphur IFe-SJ 
cluster assembly within the plastid organelle. In three distinct sections, this introductory 
chapter will describe (1) the fundamentals of malaria; (2) the plastid organelle and the 
functions attributed to it; and (3) our knowledge of the mechanisms of [Fe-S] cluster 
assembly, based on work in bacteria, yeast and vascular plants.
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1.1. FUNDAMENTALS OF MALARIA.
1.1.1. Malaria as a humanitarian catastrophe.
There is an old Italian proverb, “malaria vien’ dalla pentola” (“malaria depends on 
what comes out of the pot”).1 Malaria is, indeed, a disease of poverty. Restricted to the 
developing countries of the tropics, it is estimated to cause 515 million clinical episodes 
per year; most of the burden falls in sub-Saharan Africa (70 %) and South East Asia (25 
%).2 The alleviation of such human misery is inevitably an important motivation for the 
scientific study of malaria. However, perhaps less appreciated is the remarkable biology 
of Plasmodium  spp., the causative agents of the disease, and the intricate series of 
interactions they make with human host and mosquito vector.
1.1.2. Plasmodium spp., the aetiological agents of malaria.
1.1.2.1. Discovery o f Plasmodium spp.
Periodic fevers resembling malaria have been known since ancient times.3 Scientific 
work to identify the aetiological agent began in earnest after Pasteur (1822-1895) 
showed that microorganisms could cause disease. In 1879, Klebs (1834-1913) and 
Tommasi-Crudeli (1834-1900) attributed malaria to a soil bacterium named “Bacillus 
m a la r ia e However, the true agent is eukaryotic, Plasmodium spp. (Apicomplexa: 
Haemosporida), and was discovered in 1880 by Laveran (1845-1922) in the blood of a 
French Legionnaire serving in Algeria.5
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1.1.2.2. Taxonomy o f  Plasmodium spp.
Plasmodium spp. are members of a large (> 5000 spp.) phylum of unicellular eukaryotic 
microorganisms known as the Apicomplexa. DNA sequence analysis reveals the 
phylum to be an ancient lineage, falling among the chromalveolates. In a recent 
classification, Cavalier-Smith6 demotes Apicomplexa to a subphylum of Miozoa, 
closely allied to Protalveolata and Dinozoa. The defining feature of the Apicomplexa is 
recognisable only in certain life cycle stages and at the cell ultrastructural level. This is 
the apical complex, composed of structures called polar rings, micronemes, rhoptries 
and (dependent upon species) a conoid and dense granules.7 These structures are 
implicated in cell invasion (section 1.1.2.5). All members of the phylum are parasitic; 
several are important human and veterinary pathogens. Human malaria is attributed to 
one of four species of Plasmodium. P. falciparum  is the most common cause of 
morbidity and mortality. In the following review, I will concentrate on this species.
1.1.2.3. Evolutionary history o f P. falciparum.
DNA sequence analysis has facilitated investigation of the evolutionary history of P. 
falciparum. For example, comparison of 18S small subunit rRNA sequences from 11 
Plasmodium spp. suggested that P. falciparum is most closely related to P. reichenowi, 
a parasite of the chimpanzee, Pan troglodytes (Primates: Hominidae); divergence 
apparently occurred ~ 6-10 million years (y) ago (Ma) (coincident with the divergence 
of the hominid hosts).8 Several hypotheses are in currency over the chronology of 
subsequent evolution of P. falciparum? One hypothesis (“Malaria’s Eve”) insists on a 
recent emergence from a population bottleneck ~ 5000 y ago; alongside the invention of 
agriculture and the rise of anthropophilic mosquito vectors.10 An alternative hypothesis
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postulates greater antiquity, contemporaneous with hominid population expansion from 
Africa; specifically, that extant P. falciparum arose ca. 100-180 thousand y ago.11
1.1.2.4. Cell ultrastructure o f P. falciparum.
Clues to understanding the biology of P. falciparum have been gained by observation of 
parasites under the electron microscope (EM). The following brief discussion of cell 
morphology will focus exclusively on the erythrocytic stages of the parasite, as 
observed by Bannister, et al.12 With regard to size, single merozoites are ca. 1.6 x 1.0 
pm. Salient ultrastructural features common to all erythrocytic stages include: a 
nucleus; plastid organelle and mitochondrion (one of each per cell); an apical complex; 
microtubules; and, possibly, a Golgi apparatus. Given that the cell passes through a 
complex series of differentiations (sections 1.1.2.5 and 1.1.3.3), prominence of the 
various components varies through the lifecycle. For example, the apical complex is 
particularly important in the merozoite, an invasive stage of the parasite. Conversely, 
trophozoites and schizonts contain a pigment vacuole for sequestration of haemozoin 
derived from host haemoglobin.
1.1.2.5. Malaria in the human host.
In humans, P. falciparum undergoes cell division in two sites, namely, the liver and the 
red blood cells (RBCs) (Fig. 1.1). In the following section, the events in the human host 
are briefly described, principally based on recent accounts given by Frevert;15 and 
Bannister and Mitchell.16
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FIGURE 1.1.
LIFE CYCLE OF PLASMODIUM FALCIPARUM .
P. falciparum undergoes a complex series of differentiations in the human and mosquito 
hosts. Following inoculation of the human by an infective mosquito bite, sporozoites 
invade liver cells and undergo exo-erythrocytic schizogony (1-4). Escape from the liver 
is followed by invasion of red blood cells, allowing erythrocytic schizogony (5-11); 
Transmission forms known as microgametocytes (12-15) and macrogametocytes (lb- 
19) also develop in the blood. Ingestion by the mosquito triggers differentiation of these 
transmission stages: microgametocytes become microgametes (20) that fertilise the 
macrogamete (derived from the macrogametocyte) (21). Formation of motile stages 
known as ookinetes allows migration through the mosquito midgut wall (22). 
Encystment follows, giving oocysts (23). Rapid sporogony (24-25) leads to release of 
sporozoites (26) that migrate through the haemocoele and invade the salivary glands 
ready for inoculation. Drawing adapted from Fig. 4-1, p. 91 of Markell, eta l.13© 1999, 
W.B. Saunders Company. Inset. Early illustration of Cinchona spp. (Rubiacae), the 
botanical source of the antimalarial drug (-)-quinine, from Jonston (1662) 
Dendrographias. Drawing from Plate 1 of Honigsbaum.14 © 2001, Mark Honigsbaum.
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Hepatic parenchymal ce lls
It is important to realise that little is know about the activity of P. falciparum  as it 
moves towards, invades, and divides within, the human liver, owing to the difficulty of 
obtaining samples; instead, most data come from rodent and simian models. 
Conversely, P. falciparum erythrocytic stages are thoroughly studied, given facile 
maintenance in vitro.11 Biological justification for this emphasis lies with the finding 
that 60 % of the P. falciparum genome is transcriptionally active in RBCs.18 Cyclical 
infection of RBCs is also responsible for the clinical disease (section 1.1.2.6).
Infection begins when invasive forms of the parasite (sporozoites) are introduced 
subcutaneously as the mosquito vector takes a blood meal (< 25 sporozoites per 
probe19). Within ca. 30 min, sporozoites have entered the liver sinusoids. In patients 
with partial immunity, acquired by living in a region of endemic malaria, this process is 
hampered by immune attack. Invasion of hepatic macrophages (Kupffer cells) occurs, 
mediated by proteins on the surface of the parasite, e.g., P. falciparum circumsporozoite 
protein (PfCSP; PlasmoDB* PFC0210c). Sporozoites thus migrate through the Kupffer 
cells and enter the space of Disse. Restless migration through a series of hepatocytes 
ensues, until the parasite finally stops in a given hepatocyte. Rapid asexual division 
(exo-erythrocytic schizogony; EES) commences within a parasitophorous vacuole, 
producing ~ 1000 merozoites per hepatocyte. P. falciparum resides in the liver for ca. 6 
d, approximately corresponding to the shortest incubation period of the disease.20
Mature merozoites escape the hepatocytes and rapidly invade erythrocytes; the invasion 
process is intricate but probably involves proteins released from the apical complex of 
the parasite. A second phase of cellular division (erythrocytic schizogony; ES) occurs, 
again within a parasitophorous vacuole. Plasmodium spp. express a large repertoire of
* The Plasmodium Genome Resource (http://plasmodb.org/)
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variant surface antigens that are inserted into the RBC membrane; these can be 
recognised by the host immune system.
Parasites undergoing ES are classified morphologically as ring, trophozoite (feeding 
forms) or schizont (dividing form). Schizont rupture releases merozoites that invade 
fresh erythrocytes. In P. falciparum , ES is synchronised and typically lasts ca. 48 h, 
producing ca. 16 merozoites per schizont. Cycles of division and invasion proceed until 
the infection is: cleared by chemotherapy (section 1.1.2.7); controlled by the immune 
system; or the patient dies. A proportion ( «  10 %) of parasites differentiate into 
extracellular transmission stages (gametocytes) that are arrested in G0 of the cell cycle 
and metabolically dormant. P. falciparum gametocytes are observed in peripheral blood 
within 7-15 d of the initial wave of asexual parasitaemia; circulation for long periods 
(t1/2= 2.4 d) prolongs the window of infectivity to mosquitoes.21
1.1.2.6. Clinical features o f malaria.
Important clinical features of malaria have been reviewed by Miller, et al.22 RBC lysis 
associated with schizont rupture typically manifests itself in paroxysms of fever. 
However, P. falciparum  malaria can progress to a severe form, characterised by 
neurological and haematological sequelae. In endemic regions, severe malaria afflicts 
individuals lacking immunity, mainly children, and carries a case fatality rate of 10-20 
%. A further complication may arise in pregnancy, whereby sequestration of parasitized 
RBCs in the placental circulation leads to foetal ischaemia. Vital to controlling these 
symptoms is the rapid knockdown of parasitaemia with antimalarial drugs (section 
1.1.2.7).23
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1.1.2.7. Control o f malaria by antimalarial chemotherapy.
Synthetic analogues based on alkaloids of vascular plants comprise the bulk of the 
antimalarial pharmacopoeia.24 Notably, the sesquiterpene lactones and the quinolines. 
Antimalarial use of sesquiterpene lactones can be traced to a Chinese herbal medicine 
(qinghao) recommended for the treatment of fever by the alchemist Ge Hong (AD 281- 
340).25 Analysis of Artemisia annua (Asteraceae) disclosed the active principle to be 
artemisinin, a sesquiterpene 1,2,4-trioxane lactone. Parasiticidal action against 
Plasmodium  spp. may require activation of the drug by Fe2+; and interaction with 
specific cellular targets, e.g., a Ca2+-dependent ATPase (PfATP6; PlasmoDB 
PFA0310C).26 Quinolines, which may interfere with vesicle trafficking by binding to 
phospholipids,27 were also identified from a botanical source. According to frescoes in 
the Santo Spirito Hospital (Rome, Italy), as early as 1638 the Countess of Chinchon, 
wife of the Viceroy of Lima (Peru), was cured of fever using an Indian febrifuge called 
quinquina (“bark of barks”).14 Bark of Cinchona spp. (Rubiaceae) indeed contains 
several alkaloids with antimalarial activity, most notably (-)-quinine, a quinoline-4- 
methanol.
1.1.3. Anopheles spp., the mosquito vectors of malaria.
1.1.3.1. Discovery o f the mosquito vector.
Human malaria is exclusively transmitted by mosquitoes of the genus Anopheles 
(Diptera: Culicidae). Long suspected, notably by Manson (1844-1922) and Bignami 
(1862-1929), the role of the mosquito was conclusively demonstrated over a century 
ago.28 In 1898, Manson’s pupil, Ross (1857-1932), reported the transmission of bird 
malaria by culicine mosquitoes.29 It fell to Bignami, Bastianelli (1862-1959) and Grassi
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(1854-1925) to prove that anophelines were the vectors of human malaria.30 It did not 
escape the notice of these pioneers that their discoveries immediately suggested a way 
to control the disease (section 1.1.3.4).
1.13.2. Natural history o f Anopheles spp.
The anopheline vector system is complex and poorly understood. In sub-Saharan 
Africa, four groups probably make the largest contribution to disease transmission, 
namely, A. funestusy A. gambiae, A. moucheti and A. nili.31 Mosquitoes need water in 
which to breed. Development of offspring is holometabolous and results in sexually 
mature adults within ca. 14 d. Both sexes feed on plant nectar, but only females are 
haematophagous (and thus, transmissive of malaria) as ovulation requires ingestion of 
blood.32
1.1.3.3. Malaria in the mosquito host.
The connection between malaria and the mosquito vector is extremely intimate and 
highly specific (Fig. l.l) .33 Parasite development in the mosquito completes in ca. 14 d 
and begins with the ingestion of a small volume (1-2 pL) of blood containing a highly 
variable number of gametocytes (1-105). The mosquito midgut is the site of sexual 
recombination of malaria, which occurs after gametogenesis within 30-60 min of 
ingestion. Post fertilisation, motile ookinetes (5-6 per mosquito) migrate through the 
midgut epithelium and encyst under the basal lamina, forming oocysts (ca. 2 per 
mosquito). Notably at this stage, mosquitoes are able to mount an immune response 
against the parasite.34 Extensive cell division in oocysts culminates in the release of
18
sporozoites (~ 8000 per oocyst), which migrate through the haemocoele to the salivary 
gland, ready for injection during a blood meal.
1.13.4. Control o f malaria by destruction o f the mosquito vector.
Malaria can be suppressed by killing the mosquito vector. Until the 1940s, attack was 
principally directed at larvae by physical destruction of breeding grounds and the use of 
larvicides, e.g., copper acetoarsenite (Paris Green). However, following the introduction 
of the organochlorine insecticide dichlorodiphenyltrichloroethane (DDT) by Muller 
(1899-1965), emphasis changed to the destruction of adult insects by house spraying.35 
Cheap personal protection measures are increasingly advocated, especially the 
avoidance of mosquito bites by sleeping under insecticide-treated bed nets.36
1.1.4. New avenues in the study and control of malaria.
Despite early successes, notably eradication in Europe,37 malaria remains robustly 
endemic in many tropical countries. With so few classes of antimalarial available, rising 
drug resistance among parasites is of major concern.38 Furthermore, insecticide 
resistance among mosquitoes has significantly reduced the efficacy of vector control.39 
Hence, new ways to combat malaria are continually being sought.
Planned interventions against malaria include novel chemotherapeutic agents;40 a 
vaccine;41 and large-scale release of transgenic mosquitoes refractory to transmission 42 
All these innovations have been included in a list of Grand Challenges in Global Health 
compiled by the Bill and Melinda Gates Foundation.43
19
While new avenues in research have been opened by sequencing the genomes of 
humans,44 P. falciparum45 and A. gambiae,46 only limited progress has been made 
towards the development of a vaccine47 and refractory mosquitoes.48 Therefore, the most 
likely chance of short-term advancement lies with the development of new antimalarial 
drugs, notably, those targeting proteases, transporters, membrane biosynthesis, cell 
cycle control, the mitochondrion and the plastid organelle.49 In order to develop drugs to 
exploit these targets, a greater understanding of basic parasite biology is required. The 
remainder of this chapter focuses on the plastid organelle (section 1.2) and a process 
newly associated with it, namely, iron-sulphur cluster assembly (section 1.3).
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1.2. THE PLASTID ORGANELLE OF MALARIA.
1.2.1. Biology of the plastid organelle.
1.2.1.1. Discovery o f the plastid organelle.
Four decades ago the plastid organelle of Eimeria spp. was observed by electron 
microscopy.50 Subsequently, partitioning of P. knowlesi plastid DNA in a caesium 
chloride gradient was reported.51 However, the significance of these observations was 
overlooked, and plastid features attributed to the mitochondrion, until the 1990s, when 
the existence of a distinct plastid organelle was deduced by Wilson (review of early data 
by Wilson, et al.52). Sequencing of the plastid genome of P. falciparum added support to 
this deduction,53 while a connection was made to a specific intracellular compartment 
using in situ hybridisation techniques in Toxoplasma gondii (Apicomplexa: Coccidia)54 
and P. falciparum.55 Plastids are found in many Apicomplexan taxa besides 
Plasmodium spp. and T. gondii, notably, Theileria parva (Piroplasmida)* and Eimeria 
tenella (Haemosporida).56 However, plastids are absent from a distantly-related 
Apicomplexan, Cryptosporidium parvum 51 Thus, besides the medical oddity of 
Prototheca spp. (Chlorellaceae),58 Apicomplexan parasites are the only known group of 
plastid-bearing organisms to cause infectious human disease.
1.2.1.2. Ultrastructure o f the plastid organelle.
Hopkins, et al.59 used EM to examine plastid morphology in the erythrocytic stages of 
P. falciparum (Fig. 1.2).
* Gardner, M.J., et al. (2005), Science., in press.
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FIGURE 1.2.
PLASTID ORGANELLE OF PLASMODIUM FALCIPARUM .
Drawing adapted from Fig. 9, p. 288 of Hopkins, et al.59 © 1999, Urban & Fischer 
Verlag.
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It was shown that each cell possessed a single plastid organelle of tubular shape. 
Organelle size was variable dependent on the developmental stage. For example, plastid 
dimensions in the merozoite were ca. 0.5 x 0.15 pim; equivalent measurements in the 
trophozoite were ca. 1.6 x 0.35 ptm. Three bounding membranes were observed; 
although this number is controversial (discussed in chapter 3). Equally controversial 
was the observation of membrane invaginations, producing distinct complexes 
protruding into the lumen and inter-membrane spaces. Granular patches (diameter = 12 
nm) linked by filaments (diameter = 4 nm) were seen in the plastid lumen. On the basis 
of size, one speculation was that the granules were 70S ribosomes while the filaments 
were DNA. It is worth noting the absence of thylakoids. In all erythrocytic stages, the 
plastid was juxtaposed to the mitochondrion. Contacts with the nuclear membrane, 
pigment vacuole, endoplasmic reticulum and microtubules were also noted. Taken 
together, these data hint at metabolic interchange between the plastid and other cell 
components.
1.2.1.3. Genome o f the plastid organelle.
The plastid organelle of P. falciparum contains a circular genome of 35 kilobases (kb) 
Copy number is uncertain: Southern blotting in P. falciparum suggested one copy per 
plastid; while observations in T. gondii found wide variation (recently reviewed by 
Waller and McFadden60). The plastid genome of P. falciparum encodes: 25 tRNAs; 16S 
and 23S rRNA; three RNA polymerase genes; 17 ribosomal proteins; a translational 
elongation factor (PfEFTu; GenBank* CAA64593.1); a chaperone protein (PfClpC; 
GenBank CAA64596.1); and a member of the sulphur mobilisation (SUF) system 
(PfSufB; GenBank CAA64569.1 ).53
* GenBank (http://www.ncbi.nlm.nih.gov)
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Additionally, there were seven short open reading frames (ORFs) of unknown function. 
Similar arrangements and genes were found on the plastid genomes of T. gondii54 and E. 
tenella.56
1.2.2. Evolution of the plastid organelle.
1.2.2.1. Evolutionary history o f the plastid organelle.
The Apicomplexan plastid shares a common ancestry with plant and algal plastids. 
However, delineating its true phylogenetic placement has proved difficult, due to the 
lack of photosynthetic marker genes, e.g., pigments. However, Apicomplexans likely 
share ancestry with dinoflagellates.61,62 It is thus assumed that Apicomplexan plastids 
arose by secondary endosymbiosis.
In this context, it is useful to briefly summarise the proposed evolutionary history of the 
Apicomplexan plastid organelle. All plastid-bearing organisms probably originated by 
primary endosymbiosis, most likely of a cyanobacterium ca. 1500 Ma.63 Divergence 
into three lineages followed: (1) red algae; (2) green algae and vascular plants; and (3) 
chromists.64 Based on sequence analysis constrained by fossil evidence, divergence of 
red and green lineages is estimated to have occurred ca. 1340 Ma.65 A second 
endosymbiotic event followed, leading to extant Miozoa (section 1.1.2.2).
In the Apicomplexa, it is uncertain whether secondary endosymbiosis was from the red 
or green lineage (reviewed by Funes, et al.66). Hints of red ancestry are found in the 
super-operon structure of the ribosomal proteins encoded on the plastid genome;67 and
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the sequences of plastid-targeted glyceraldeyhde-3-phosphate dehydrogenase (GAPDH) 
genes.62 Recently it was shown that T. gondii amylopectin resembled the starch 
accumulated by red algae.68 Conversely, the plastid EF-Tu sequence54 and the nuclear 
location and structure of genes encoding subunit II of cytochrome c oxidase (COXII)69 
argue for a green lineage. However, it is worth noting that the validity of the COXII 
evidence has been challenged.70 Recent analysis of the RNA polymerase genes encoded 
by the plastid genome of E. tenella also points to a green ancestry.56
/.2.2.2. Transposition o f genes.
Cursory examination of the size of plastid genomes of extant eukaryotes, as compared 
to extant cyanobacteria, suggests that genes have been transposed. This is readily 
apparent for the plastid genome of P. falciparum (35 kb) as compared to the genome of, 
e.g., the cyanobacterium Synechocystis sp. PCC 6803 (3.57 Mb). Thus, concomitant 
with endosymbiosis, there must have been a significant transposition of DNA. 
Overwhelmingly, this would have been from endosymbiont genome to nuclear genome, 
given the minimal genome of extant plastids. Additionally, sequence analysis has been 
used to postulate a transfer of ribosomal protein genes from the mitochondrion to the 
plastid.71 Lateral gene transfer from bacteria has also been postulated.72
Gauging the tempo of such genetic transpositions is difficult as rates probably vary. For 
example, the rates of chloroplast to nuclear gene transfer have been assessed in 
N ico tiana  tabacum  (Solanaceae) and C hlam ydom onas re in h a rd tii  
(Chlamydomonadaceae) by tracking a reporter gene transfected into the chloroplast 
genome. In N. tabacum, transfer rates were high. Huang, et al.73 detected one 
transposition event per 1.6 x 104 male gametes; using a different method, Stegemann, et
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a/.74 detected one transposition event per 5 x 106 vegetative cells. Conversely, no 
transfer was detected in C. reinhardtii.15
1.2.3. Protein trafficking to the plastid.
Products of genes that now reside in the nucleus are imported back to the plastid where 
they act. Hence, the key to understanding the function of the plastid lies with identifying 
which gene products are trafficked to the plastid. Proteins are probably targeted to the 
plastid by an N-terminal bipartite leader sequence.76 The length and amino acid 
composition of the plastid-targeting signal appears poorly conserved. Furthermore, one 
plastid-targeting signal can be shared by two different genes, as exemplified by stromal 
processing peptidase (PfSPP; GenBank AF453250) and porphobilinogen synthase 
(PfPBGS; PlasmoDB PF14_0381).77 These factors make plastid-targeted proteins 
difficult to identify by conventional genome mining. Nevertheless, attempts have been 
made using in silico methods.78,79 Such genome mining suggests that 545 nuclear- 
encoded proteins are imported to the plastid in P. fa lc ip a r u m Plastid trafficking is 
discussed in chapter 3.
1.2.4. Activity of the plastid organelle through the lifecycle.
1.2.4.1. Morphology o f the plastid organelle through the lifecycle.
The morphology of the plastid organelle during ES has been extensively studied by 
light microscopy of P. falciparum transfected with plastid-targeted fluorescent markers, 
e.g., green fluorescent protein (GFP) (Sato and Wilson, NIMR, London, UK, 
unpublished observations). By these methods, it was shown that the plastid elongated
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into a branched form during the trophozoite phase. This shape persisted through 2-3 
nuclear divisions into the late schizont phase, when plastid segregation occurred. One 
plastid was faithfully bequeathed to each daughter cell.
In order to understand the basis of late segregation of the plastid, Striepen, et al.81 
studied plastid division in T. gondii, which benefits from unambiguous cell 
morphology. By this means, it was shown that the plastid organelle was connected to 
the nucleus, possibly via association with centrosomes. Consequently, it was suggested 
that the mitotic spindle and pellicle of the parent cell generated the forces necessary for 
division of the plastid. Plastid division factors, e.g., FtsZ and Min, have not been 
identified in the P. falciparum genome; hence, the molecular basis of division remains 
obscure. Also obscure is the morphology of the plastid in the EES and mosquito stages 
of the parasite. In this context, it is worth noting legacy EM observations of 
membranous structures in P. falciparum  oocysts that are reminiscent of plastid 
organelles.82
1.2.4.2. Metabolic activity o f the plastid organelle through the lifecycle.
Transcriptomic and proteomic studies offer a picture of plastid activity throughout the 
lifecycle of the parasite. Examination of these datasets provides a convenient, if rough, 
indication of plastid activity.* Erythrocytic stages of the parasite have been the most 
extensively studied. For example, Bozdech, et al.18 showed that nuclear genes encoding 
plastid-associated proteins were expressed in all erythrocytic stages; while genes 
encoded on the plastid genome were upregulated in schizonts (33-36 h), coincident with
* Published transcriptomic and proteomic data were interrogated using the DGET 
function in Microsoft Excel. Interrogation was done using the PlasmoDB codes for the 
545 putative plastid-targeted P. falciparum proteins generated by Ralph, et al.80
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cell division. Le Roch, et al.® additionally demonstrated transcriptional activity of 
plastid-associated genes in the merozoite and sporozoite stages; activity was even 
observed in the metabolically dormant gametocyte stage. It is also worth noting that a 
microarray study of P. falciparum erythrocytic stages isolated from the venous blood of 
five malaria patients suggested that the plastid was active.84
Given the discrepancy between levels of mRNA and protein in P. falciparum ,85 it is 
vital to note additional evidence of plastid activity from proteomic studies. Analysis by 
multidimensional protein identification technology (MudPIT) of the erythrocytic stages 
of P. falciparum revealed a large number (234) of putative plastid-targeted proteins.86 
These data were confirmed by another proteomic study that also detected plastid- 
targeted proteins in gametocytes.87
Information on the activity of the plastid in EES and mosquito stages of the parasite is 
lacking. However, inferences can be drawn. For example, Wang, et al.M conducted an 
expressed sequence tag (EST) analysis of axenic pre-erythrocytic stages of P. yoelii and 
showed transcription of plastid-associated genes. Hints of plastid activity in gametes 
were provided by a mass spectroscopic study in P. falciparumf7 Additional evidence 
for plastid activity in the ookinete, oocyst and salivary gland sporozoite stages was 
provided by MudPIT of P. berghei passaged through A. stephensi mosquitoes.89 Taken 
together, these data suggest that the plastid is active throughout the malaria lifecycle.
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1.2.5. Metabolic activities of the plastid organelle.
1.2.5.1. Functional analysis o f the plastid by genome mining.
There is no genomic, transcriptomic, proteomic, structural or biochemical evidence for 
photosynthesis in the Apicomplexan plastid; hardly surprising, given the tenebrous 
lifecycle of P. falciparum and related organisms (Drs. B. Clough and R. J. M. Wilson, 
N1MR, pers. comm.). Therefore, intense efforts are being made to find other metabolic 
roles for the plastid organelle. One major block to progress has been the inability to 
fractionate Apicomplexan plastids, thus preventing biochemical and proteomic analysis. 
Hence, the only applicable method has been genome mining. Constrained by knowledge 
of heterotrophic plastids of vascular plants,90 this entails the assembly of metabolic 
pathways in silico by reference to the plastid genome, and the set of 545 putative 
plastid-targeted proteins encoded by the nuclear genome. Such analysis has given some 
insights, but very few of the predictions have experimental support. I have structured 
this section principally according to the exhaustive in silico paper by Ralph, et al-80
1.2.5.2. Information processing.
One major activity of the plastid is the replication of the plastid genome.91 Sequencing 
of the genes encoded by the plastid genome additionally suggested the plastid to be a 
minor site of transcription and translation.53 Indeed, active transcription has been 
demonstrated.18 Evidence for protein synthesis in the plastid has also been found.92,93
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1.2.5.3. Energy, carbon and reducing power.
For anabolic biosynthesis to occur, energy, carbon and reducing power are required. 
Remarkably, mechanisms of energy generation remain obscure in the malaria plastid. 
Carbon acquisition pathways are modelled by reference to the heterotrophic plastids of 
vascular plants. In such plastids, Calvin cycle chemistry is not available and so carbon 
may be obtained by metabolism of precursors imported from the cytosol.94 Appropriate 
transporters and enzymes for this process are apparently present in the nuclear genome 
of P. falciparum  and are predicted to target the plastid organelle.80 Reducing power 
could be supplied by ferredoxin (PfFDX; PlasmoDB MAL13P1.95), recycled by the 
action of ferredoxin NADP* reductase (PfFNR; PlasmoDB MAL6P1.197); both 
proteins have been shown to target the plastid in T. gondii?5
1.2.5.4. Fatty acid biosynthesis.
Fatty acid biosynthesis was indicated by acetate incorporation in P. falciparum.96 
Indeed, the complete pathway of type II fatty acid biosynthesis can be reconstituted in 
silico; enzymes of the pathway are predicted to target the plastid. These data have been 
strongly supported by targeting experiments. Notably, the plastid was targeted by acyl 
carrier protein (PfACP; PlasmoDB PFB0385W);97 acetyl-CoA carboxylase 
(PfACCase);98 and the pyruvate dehydrogenase complex (PfPDHC).99 It is known that 
activation of PfPDHC requires lipoylation. Critically, a lipoic acid synthesis system was 
also localised to the plastid in P. falciparum1™ and T. gondii.101 Evidence for the 
pathway also comes from the use of inhibitors. For example, it was noted that 
graminaceous weeds infesting broadleaf crops are selectively killed with 
aryloxyphenoxypropionic herbicides, via non-competitive inhibition of ACCase.102 As
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Apicomplexan ACCase shares features with susceptible plant enzymes, it was 
unsurprising that such herbicides were inhibitory to the growth of P. falciparum and T. 
gondii.98'103
1.2.5.5. Isoprenoid biosynthesis.
Isoprenoid synthesis in P. falciparum was recently demonstrated.104 Genome mining 
indicates the pathway to be of type II (mevalonate independent), as found in bacteria 
and the chloroplasts of vascular plants.105,106 Furthermore, it is predicted to be plastid- 
targeted.80 Indeed, there is some evidence for plastid targeting, notably, the plastid 
localisation of 1 -deoxy-D-xylulose 5-phosphate reductoisomerase (PfDXR; PlasmoDB 
PF14_0641) in T. gondiim  and 4-diphosphocytidyl-2C-methyl-D-erythritol kinase 
(PflspE; PlasmoDB PFE0150c) in P. falciparum.1™
1.2.5.6. Haem biosynthesis.
Most of the enzymes of haem biosynthesis can be identified in the P. falciparum 
nuclear genome.80 However, it appears that steps of the pathway are shared between 
mitochondrion, plastid and cytosol; an unprecedented division of labour. Critical 
enzymes of the pathway have been shown to target the plastid, notably PfPBGS,109 
hydroxymethylbilane synthase (PfHMBS; PlasmoDB PFL0480w)109 and ferrochelatase 
(PfFC; PlasmoDB MALI3P1.326).110 Additionally, complementation experiments in E. 
coli strongly suggest that PfPBGS111 and PfFC112 are enzymatically active.
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1.2.6. Exploitation of the plastid organelle as a drug target
1.2.6.1. The plastid organelle is essential and is susceptible to drug attack.
A working plastid is essential for the survival of Apicomplexan organisms and therefore 
constitutes a potential drug target.113 Given the similarity between bacterial and plastid 
pathways, many existing antibiotics inhibit the plastid and are active against malaria.114 
For example, clindamycin, macrolides, chloramphenicol and doxycycline most likely 
attack the ribosomal subunits of the plastid organelle.115 Doxycycline is indicated for 
antimalarial chemoprophylaxis.116 The remainder of this section describes two cases 
where novel antimalarial drugs have been identified rationally from an understanding of 
plastid metabolism.
1.2.6.2. Attack on type II fatty acid biosynthesis.
Type 11 fatty acid biosynthesis constitutes an important potential target for antimalarial 
action as it is absent from the human host.117 Greatest success has been achieved against 
enoyl ACP reductase (PfENR; PlasmoDB PFF0730c). This is due to the availability of 
an inhibitor, triclosan, patented as a biocide by Ciba-Geigy in 1966.118 Triclosan was 
recently shown to be parasiticidal to P. falciparum erythrocytic stages in vitro (IC^ = 
0.7 pM).96'119 Triclosan is also parasiticidal to T. gondii;120 confirmation of action in the 
T. gondii plastid was achieved by attachment of the drug to a rhodamine-conjugated 
octo-arginine oligomer, thus allowing localisation in live T. gondii.121 In P. berghei- 
infected rodents, a single bolus of triclosan (38 mg.kg!) achieved radical cure of 
malaria.96
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1.2.6.3. Attack on type II isoprenoid biosynthesis.
Absence from the human host makes type II isoprenoid biosynthesis another compelling 
target for drug design.122 To my knowledge, this is the only target exploited in the 
clinical setting on the basis of rational knowledge of the plastid. Indeed, there has been 
marked success against PfDXR using fosmidomycin, a phosphonic acid antibiotic 
isolated from Streptomyces lavendulae.123 It has antimalarial properties in vitro and in 
animal models.107 Furthermore, clinical evaluation in Gabon124125 and Thailand125 
indicated the value of the drug for treating P. falciparum infection. The drug was of 
greatest clinical value in a 3:1 ratio with clindamycin.126,127 Recall that clindamycin is 
also known to target the plastid.115 These data validate the contention (section 1.1.4) that 
an understanding of basic plastid biology can rapidly lead to clinical innovation.
1.2.7. The plastid organelle as a site of iron-sulphur cluster assembly.
|Fe-S] clusters are ubiquitous and extremely versatile prosthetic groups.128 The plastid 
in malaria is likely to have a high demand for [Fe-SJ clusters. For example, ferredoxin95 
and lipoic acid synthase,101 both [Fe-S] cluster-containing proteins, target the plastid. 
Also, two of the enzymes of the type II isoprenoid biosynthesis pathway contain |Fe-S| 
clusters.129,130
Given the multiple membranes of the plastid, it is difficult to imagine how mature [Fe- 
SJ clusters could be imported. Therefore, [Fe-SJ clusters may be assembled in situ.131 In 
light of the already established involvement of the plastid in haem biosynthesis (section 
1.2.5.6), this suggests that a major role of the plastid organelle is the metabolism of
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iron. The remainder of this chapter describes the current state of knowledge of
biological (Fe-SJ cluster assembly.
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1.3. IRON-SULPHUR CLUSTERS.
1.3.1. [Fe-S] clusters in biology.
13.1.1. Discovery o f [Fe-S] clusters.
As early as 1958, studies of the mitochondrion conducted by Crane132 suggested the 
existence of a novel class of non-haem iron proteins; by 1960, Beinert and Sands133,134 
had expanded these data using electron paramagnetic resonance spectroscopy. In the 
following decade, [Fe-SJ clusters were conclusively identified in biological material 
using various spectroscopic techniques (e.g., Mossbauer), interpreted according to a 
new model of electron spin (historical review by Beinert135).
1.3.1.2. Structure and function o f [Fe-S] clusters.
|Fe-S | clusters exhibit great diversity of structure and function. As a structural 
approximation, iron is in a tetrahedral configuration with sulphur. Two of the simplest 
clusters are rhombic |2Fe-2Sl and cubane [4Fe-4S|; conversions between clusters 
readily occur. In |2Fe-2Sl clusters, the Fe-S bond measures ca. 0.22 nm and clusters 
adopt a butterfly shape. Attachment to proteins is predominantly through the thiol 
groups of cysteine residues. According to protein environment, a wide range of 
reduction potentials (+400 to -700 mV) are available; however, the majority are highly 
negative, a property exploited in redox catalysis.136 [Fe-S] clusters are also implicated in 
non-redox processes, notably, binding and activation of substrates; stabilisation of 
protein structure; and oxygen sensing.128
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1.3.1.3. Discovery of the mechanisms of biological [Fe-S] cluster assembly.
Pioneering studies of the nitrogen fixation (NIF) system of the free-living diazotrophic 
bacterium Azotobacter vinelandii conducted by Dean provided clues to the biological 
assembly of [Fe-SJ clusters. Specifically, it was demonstrated that the lMo-7Fe-9SJ 
cofactor of the nitrogenase was assembled by the action of a cysteine desulphurase 
(NifS) and a scaffold protein (NifU).137 [Fe-S] cluster assembly mechanisms have since 
been discovered in bacteria and eukaryotes. Three main systems are known, namely, 
NIF; iron-sulphur cluster assembly (ISC); and sulphur mobilisation (SUF). In bacteria, 
the three [Fe-S] cluster assembly systems are organised into operons (Table 1.1). In E. 
coli, it is worth noting the existence of a fourth cysteine desulphurase (CSD) encoded 
alongside a SufE-like protein (YgdK); these proteins might contribute to another 
pathway of [Fe-S] cluster assembly. Organisms use one or more of these systems to 
assemble [Fe-S[ clusters, as has been exhaustively reviewed.13* 142
1.3.2. Chemistry of [Fe-S] cluster assembly.
1.3.2.1. [Fe-S] cluster assembly.
The chemistry of biological [Fe-S| cluster assembly remains unclear. In particular, how 
clusters, which are exquisitely oxygen sensitive, can be assembled under aerobic 
conditions. Nevertheless, study of low molecular weight structural analogues has 
provided some clues, indicating that clusters are readily formed by reaction of Fe2+, 
sulphide and thiol in an aprotic, anaerobic solvent.143
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TABLE 1.1
IRON-SULPHUR CLUSTER ASSEMBLY SYSTEMS IN BACTERIA.
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Protein GenBank number Annotation
suf operon (Escherichia co li)
SufA P77667 Alternative Fe-S assembly scaffold
SufB P77522 Component of SufBCD complex
SufC P77499 Soluble ABC ATPase
SufD P77689 Component of SufBCD complex
SufS P77444 Cysteine desulphurase
SufE P76194 Acceptor of sulphur from SufS
isc operon (E. coli )
IscR AAC75584 Transcriptional regulator
IscS P39171 Cysteine desulphurase
IscU P77310 Fe-S assembly scaffold
IscA AAC75581 Alternative Fe-S assembly scaffold
H scA P36541 Hsp70 class chaperone
H scB F36540 DnaJ domain protein
Fdx AAG57639 Ferredoxin
nif operon {Azotobacter spp.)
Nif-IscA AAC24474 Alternative Fe-S assembly scaffold
NifU P05340 Fe-S assembly scaffold
NifS P05341 Cysteine desulphurase
NifV P05342 Homocitrate synthase
CysE/SAT P23145 Serine O-acetyltransferase
Orphans (E. coli )
CSD Q46925 Cysteine desulphurase
YdgK P76180 Acceptor of sulphur from CSD?
Biological assembly may occur by a similar route but under different conditions, as 
illustrated in vitro with the [4Fe-4S]3+ cluster of the high potential iron-sulphur protein 
(HiPIP; GenBank IHKREV) of Alloc hr omatium vinosum.144 Such clusters can be 
assembled on isolated apoprotein (HiPIPapo) by mixing with Fe2+ and sulphide in a 
reducing environment. Mass spectroscopic and enzymatic data suggest that HiPIPapo is 
first metalled then sulphured (Eq. 1.1).
HiPIPapo— *HiPIP[4Fe]— »HiPIP[4Fe -  4S]3* (Eq , ^
1.3.2.2. [Fe-S] cluster repair.
[Fe-S] clusters are sensitive to damage. Therefore, it is useful to consider mechanisms 
of repair. Two repair chemistries may exist, reflecting the two types of damage that 
occur, namely, loss of Fe and loss of S.
It is worth noting that (Fe-SJ clusters in different coordination environments of proteins 
exhibit markedly different susceptibilities to damage. For example, (4Fe-4S]2+ clusters 
in dehydratases may be especially susceptible to oxidative damage because only three 
Fe atoms are coordinated by protein cysteine residues; leaving one Fe atom vulnerable 
to oxidative attack and disassociation. This scenario is classically exemplified by 
ammonium persulphate action on the |4Fe-4S]2+ cluster of cardiac mitochondrial 
aconitase (EC 4.2.1.3) of Bos taurus (Artiodactyla: Bovidae).145 Oxidation was shown to 
destabilise the cluster, leading to the rapid (15-20 min) loss of one Fe atom forming a 
somewhat stable [3Fe-4SJ1+ cluster; however, if oxidative conditions were prolonged (~ 
h), the cluster disintegrated completely.
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Chemistry described in section 1.3.2.1 would be critical for the regeneration of 
completely disintegrated clusters. However, in vivo, it is difficult to envisage a situation 
where damage would be allowed to proceed unabated without [Fe-S] cluster repair. 
Hence, in vivo, oxidative attack would generate damaged clusters that the cell would 
immediately re-metal. A hypothetical scheme offered by Djaman, et al.146 suggests that 
re-metalling may be achieved by reduction (Eq. 1.2) followed by insertion of iron (Eq. 
1.3).
[3Fe -  4S]“  +e — [3Fe -  4S]°
[3Fe -  4S]° + Fe2* — [4Fe -  4S]2*
(Eq. 1.2)
(Eq. 1.3)
Parsimony dictates that such a mechanism would require only two catalytic participants, 
namely, an electron donor, and an iron donor. Actually, oxidatively damaged clusters of 
the aconitase could be re-metalled in vitro by mixing with dithiothreitol (DTT) under 
anaerobic conditions; Fe2+ was supplied endogenously by pilfering from a 
subpopulation of (Fe-SJ clusters.145 Hence, in vitro, repair is spontaneous. However, in 
E. coli, uptake of iron from the extracellular milieu and contributions from the iron 
storage proteins bacterioferritin and ferritin are implicated in the re-metalling of [3Fe- 
4S]1+ clusters.147
The second form of (Fe-SJ cluster damage, loss of sulphur, requires re-sulphuration. 
The paradigm in this case might be NO (g) attack on the [2Fe-2Sl clusters of E. coli 
ferredoxin.148 Biomimetic studies indicated that addition of NO (g) led to the reductive 
elimination of sulphur from the cluster to form a stable protein-bound dinitrosyl iron
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complex [Fe-2NO].149 Resulphuration in vitro was achieved by addition of L-cysteine 
and a cysteine desulphurase (E. coli IscS).150
1.3.3. Biology of [Fe-S] cluster assembly.
1.3.3.1. Biological distinction between [Fe-S] cluster assembly and repair.
Chemical distinction between cluster assembly and repair (section 1.3.2) assumes 
greater significance in consideration of the biology of the process. Specifically, it is 
important to distinguish between de novo cluster assembly; and cluster repair. De novo 
assembly, probably of basic subunits, i.e., [2Fe-2S] and [4Fe-4S], is assumed to occur 
on a “professional” scaffold protein.151 Subsequently, pre-assembled [Fe-S] clusters may 
be passed downstream to target proteins where they can be processed into more 
complex clusters. Conversely, repair may be affected in situ on the target protein, 
without the involvement of a scaffold.146 Hence, de novo cluster assembly requires a 
large repertoire of proteins; while for repair, only a subset of the repertoire is needed.
1.3.3.2. Minimum protein components for [Fe-S] cluster assembly.
What constitutes the complete repertoire of proteins for [ Fe-S ] cluster assembly is 
inadequately described, but is likely to be extremely complex, involving many proteins 
and chaperones.152 Chemical evidence (section 1.3.2.1) implies that de novo assembly 
centres on a three-way interaction between a scaffold protein, an iron donor and a 
sulphur donor (in a reducing environment); for cluster repair, the scaffold may be 
omitted. In all cases, energy must also be required.153 Considerable information about
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the process has been derived from the study of the ISC systems of E. coli and 
Saccharomyces cerevisiae (Ascomycota).
1.3.3.3. Scaffold proteins.
De novo assembly probably requires a scaffold protein to physically support the 
formation of |Fe-Sl clusters prior to transfer to the target protein. Indeed, as the scaffold 
must probably interact with numerous different downstream targets, it seems reasonable 
a priori to assume the existence of scaffold proteins bearing different interaction 
specificities. However, only two types of scaffold protein (A and U) are known. 
Examples of type A scaffolds include Nif-IscA, IscA and SufA; while examples of type 
U scaffolds include NifU and IscU. IscA and IscU exhibit structural similarities.154'156
1.3.3.4. Iron donors.
An iron donor must be involved, given the cellular toxicity of free iron. Specifically, 
Fe2+ contributes to oxidative stress via Fenton chemistry (Eq. 1.4).157
Fe2+ + H20 2 — Fe3+ + HO* + HO* (Eq j 4)
A yeast protein called frataxin (YFH1) is essential for [Fe-S] cluster formation in 
isolated yeast mitochondria.153 This has lead to the suggestion that frataxin is the iron 
donor for [Fe-S] cluster assembly in the ISC system. Studies on human frataxin 
revealed that one protein equivalent could retain 6-8 Fe2+ and was able to bind human 
IscU.158 Indeed, frataxin was directly implicated in the re-metalling of oxidatively
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damaged [4Fe-4S]2+ clusters of aconitase.159 Additional iron donors associated with the 
NIF and SUF systems are unknown.
1.3.3.5. Sulphur donors.
The sulphur donor is an enzyme with cysteine desulphurase activity.160 Such enzymes 
catalyse the oxidation of cysteine to sulphur and alanine. The free L-cysteine 
concentration of the cytosol in aerobically grown E. coli was estimated to be ~ 0.2 
mM;161 an adequate substrate reserve. Four important enzymes showing cysteine 
desulphurase activity are: NifS,162 IscS,163 CSD164 and SufS.165,166 It is worth noting that 
besides (Fe-S] cluster assembly, these enzymes may take part in other cellular 
processes. For example, IscS could contribute sulphur to thiolated tRNAs167 and thiazole 
synthesis;168,169 while cysteine desulphurases could be involved in selenium metabolism 
owing to their deselenating action.170
1.3.4. Trend of specialisation among [Fe-S] cluster assembly systems.
1.3.4.1. Copy number o f [Fe-S] cluster assembly systems.
The existence of three different systems of (Fe-S 1 cluster assembly that nevertheless 
share common features (section 1.3.1.3) suggests divergence of function. To consider 
this further, it is useful to compare organisms possessing one [Fe-S] cluster assembly 
system with those organisms possessing two or more [Fe-SJ cluster assembly systems.
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1.3.4.2. One [Fe-S] cluster assembly system.
Numerous species possess only one system of [Fe-S] cluster assembly. Bacterial 
examples include Mycobacterium tuberculosis and Thermatoga maritima (SUF); and 
Heliobacter pylori (NIF).* Eukaryote taxa lacking a plastid also possess only one [Fe- 
SJ cluster assembly system; well-characterised examples include S. cerevisiae and 
humans, both exclusively reliant upon the ISC system.141 Presumably, in these 
organisms, the solo system is required to fulfil the entire cellular demand for IFe-S] 
clusters. In support of this conclusion, it should be pointed out that the NIF system from 
the eukaryote Entamoeba histolytica (Amoebida: Entamoebidae) is functionally 
interchangeable with SUF and ISC systems, as evidenced by complementation of a 
SUF/ISC knockout (KO) strain of E. coli under anaerobic conditions.171 This contrasts 
markedly with the specialised NIF system of A. vinelandii (section 1.3.4.3).
1.3.4.3. Two or more [Fe-S] cluster assembly systems.
A more complex situation arises in organisms possessing two or more |Fe-SJ cluster 
assembly systems, as exemplified by numerous bacteria and plastid-bearing eukaryotes 
(section 1.3.4.4). For example, A. vinelandii retains both ISC and NIF systems. In this 
organism, the ISC system is presumably tasked with the constitutive supply of [ Fe-S) 
clusters (“housekeeping”) to proteins, e.g., aconitase; while the NIF system fulfils the 
specialised role of supplying clusters to the nitrogenase. It is worth noting that ISC can 
partially substitute the nitrogenase supply role in cells ablated for NIF;137 conversely, 
NIF cannot functionally compensate ISC.172 Hence, the NIF system of A. vinelandii is 
highly specialised for delivery of [Fe-S] clusters to the nitrogenase.
* Johnson, D.C., Dean, D.R., Smith, A.D. and Johnson, M.K. (2005) Annu. Rev. 
Biochem., in press.
45
In E. coli, possessing ISC and SUF systems, and possibly a third system (CSD/YgdK), 
the division of labour is more opaque. It is however clear that the systems function 
independently, e.g., E. coli IscU can only make a functional (sulphur exchange) 
interaction with IscS, not with SufS or CSD.173
Genetic and transcriptomic studies provided some clues to the division of labour in E. 
coli. For example, an ISC KO strain of E. coli was able to grow, albeit slowly, 
suggesting that SUF was able to compensate.174 Therefore, it was concluded that while 
the ISC system provided the bulk of [Fe-S] clusters, SUF supplied a limited number (at 
least sufficient for survival against an ISC KO background).
Transcriptomic study of the bacterium under oxidative stress indicated that both ISC 
and SUF systems upregulated;175 unsurprising given that oxidative stress damages fFe- 
S] clusters. However, evidence for differential function came from the finding that ISC 
and SUF responses to oxidative stress were regulated by different mechanisms. In E. 
coli, ISC genes responded to IscR (GenBank AAC75584), a |2Fe-2S]1+ cluster- 
containing transcriptional repressor that probably unblocks expression from the isc 
operon when intracellular (Fe-SJ cluster levels fall.176 Oxidative stress damages (Fe-Sl 
clusters, thereby reducing their intracellular concentration and indirectly stimulating 
ISC. Conversely, the suf operon of E. coli was directly regulated by OxyR (GenBank 
AAC76943), a transcriptional activator that responds to peroxide stress by binding to a 
promoter region 220 bp upstream (sufAp) from the transcriptional start of sufA, thus 
inducing SUF.175177
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These data immediately suggested that the ISC system fulfilled a constitutive role. 
Additionally, it is worth noting that the ISC system was capable of repairing [Fe-S] 
clusters damaged by oxidative stress.146 In contrast, the SUF system came to the fore 
during prolonged periods of oxidative stress, possibly as a backup; but was unable to 
repair oxidatively damaged clusters.146 Prolonged periods of oxidative stress (section 
1.3.2.2) are likely to saturate the capacity of repair mechanisms, thus requiring 
extensive de novo synthesis to restock the cell with [Fe-S] clusters.
Recently, Outten, et al.178 have proposed another model of ISC and SUF regulation in E. 
coli. It was suggested that oxidative stress was merely the proximate cause of induction 
of the SUF system in E. coli while the ultimate cause was iron starvation. The rationale 
given was that the intracellular labile Fe2+ pool becomes dangerous under conditions of 
oxidative stress, due to classical Fenton chemistry (Eq. 1.4). Consequently, the cell may 
take measures to lower the intracellular iron concentration, including reduction of 
uptake from the environment; and sequestration into proteins such as DNA binding 
protein from starved cells.
This scenario would create an iron-limited environment unfavourable to [Fe-S) cluster 
assembly via the ISC pathway. Hence, it was proposed that the SUF system mediates 
[Fe-S 1 cluster assembly under such conditions. While this iron limitation hypothesis 
awaits further experimental study, it fits with circumstantial evidence. For example, in 
E. chrysanthemi, SUF genes are regulated by the iron-responsive transcription factor 
Fur (GenBank A ADO 1582).179 Additionally, in bacteria lacking an obvious Fur system, 
e.g., Rhizobium leguminosarum biovar viciae,190 regulation of SUF genes by the 
rhizobial iron regulator (RirA; GenBank CAC35510) has been reported.181
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1.3.4.4. Compartmental specialisation in eukaryotes.
In plastid-bearing eukaryotes possessing two [Fe-S] cluster assembly systems per cell, 
division of labour is perhaps related less to function and more to the imperative of 
intracellular compartmentalisation. In A. thaliana, there is good evidence for the 
localisation of the SUF system in the plastid (section 1.3.6); and the ISC system in the 
mitochondrion.182,183 Iron starvation may be a problem in alkaline soils, due to the poor 
solubility of iron at high pH.184 However, low iron did not stimulate transcription of 
AtsufACDES, and even downregulated AtsufB.185
1.3.5. SUF system in bacteria.
1.3.5.1. The suf operon.
Patzer and Hantke166 coined the term sulphur mobilisation (SUF) and implicated SufS 
and SufD in the assembly of [2Fe-2Sl clusters in E. coli. Existence of a su f operon 
(sufABCDES) was subsequently shown; all but sufD were essential for viability against 
an ISC KO background.174 Indeed, with the exception of sufD, all members of the 
operon have been studied. The following discussion dissects the function of each 
protein.
1.3.52. E. coli Suf A.
Suf A of E. chrysanthemi has been studied by Ollagnier-de Choudens et a/.151,186 using 
recombinant protein probed with Mossbauer spectroscopy. At the protein sequence 
level, SufA and IscA cannot be distinguished, immediately suggesting a similar
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function. In actuality, both proteins operated by a similar mechanism. Specifically, it 
was shown that [Fe-S] clusters of [2Fe-2S]2+ and [4Fe-4S]2+ type were assembled upon 
the SufA scaffold; before transfer to a target protein, as demonstrated by the interaction 
between SufA and biotin synthase. Critical to the transfer reaction was a conserved 
group of cysteines. Structural information for E. coli SufA is presently being derived by 
NMR.187
1.3.5.3. E. coli SufB and SufC.
SufBC were shown to be essential by KO in the cyanobacterium Synechocystis sp.188 
Bacterial SufC proteins have been thoroughly examined. For example, SufC was 
implicated in the protection of [Fe-S] clusters under oxidative stress.189 Primary amino 
acid sequence of SufC predicts ATPase activity, attributable to standard ATP-binding 
cassette (ABC) features (Walker box and C motifs). Indeed, Rangachari, et al.190 
detected ATPase activity in recombinant Thermatoga maritima SufC (Km = 45 //M); a 
similar trend was obtained by Nachin, et a/.189 for E. chrysanthemi SufC (Km = 290 
piM). Interactions between SufBC189,190 and D189 were also demonstrated. Furthermore, 
in E. coli, Outten, et a /.191 reported that SufBCD was able to increase the cysteine 
desulphurase activity of SufS by a factor of 32 over isolated SufS. In Erwinia  
chrysanthemi, SufBCD fractionated with the cytosol, suggesting a cytosolic location189. 
Conversely, immunogold EM of SufBC in T. maritima unequivocally indicated a 
membrane location.190
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1.3.5.4. E. coli SufS and SufE.
SufS enzymes of two related enteric bacteria (E. coli and E. chrysanthemi) and the 
cyanobacterium Synechocystis sp. have been subjected to extensive study (chapter 4). It 
is vital to note that SufS may interact with other members of the suf operon, forming a 
multicomponent cysteine desulphurase. For example, the activity of E. chrysanthemi 
SufS against L-cysteine was enhanced 50-fold by binding to SufE;192 the equivalent 
figure for the E. coli proteins was 8-fold.191 It was subsequently shown by mass 
spectrometry of the E. chrysanthemi proteins that sulphur generated by the action of 
SufS was transferred to a conserved cysteine (C51) on SufE.193 Recent structural 
information for E. coli SufE reveals similarity to IscU.194
1.3.6. SUF system in vascular plants.*
1.3.6.1. [Fe-S] cluster assembly in the chloroplast.
Numerous proteins found in chloroplasts of vascular plants contain I Fe-S 1 clusters, 
suggesting a high demand for in situ assembly. Indeed, cluster assembly has been 
demonstrated in isolated chloroplasts of Spinacia oleracea (Chenopodiaceae).200,201 It is 
also worth noting the oxygen rich environment of a photosynthesising chloroplast,202 
hinting at the need for efficient [Fe-SJ repair.
The system is likely to be complex, but recent bioinformatic analysis by Xu and 
M0ller197 indicates that A. thaliana chloroplasts contain all the proteins of the bacterial
* Designations for SUF proteins differ between the plant and bacterial taxa. For 
example, in A. thaliana, SufA is Atlsal;195 SufB is LAF6,196 AtABCl196 or AtNAPl;185 
SufC is AtNAP7;197 SufD is AtNAP6;197 and SufS is NFS2198 or CpNifS.199 For clarity, I 
exclusively use the bacterial terminology (SufABCDS).
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SUF system. These proteins are encoded by the nuclear genome but are imported to the 
chloroplast.
1.3.6.2. A. thaliana SufA/IscA and NifU.
SufA/IscA (TAIR* locus AT 1G10500) was detected in the A. thaliana genome and 
predicted to target the chloroplast in silico.19? Localisation of a SufA-like sequence to 
the chloroplast has been reported in A. thaliana (Leon, Briat and Lobreaux, INRA, 
Montpellier, France, unpublished observation cited by Touraine, et al,195). Given the 
need to interact with different target proteins within the chloroplast (section 1.3.3.3), it 
seems reasonable to predict the existence of alternative scaffold proteins. Indeed, it is 
worth noting that NifU-like proteins (NFU1-5) are present in the A. thaliana genome. 
NFU1-3 target the chloroplast while NFU1-2 were able to complement yeast strains 
defective for ISU1.182 Furthermore, A. thaliana lines disrupted in NFU2 exhibited 
stunted growth as compared to wild type plants; the mutant phenotype was attributed to 
photosynthetic defects.195,203 Together, these data hint at the availability of several 
alternative scaffolds for cluster assembly in the chloroplast.
1.3.6.3. A. thaliana SufB
The properties of AtSufB (TAIR locus AT4G04770) have been examined by Xu, et 
a/.185 It was shown that the protein could complement a SufB KO strain of E. coli placed 
under oxidative stress. Further, homodimerisation and heterodimerisation (with AtSufC) 
was demonstrated by yeast two-hybrid technology and bimolecular fluorescence 
complementation in cells of N. tabacum. Immunocytochemistry in A. thaliana localised
* The Arabidopsis Information Resource (http://www.arabidopsis.org/)
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SufB to the chloroplast inner envelope.196 Heterologously expressed AtSufB possessed 
ATPase activity (Km = 36 piM) which could be stimulated 2-fold by Fe3+.
1.3.6.4. A. thaliana SufC
AtSufC (TAIR locus AT3G10670) is also likely to be functional, as reported by Xu and 
M0ller.197 Principally, AtSufC was able to rescue the phenotype of a SufC KO E. coli 
strain. Disruption of AtSufC in A. thaliana produced an embryo-lethal phenotype in the 
homozygote; examination of cell ultrastructure revealed morphological abnormalities in 
the plastid. Finally, transient transfection of N. tabacum indicated plastid targeting.
1.3.6.5. A. thaliana SufD,
Disruption of AtSufD (TAIR locus AT1G32500) reduced the number of viable seeds, 
indicating the gene to be important but not essential.204 Transient transfection with 
AtSufD transit peptide revealed plastid targeting.197 Furthermore, yeast two-hybrid 
analysis197 indicated that AtSufD interacted with AtSufC.
1.3.6.6. A. thaliana SufS and SufE.
SufS (TAIR locus AT4G26500) is found in A. thaliana. It targets the chloroplast and 
shows similar enzymatic activity against L-cysteine and L-selenocysteine to EcSufS in 
vitro.198199 While SufS barely contributes to the stromal proteome (0.06 ± 0.02 %205), it 
is probably essential, as indicated by the finding that SufS KO in Synechocystis sp. is 
lethal.206 Ye, et al.205 demonstrated that purified AtSufS can participate in [Fe-S] cluster 
assembly in vitro. However, AtSufS specific activity was 50-80 fold higher in
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chloroplast stroma (as compared to isolated enzyme in vitro); furthermore, a proportion 
of native AtSufS co-purified at a molecular mass of 600 kDa on a gel filtration column. 
These data imply binding and stimulation by high molecular weight accessory factors, 
e.g., AtSufBCDE. It is worth noting that sequence encoding AtSufE (TAIR locus 
AT4G26500) was identified in the A. thaliana genome and predicted to target the 
chloroplast.197
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1.4. PROJECT OBJECTIVE AND OVERVIEW.
The objective of this project was to investigate an ORF in P. falciparum with homology 
to SufS of E. coli and A. thaliana, known as P. falciparum SufS (PfSufS). In subsequent 
chapters, I consider my own studies in which I have used a number of different 
techniques to examine the properties of PfSufS. Chapter 2 describes initial 
investigations of PfSufS using bioinformatic and simple in vitro techniques. Preliminary 
experiments on the intracellular targeting of PfSufS are discussed in chapter 3. The 
major focus of this project was to investigate the enzymatic properties of PfSufS. This 
required the development of a simple colorimetric cysteine desulphurase assay (chapter 
4) and the production of recombinant enzyme (chapter 5).
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CHAPTER 2.
INITIAL ANALYSIS OF PLASMODIUM FALCIPARUM  SUFS.
Genome sequencing has facilitated the search for SUF genes in diverse organisms. This 
chapter briefly describes the various Apicomplexan genomic data sets available, before 
discussing both the conservation and divergence of SufS sequences across taxa. 
Descriptions are provided of the putative SUF system in P. falciparum  and 
investigations of P. falciparum SufS using in silico and laboratory techniques.
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2.1. INTRODUCTION.
2.1.1. Survey of Apicomplexan genomes.
2.1.1.1. Apicomplexan nuclear genomes.
Numerous Apicomplexan nuclear genomes have been, or are being, sequenced. Whole 
genome information is currently available for P. falciparum 3D745 and P. yoelii yoelii 
17XNL.207 The P. falciparum genome is further discussed in section 2.1.2. Incomplete 
genomic information has been deposited for P. vivax and several non-human models, 
notably simian (P. knowlesi) and rodent malarias (P. berghei and P. chabaudi 
chabaudi). All these data are available via the Internet in PlasmoDB.208 Sequence data 
also are available for other Apicomplexan organisms, with a bias towards the major 
human and veterinary pathogens, e.g., the complete genomes of Cryptosporidium 
hominis TU502209 and C. parvum  IOWA;210 alongside patchy coverage of Eimeria 
tenella, Perkinsus marinus, Theileria parva and T. gondii. Available via the Internet are 
genomic data for Cryptosporidium spp.211 and T. gondii.212
2.1.1.2. Apicomplexan organellar genomes.
Organellar genome sequences are available for P. falciparum,53,213 T. gondii54 and E. 
tenella
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2.1.2. Plasmodium falciparum genome.
2.7.2.7. Holotypic strain o f P. falciparum.
A common laboratory strain (3D7) of P. falciparum was selected as the holotype for the 
genome sequencing project.45 However, there is considerable historical distance 
between the holotype and parasites directly isolated from infected patients. 
Specifically, 3D7 was cloned by limiting dilution214 from P. falciparum NF54, a strain 
isolated from a baggage handler at Schipol Airport (Amsterdam, The Netherlands).215 In 
the intervening years, the cell line has been repeatedly passaged in vitro. Hence, it has 
been relieved of immune pressure in the human host, and out-crossing in the mosquito.
2.1.2.2. Structure o f the nuclear genome.
The nuclear genome of P. falciparum 3D7 is composed of 22.8 megabases (Mb) of 
DNA packaged into fourteen chromosomes 45 The adenine and thymine (AT) content of 
the DNA is high (80.6 %45), a feature that poses a major challenge to sequence analysis 
and molecular biology.
2.1.2.3. Structure o f the organellar genomes.
DNA is additionally contained in the mitochondrion and plastid organelle of P. 
falciparum. The mitochondrial genome is 6 kilobases (kb) long213 while the plastid 
genome is 35 kb long.53 Both organellar genomes contain a minimal set of genes.
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2.1.2.4. Prediction of open reading frames in the nuclear genome.
Prediction of ORFs in the nuclear genome of P. falciparum has generally been done 
automatically using algorithms such as GlimmerM and Genefmder; the problems of 
such ab initio gene prediction are well-known216 and are especially acute in AT-rich 
DNA as intron boundaries are difficult to identify. Intracellular localisation of proteins 
has also been predicted using automatic methods, e.g., PlasmoAP and PlasMit (chapter 
3).
2.1.2.5. Transcriptomic andproteomic analysis.
A number of transcriptomic and proteomic analyses of Plasmodium spp. have been 
conducted. Of particular note are studies of the P. falciparum erythrocytic18,83,217 219 and 
sporozoite83 stages. One EST study is available for the liver stages of P. yoelii.88 Also 
published are studies of the P. berghei erythrocytic89 and sporozoite220 stages.
Environmental modulation of transcription has been investigated. For example, a serial 
analysis of gene expression of the response of erythrocytic stages of P. falciparum to 
the anti malarial drug chloroquine.221 Proteomic analyses have been conducted for the 
erythrocytic stages of P. falciparumj86,87 while a study of the mosquito stages of P. 
berghei recently became available.89 Unsurprisingly, meta-analysis222 has revealed 
significant inconsistencies between studies.
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2.1.3. Cautionary remarks.
While genomic, transcriptomic and proteomic data facilitate investigation of the biology 
of Apicomplexan organisms, it is essential to be cautious. In particular, the AT bias of 
Plasmodium spp. DNA makes gene prediction unreliable. Data from transcriptomic 
studies must also be interpreted with care. Finally, it is easy to challenge the validity of 
P. falciparum 3D7 as a model for clinical malaria.
2.1.4. Chapter objective and overview.
The objective of this chapter is to set the scene for subsequent data by reporting my 
initial studies of PfSufS. Results in this chapter derive from bioinformatic analysis of 
published genomic and transcriptomic information and simple in vitro experiments. 
Following the Materials and Methods, the results section begins with a discussion of 
|Fe-S| cluster assembly in P. falciparum  (emphasis on the putative SUF system). 
Subsequently, the focus shifts to SufS. I provide a definition of SufS in terms of amino 
acid sequence motifs. I report a survey of genomes encoding SufS among the bacterial, 
protozoan, algal and vascular plant taxa. Based on computational studies, a description 
of PfSufS at nucleotide, amino acid and structural levels is presented. This is followed 
by in vitro evidence for the chromosomal location and transcription of PfsufS. Finally, I 
describe my investigations of the transcriptional control of PfsufS under conditions of 
oxidative stress and iron limitation.
59
2.2. MATERIALS AND METHODS.
2.2.1. Computational methods.
2.2.1.1. Nucleic acid sequences.
Rates of synonymous (dS) and non-synonymous (dN) mutation were estimated 
according to the method of Goldman and Yang245 implemented in the codeml algorithm 
in the PAML software.246* Conserved motifs were identified with MEME.247 Quality of 
PCR primers was checked with the Amplify software. DNA sequences were analysed 
using the AB1 Prism Sequencing Analysis software (Perkin Elmer) running on an Apple 
Power Mac G4 and assembled using the SeqMan software (DNASTAR).
2.2.1.2. Protein sequences.
SufS sequences were retrieved from genome databases using the TBLASTN algorithm 
with EcSufS (GenBank P77444) or AtSufS (TAIR locus AT4G26500) as probes. 
Amino acid sequences were aligned using T-COFFEE248* or Clustal W249* and refined 
by eye. Phylogenetic trees were constructed from protein sequence alignments using the 
PHYLIP software (J. Felsenstein, University of Washington, USA5) running on an 
Apple iBook. Trees were constructed by: (1) neighbour-joining (FITCH); (2) parsimony 
(PROTPARS); and (3) maximum likelihood (PROTML) according to the JTT 
probability model.250 Consensus trees were abstracted using CONSENSUS and drawn 
with DRAWTREE. Bootstrapping (100 pseudoreplicates) was done with SEQBOOT.
* http://abacus.gene.ucl.ac.uk/software/paml.html
+ http://www.ch.embnet.org/software/TCoffee.html
* http://www.ebi.ac.uk/clustalw/
5 http://evolution.gs.washington.edu/phylip.html
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2.2.1.3. Protein properties and structure.
Kyte-Doolittle hydropathy plots were constructed with an Internet-based 
implementation.233* The ExPASy ProtParam tool1 was used to predict the molecular 
weights of proteins from primary sequence. Molecular modelling was conducted by Dr. 
J. W. Saldanha (NIMR). A homology model of PfSufS was produced via threading 
using the 2.0 A X-ray crystal structure of EcSufS (PDB 1JF9251) as a template. 
Molecular models were manipulated with the RasMol software.
2.2.2. Plasmodium falciparum red blood cell stage culture.
P. falciparum 3D7 and CIO erythrocytic stages were cultured in vitro by standard 
methods252 in leukocyte-depleted whole blood obtained from the National Blood Service 
(UK). CIO is a cloned line derived from an artificial mixture of BW (The Gambia) and 
Palo Alto (Uganda) isolates.253
2.2.3. Mlolecular biology techniques.
P. falciparum 3D7 genomic DNA was a gift from Dr. B. Clough (NIMR). Total RNA 
was isolated from P. falciparum 3D7 mixed erythrocytic stage parasites (parasitaemia 
ca. 10 %) essentially as described254 but using the TRIzol reagent (Invitrogen). DNA 
was removed from RNA preparations by treatment with TURBO DNase (Ambion) for 
30 min at 37 °C. Quality of isolated RNA was verified on agarose gel by inspection of
♦http://occawlonline.pearsoned.com/bookbind/pubbooks/bc_mcampbell_genomics_l/rn 
edi al i b/acti vi ties/kd/ky te-dool i ttl e. htm 
f http://www.expasy.org/tools/protparam.html
61
28S and 18S ribosomal bands. Copy DNA was made using the RETROscript kit 
(Ambion) while PCR was done with AmpliTaq (Perkin Elmer) or the LA PCR kit 
version 2.1 (Takara). Primers were obtained from Eurogentec or Sigma-Genosys. 
Primer sequences are indicated in Table 2.1. PCR was done on a Biometra T3 
Thermocycler. PCR products were purified with the QIAquick or QIASpin kits 
(Qiagen). To avoid nicking, excision of DNA from agarose gels was guided by blue 
light (Dark Reader Transilluminator, Clare Chemical Research). Restriction enzymes 
were obtained from Roche or NEB. Vector inserts were confirmed by restriction digest 
and Sanger sequencing using the BigDye Terminator v l.l Cycle Sequencing chemistry 
(Applied Biosystems) resolved on an ABI Prism 377 DNA sequencer (Perkin Elmer). 
Plasmids were maintained in INVaF' E. coli cells (Invitrogen). All other molecular 
biology procedures were done using standard techniques.255
2.2.4. Recovery of genes by PCR.
A 690 bp fragment of P. falciparum sufB (PfsufB[690|; GenBank CAA64569) was 
amplified with primers 2.1 and 2.2. Thermocycling conditions were: denaturation at 95 
°C for 3 min; followed by 34 cycles of 95 °C for 30 s; 45 °C for 30 s; and 68 °C for 2 
min; followed by 72 °C for 10 min.
PfsufS (PlasmoDB PF07_0068) predicted to encode the mature enzyme (D62-K546; 
PfSufS(Ml) was recovered from cDNA using two overlapping sets of primers in two 
separate PCR reactions. The 5' region of PfsufS[M| was recovered with primers 2.3 and 
2.4; the 3' region was recovered with primers 2.5 and 2.6.
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TABLE 2.1.
PCR PRIMERS USED IN CHAPTER 2.
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ID DNA sequence
2.1 5 'T A A ATTT AT ATTT A AT A AG AC A AGG ATT A
2.2 3 'T A ACC AT AT CTTTT ACT ATT ATTT CT ACT AT AGC
2.3 5'G AGCTCG ATT ATTTT AAAAATGT A AG AG A ACAT
2.4 3 'C ATT AGTT ATT AT ATT ACT ACC AT
2.5 5'GTGCATCACT AGGT ACAGGT
2.6 3 'CT CG AGTTTTT C ATTTTT C ATTT C ATTT A AC AT
2.7 5'AAAATGAGTGAGTTTTATAAAAAGG
2.8 3 'TTTTT C ATTTTT C ATTT C ATTT A AC
2.9 5'ATGGGAGAAGAAGATGTTCAAGCTTTAG
2.10 3'GAAACATTTTCTGTGGACAATACTTGGTCC
Critically, primers 2.3 and 2.4 amplified sequence across the intron boundary, thus 
allowing the detection of contaminating genomic DNA. Thermocycling conditions for 
both reactions were: denaturation at 94 °C for 1 min; followed by 30 cycles of 98 °C for 
20 s; 45 °C for 30 s; and 72 °C for 1 min.
PfsufS exon 2 (PfsufS (E2J) was amplified from genomic DNA with primers 2.7 and 
2.8. Thermocycling conditions were: denaturation at 95 °C for 3 min; followed by 34 
cycles of 95 °C for 30 s; 45 °C for 30 s; and 68 °C for 1.5 min; followed by 72 °C for 
10 min. The fragment was inserted into the pCRII TA cloning vector (Invitrogen) 
between Sp6 and T7 promoters. This construct was known as pCRll:PfsufS[E2].
P. falciparum actinl256 (PfactinI; GenBank P10988) was recovered from genomic DNA 
by PCR using primers 2.9 and 2.10. Thermocycling conditions were: denaturation at 95 
°C for 3 min; followed by 34 cycles of 95 °C for 30 s; 64 °C for 2.5 min; followed by 
72 °C for 10 min. Amplicons were cloned into pCRII behind the Sp6 promoter, giving 
pCRIlrPfactinl. Sequence was confirmed by Sanger sequencing.
2.2.5. Chromosomal localisation of PfsufS.
2.2.5./. Pulsed field gel electrophoresis and blotting.
Chromosomes were separated by pulsed field gel electrophoresis (PFGE). P. falciparum 
3D7 and CIO red blood cell stage parasites were embedded in blocks of low melting 
point (LMP) agarose (Seaplaque GCG) and extracted by treatment with 4 % sodium 
lauryl sarcosinate in 250 //g.mL1 proteinase K255 by Mr. P. W. Moore and Dr. D. H. 
Williamson (NIMR). Blocks were subjected to PFGE through 1 % chromosomal grade
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agarose (BRL) using a custom-built contour clamped homogenous electric field (CHEF) 
apparatus, as described.91 Yeast genomic DNA was run as a control. The gel was 
Southern blotted to Hybond N+ membrane (Amersham) as described.255
2.2.5.2. Synthesis o f radiolabelled probe.
PfsufS[E2] was excised from pCRII:PfsufS[E2] by EcoRI digest and run into LMP 
agarose. PfsufS[E2] DNA was eluted from LMP agarose into redistilled water by 
heating at 65 °C for 5 min, followed by boiling for 3 min. Eluted DNA (25 ng per 
reaction) was radiolabelled with [a32P]adenosine triphosphate (Amersham) using the 
Prime-it II kit (Stratagene). The hybridization probe was purified through a ProbeQuant 
G-50 micro column (Amersham).
2.2.53. Probing CHEF blot.
CHEF blots were immersed in hybridisation buffer (0.5 % dried milk, 36 mM NaCl, 20 
mM sodium phosphate, 2 mM EDTA, 1 % SDS, 250 pig.mL1 salmon sperm DNA, 10 
% dextran sulphate in redistilled water) and incubated at 65 °C for 2 h in a Hybaid 
Micro 4 hybridisation rotisserie. Radio-labelled PfsufSIE2| probe (50 pL) was added 
and the mix incubated for a further 12 h. Blots were washed at 65 °C sequentially in 2 
x, 1 x and 0.1 x SSPE diluted from 20 x SSPE (140.26 g NaCl, 88.23 g tri-sodium 
citrate, 35.38 g KH2P04, 7.44 g EDTA in 1 L redistilled water). The blot was 
autoradiographed.
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2.2.6. Response of parasites to iron limitation and oxidative stress.
2.2.6.1. mRNA assay.
Asynchronous P. falciparum 3D7 erythrocytic stages (25 mL; 13 % parasitaemia; 1 % 
haematocrit) were treated with either 2,2'-bipyridyl (BIP) or H20 2. BIP (Sigma) was 
dissolved in DMSO and added at concentrations of 10 or 0 mM. H20 2 (Sigma) was 
added at concentrations from 0-100000 parts per million (ppm). Parasites were 
incubated with BIP or H20 2 for 3 h at 37 °C under 5 % 0 2, 5 % C 02 in N2. Total RNA 
was immediately isolated.
2.2.6.2. RNase protection assay.
RNAse protection was used to quantify the level of PfsufS mRNA under different BIP 
and H20 2 treatments. PfsufS[E21 was derived from pCRII:PfsufS 1E21 by blunt-end 
digestion with Dral. Pfactinl was used as a loading control and derived from 
pCRlIiPfactinl by blunt-end digestion with Sspl. In order to generate radio-labelled 
RNA probes, digested vectors were transcribed in vitro using Sp6 polymerase and 
la32PJuracil triphosphate (Amersham), gel purified and eluted in Ambion elution buffer 
at 37 °C for 12 h. RNA probes were quantified by counting on a Beckman LS6000IC 
spectrometer.
RNAse protection assay was performed with the RPAIII kit (Ambion), essentially as 
described by the manufacturer. In a typical reaction, 100 ng total RNA was mixed with 
50000 counts per minute of RNA probe and hybridised at 42 °C for 48 h. The 
hybridisation reaction was digested at 37 °C for 30-120 min with RNAse H/Tl
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(Ambion) to remove single stranded RNA. The reaction was separated on 6 % 
acrylamide, 8 M urea gel and autoradiographed. Transcripts bound to RNA probe were 
protected from digestion and appeared as bands on the autoradiograph.
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2.3. RESULTS AND DISCUSSION.
2.3.1. ISC system in the mitochondrion.
Putative genes specifying components of the ISC system have been identified in the P. 
falciparum genome. P. falciparum IscS (PflscS; PlasmoDB MAL7P1.150) has been 
shown to target the mitochondrion in vivo.223 N-terminal sequences of C. parvum IscS 
and IscU address GFP to the mitochondrion of S. cerevisiae.224 Thus, mirroring the 
situation in other eukaryotic cells, the ISC system of Apicomplexa is probably 
mitochondrial.
2.3.2. SUF system in the plastid.
2.3.2.1. Database mining for SUF genes.
It is probable that all members of the SUF system are encoded by P. falciparum (Table 
2.2; Ellis, et al.225\ Sato, Clough, Rangachari and Wilson, NIMR, unpublished 
observations). As SufA and IscA cannot be distinguished by amino acid sequence 
(chapter 1), there are at least two candidates for PfSufA (PfSufAl-2). PfNFU may be 
included in the SUF system (loosely defined), as it could provide an alternative scaffold 
for |Fe-S | cluster assembly. It would not be surprising to find multiple scaffolds given 
the need to interact with, and load (Fe-SJ clusters onto, multiple downstream targets. 
Plastid-localised ferredoxin may act as reductant for |Fe-S| cluster repair.
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TABLE 2.2.
SUF SYSTEM PROTEINS IN THE GENOME OF P L A S M O D I U M  
FALCIPARUM.
Accession number for PfSufB refers to GenBank. All other accession numbers refer to 
PlasmoDB.
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Protein Accession Genomic location Putative function
PfSufAl PFB0320c Chr2 
PfSufA2 PFE1135w Chr5 
PfNFU PFI 1050c Chr9 
PfSufB CAA64569 Plastid genome 
PfSufC PF14_0133 Chr 14 
PfSufD PFI 1_0044 Chr 11 
PfSufS PF07_0068 Chr 7 
PfSufE PFB0270w Chr 2
[Fe-S] cluster assembly scaffold 
[Fe-S] cluster assembly scaffold 
[Fe-S] cluster assembly scaffold 
Component of SufBCD complex 
Soluble ABC ATPase 
Component of SufBCD complex 
Cysteine desulphurase 
Acceptor of sulphur from PfSufS
2.3.2.2. Evidence for plastid location of SUF system.
Circumstantial evidence for the plastid localisation of the SUF system in P. falciparum 
can be marshalled from several directions. Firstly, PfSufB is encoded by the 35 kb 
plastid genome; transcription of the gene has been observed (Fig. 2.1).18 Secondly, there 
is bioinformatic evidence for localisation of PfSufS to the plastid organelle (chapter 3). 
Given the unreliability of gene models, bioinformatic tests of intracellular localisation 
are generally uninformative for other members of the SUF system (data not shown). 
However, PfSufC and PfNFU have been localised to the plastid in P. falciparum using a 
fluorescent reporter fusion (Sato, Thakrar, Clough and Wilson, NIMR, unpublished 
observations). Thirdly, in Apicomplexan cells lacking a plastid (e.g., C. parvum), the 
SUF system is absent. Finally, compelling analogy can be made to the chloroplastic 
SUF system of A. thaliana.
2.3.2.3. Transcription o f SUF genes.
Although the SUF genes are scattered around the genome of P. falciparum , their 
expression might be coordinated at transcriptional and translational levels (based upon 
the ancestral prokaryotic operon model). Transcriptional co-regulation of proteins that 
physically interact (e.g., PfSufSE) can be tight.226 Furthermore, P. falciparum genes in 
the same biochemical pathway are believed to be co-regulated at the transcriptional 
level.227
However, no obvious correlation could be observed in published microarray data for the 
candidate SUF genes (Fig. 2.2).
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FIGURE 2.1.
PLASMODIUM FALCIPARUM  SUFB.
A fragment of PfsufB (PfsufB[690]) was recovered by PCR from cDNA (R) and 
genomic DNA (G) extracted from P. falciparum 3D7. Prior to RT-PCR, genomic DNA 
contamination was removed from RNA preparations by treatment with TURBO 
DNAse. Control PCR lacking nucleic acid is presented (-). Other abbreviations are as 
follows, bp: base pair; M: 123 bp ladder (Sigma).
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PfsufB[690]
FIGURE 2.2.
TRANSCRIPTIONAL TIME COURSE OF PLASMODIUM FALCIPARUM SUF.
Transcriptomic information for the SUF system genes in erythrocytic stages of P. 
falciparum18 was downloaded from PlasmoDB and plotted as a line graph. The ordinate 
is reported as a percentage of the expression level of the most abundant transcript at that 
time point. The transcriptional profile of PfactinI is given for comparison.
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In general terms, there is probably a peak of expression in trophozoites, coinciding with 
the time of greatest metabolic activity. For example, transcriptional peaks of PfsufS (24 
h) and PfsufE (21 h) are similar. Mature protein might appear in the plastid ca. 30-40 
min later (taking into account the delay associated with translation, trafficking and 
maturation).77
To further investigate the possibility of co-regulation, genomic sequence 1 kb upstream 
of the predicted translational start codon of each candidate SUF gene was submitted to 
the MEME algorithm. This algorithm uses a Hidden Markov Model (HMM) to identify 
conserved motifs. Several motifs were uncovered by this method: the majority were 
rejected as artefactual on the basis of shortness (> 15 bp) or AT bias (100 %). Low- 
complexity (poly-T) tracts are common in P. falciparum intragenic regions and 
confused the algorithm. However, one shared motif comprised poly-T ATA tracts (E- 
value = 9.2c'066) that may correspond to the archetypal eukaryotic TATA-box. Another 
motif was GC-enriched* and was present in the upstream regions of PfsufCDES (E- 
value = 4.6e 002); but was apparently absent from the PfsufA and Pfnfu candidates. 
Along with PfSufB (supplied by the plastid genome), PfSufCDES are supposed to form 
the multicomponent cysteine desulphurase.191 Thus, harmonised regulation might be 
postulated.
* The consensus sequence was GGTTGTTACAAAGAAAG.
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2.3.3. Definition of SufS.
2.3.3.1. Central importance o f SufS in [Fe-S] cluster assembly.
Cysteine desulphurases (EC 2.8.1.7) are a phylogenetically ubiquitous class of enzymes 
that hydrolyse L-cysteine to L-alanine and sulphur. They are all dependent on pyridoxal 
5 '-phosphate (PLP) and fall into the aspartate aminotransferase (AAT) category. 
Cysteine desulphurases may be considered the hallmark of [Fe-Sl cluster assembly. 
Therefore, for the remainder of this thesis, I focus on SufS as a surrogate for the entire 
SUF system.
2.3.3.2. Definition o f SufS at the level of amino acid sequence.
In order to interrogate genomic databases for SufS, it is vital to have an exact definition 
of the enzyme at the level of primary amino acid sequence. Noting the differences in 
active site motif among the cysteine desulphurases, Mihara and Esaki160 subdivided 
them into class I and II. According to this system, class I enzymes contain variants of 
the SSGSACTS motif, while class II enzymes contain the GHHCA motif. By these 
criteria, IscS is class I; while SufS is class II. In eukaryotic cells possessing a plastid, 
SufS may secondarily be defined as a cysteine desulphurase possessing a plastid- 
targeting signal (c.f., IscS, with a mitochondrial targeting signal).
If the GHHCA criterion is weakened, highly divergent taxa, e.g., the Archaea, appear to 
encode SufS. Most divergent is a NifS-like gene from Halobacterium salinarum NRC-1 
(GenBank NP_281065), an obligately halophilic Archean, possessing a GDHCT 
motif.228 In this organism, two deviations from the expected Mihara-type motif are
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noted (H -*> D; A -* T). However, it is evident that such changes are minor as both sets 
of amino acids exhibit similar properties: H and D are charged and hydrophilic; while A 
and T are small and hydrophobic. It is worth noting that the active site motif of T. 
gondii SufS (TgSufS) exhibits a departure from the expected (GHHCC). However, once 
again, the change is trivial given that A and C are both small and hydrophobic amino 
acids. An A C change is also seen in the last position of the active site motif of other 
SufS proteins, e.g., in the cyanobacterium, Anabaena sp. Taken together, these data 
suggest considerable plasticity in the active site sequence, provided that there is 
conservation of amino acid properties. In contrast, the chemistry of cysteine 
desulphuration demands immutability of the PLP-binding K and active site C (chapter 
4). In conclusion, I classified protein sequence as SufS if it contained both a PLP- 
binding motif (SXHK) and a modification of the Mihara-type active site motif 
(GXHCX).
2.3.4. Survey of SufS-like sequences.
2.3.4.1. SufS-like sequences are ubiquitous.
SufS-like sequences are present as a single copy in the genomes of organisms from all 
kingdoms except Metazoa and Fungi: these two groups apparently rely on the ISC 
pathway (chapter 1). SufS sequences from different taxa were aligned (Fig. 2.3). 
Inspection of the sequence alignment revealed many short regions of conservation.
Representative sequences between the two anchor motifs (SXHK and GXHCX) were 
chosen for construction of a phylogenetic tree. For this purpose, large insertions present 
in the Apicomplexan sequences were also excised.
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FIGURE 2.3.
MULTIPLE SEQUENCE ALIGNMENT OF SUFS PROTEIN SEQUENCES.
SufS sequences are found in all taxa except fungi and Metazoa. Essential catalytic 
residues are conserved across taxa, e.g., the PLP-binding (yellow) and active site (red) 
motifs. PfSufS possesses a penta-isoleucine tract and an insertion of 51 amino acids 
(both marked in blue). For this alignment, SufS sequences were chosen to exemplify 
taxonomic ubiquity. Prokaryotic sequences are taken from the Archaea (Halobacterium 
salinarum and Pyrococcus furiosus), enterobacteria (Escherichia coli and Erwinia 
chrysan them i), a-proteobacteria (Legionella pneumophila), P-proteobacteria 
{Nitrosomonas europaea), 6-proteobacteria {Bdellovibrio bacteriovorus), cyanobacteria 
(Anabaena sp.), high GC Gram+ bacteria {Mycobacterium tuberculosis) and spore- 
forming bacteria {Bacillus anthracis). Eukaryotic sequences are from an Apicomplexan 
parasite {P. falciparum), a red alga {Cyanidioschyzon merolae), a monocotyledonous 
plant {Oryza sativa) and a dicotyledonous plant {Arabidopsis thaliana). Some of the 
sequences have been truncated at the N-terminal. Abbreviations are as follows. HSALI: 
H. salinarum ; PHORI: P. furiosus; ECOLI: E. coli\ ECHRY: E. chrysanthemi; 
NEURO: N. europaea; LPNEU: L. pneumophila; BBACT: B. bacteriovorus; ANABA: 
Anabaena  sp.; MTUBE: M. tuberculosis; BANTH: B. anthracis; PFALC: P. 
falciparum; CMERO: C. merolae; OSATI: O. sativa; ATHAL: A. thaliana.
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CLUSTAL FORMAT for T-COFFEE Version_l.41, CPU-58.23 sec, SCORE-68, Nseq-14, Len-641
HSALI  MEATEQGPIDVEAVRADFPILEREVAGGEDLVYLDNAATSHTPEPWDAIAD
PHORI ---------------MKIPDDVRKDIPLTQE------ VIYFDNTATSLTPKPVIEAMDE
ECOLI  MIFSVDKVRADFPVLSREVN-GLPLAYLDSAASAQKPSQVIDAEAE
ECHRY  MNYPVEHYPIDRVRADFPILQQSVN-GQPLAYLDSAASAQKPLAVIDRERD
NEURO PERHDRAAQIPAAHPPFDIHAIRRDFPILQEHVN-GHSLVWLDNAATTQKPQAVIDRLTY
LPNEU  MSTNPSLMTSFDVNKIRKDFPVLHQKIN-EYDLVYFDNAATTQKPKAVIDAIAQ
BBACT  MSNLDDIFASVRSQFPALTQKVH-GKNLVYLDSGATTLKPQSWDRIAH
ANABA MT-------- YTPTKTLADKVRADFPILHQEVN-GKTLVYLDNAATSQKPLFVLNALRD
MTUBE -------- MTASVNSLDLAAIRADFPILKRIMRGGNPLAYLDSGATSQRPLQVLDAERE
BANTH ----------------MNI HE IRKQFPILDQKVN - GKQLVYFD S AAT SQKPIQVIE TLER
PFALC --------------1IDYFKNVREHFPFFKEN KSLIYFDSAATTHKP SCVIEKMSE
CMERO VEAPGH---- RRNRPAIAALDKDSFPILERTTTEGKQLVYLDSAATSQKPLQVIEALSH
OSATI RE-------- AESAASLGDLTRVDFPILDQEFD-GSKLVYFDNGATSQKPSCVMKTLDE
ATHAL ST---------DSE SV SLGHRVRKDFRILHQEVN-GSKLVYLDS AAT SQKPAAVLDALQN
: : . * * : .
HSALI YYRRYNSNVHRGLHELSQEASVAYEDAHDKLAAFVGGEDREEMVFTKNTTEAENLVAFAW
PHORI YYLKYRANVHRGVHRLSQMATQKYEESRKWADFINAK-FEEIVFTKNTSESLNLVALGL
ECOLI FYRHGYAAVHRGIHTLSAQATEKMENVRKRASLFINARSAEELVFVRGTTEGINLVANSW
ECHRY FYLHEYAAVHRGIHTLSARATSAMEEVRAKVATFIHAASAEDIVFVRGTTEAINLVANSY
NEURO FYTHENSNIHRAAHELAARATDAYEESRNKVRQFLNAASTDEIIFLRGTTEAINLVAQSW
LPNEU FYEKDNSNVHRGVHALSVRATEMYEAARAKVKRFINARSPRECIFVRGTTEAINLVAQSL
BBACT FYS YETSNVHRGAH YLGDVATGHFEAARQKVAEFLGARQSEEIIFVRGTTEGVNLVANSW
ANABA Y YEQ YNSNVHRGAHTLSAKATDAYEGARDKVAKFINAASRKEIVYTRNASEAINLVAY SW
MTUBE FLTASNGAVHRGAHQLMEEATDAYEQGRADIALFVGA-DTDELVFTKNATEALNLVSYVL
BANTH YYKEYNSNVHRGVHTLGTKATDAYEGAREKVRKFINAKSMEEIIFTCGTTTALNTVAASY
PFALC FYKKENSNIHRGIYKLSHNATNNYEKVRETIKE YINCEKNDNIIFTNGSTYGLNWCKMM
CMERO F YRYENANVHRGAHRLSQQATEAFE SARAKVARFLNAKKDTEIVFTRNATE AINTVAYAW
OSATI Y YRFYNSNVHRGIHVLSAKATDAYESARTKVANFVNAANSREIVFTRNATEAINLVAY SW
ATHAL YYEFYNSNVHRGIHYLSAKATDEFELARKKVARFINASDSREIVFTRNATEAINLVAYSW
•  * •  *  •  • •  5 S S
HSALI GL— NEL GPG-DEWLTQMEHHASLVTWQ-QVADETGAEVKYIPITDD-GHLDMDA
PHORI E HTF KKG-DKIVTTPYEHHSNLLPWQ-RLAKKLGLKLEFIEGDDE-GNLDLSD
ECOLI GN— SNV RAG-DNIIISQMEHHANIVPWQ-MLCARVGAELRVIPLNPD-GTLQLET
ECHRY GR— TAF QPG-DNLVISEMEHHANIVPWQ-MLAQARGLTLRVLPITDD-GELDMAQ
NEURO GR— QHI SAG-DEIIITWLEHHANIVPWQ-MLCNETGARLRWPVDED-GQVLLEE
LPNEU VA— PRI LPD-EEILITHMEHHSNIVPWQ-MVCKKMGCKLQVAPISLN-GEVILEE
BBACT GL— SNL KAG-DEILITVMEHHGNIVPWQ-MVAEKVGAKWAADILDN-GELDLED
ANABA GM— NNL QAG-DEIILSVMEHHSNIVPWQ-FVAQKTGAVLKFVELTPE-QTLDMEQ
MTUBE GD— SRFERAVGPG-DVIVTTELEHHANLIPWQ-ELARRTGATLRWYGVTDD-GRIDLDS
BANTH GL— ENV KEG-DEIVIS YMEHHSNIIPWQ-QVAKKTGATLKYLPLQPD-GTISIED
PFALC IE— Eli KKEEDEIYLSYMEHHSNIIPWQEYINKEKKGRIKYVPLNKS-GYINIKK
CMERO GLLGGNL TPG-DEIIVSVAEHHANLVPWQ-LVAQRTGARLRHIPLLPQVQALDMDT
OSATI GM— SNL KQG-DEIVLTIAEHHSAIVPWQ-FVSQKTGATLKYVGLTKE-GVPDIEQ
ATHAL GL— SNL KPG-DEVILTVAEHHSCIVPWQ-IVSQKTGAVLKFVTLNED-EVPDINK
• : : : ***. : : . : • # *
HSALI AADMITDDTALVNAVHISNTLGTVNPVGELADIAHDHGAYIFV— DGAQAAPTRAVDVQE
PHORI AEKKIK-GAKLVAVQHVSNALGVIHEVEELGRMAKEEGAIFW— DAAQSVGHMEVDVKK
ECOLI LPTLFDEKTRLLAITHVSNVLGTENPLAEMITLAHQHGAKVLV— DGAQAVMHHPVDVQA
ECHRY LPALLDERTRLVAVTQVSNVLGTVNPLAEIIRQAHACGAKVLV— DGAQAVMHQAVDVQA
NEURO YQKLLNSHTRLVAFSQVSNALGTITPARQMVEMAHRVGARVLV— DGAQSVSHMRVDVQQ
LPNEU FERKLNENTKMVAINYASNSLGTINPVKTMIKMAHEVGAKVLL— DGAQATAHLIVDVQD
BBACT FKKKLNSRTKMVAFTAS SNVLGTNTDMKLLTKLAHEVGAKVLV— DGAQIVSQLPVDVSD
ANABA FKQLICEKTKLVSIVHVSNTLGCINPVAEIAEITHRYGAKFLV— DACQSVPHIPVDVQQ
MTUBE L— YLDDRVKWAFTHH SNVTGVLTPVSELVSRAHQ SGALTVL— DACQSVPHQPVDLHE
BANTH ARQTITPNTKIVSIMYVSNVLGTINPVKEIGAIAHENGAIMW— DGAQSTPHMKVDVQD
PFALC LISNMNINTKVISICHASNVIGNIQNIEKIIKKIKNVYPHIIIIIDASQSFAHIKYDIKK
CMERO FEKMLSERTKLVAIAYVGNVLGYVQDVRRITELAHQAGASVLV— DACQAVPHMP VDVQD
OSATI LKGLL SNKTKIVWHHV SNVLV SMLPIEDIVTWSNRIGAKVLV— DACQSVPHMPVDVQR
ATHAL LRELISPKTKLVAVHHVSNVLAS SLPIEEIWWAHDVGAKVLV— DACQSVPHMWDVQK
HSALI
PHORI
ECOLI
ECHRY
NEURO
LPNEU
BBACT
ANABA
MTUBE
BANTH
PFALC
CMERO
OSATI
ATHAL
HSALI
PHORI
ECOLI
ECHRY
NEURO
LPNEU
BBACT
ANABA
MTUBE
BANTH
PFALC
CMERO
OSATI
ATHAL
HSALI
PHORI
ECOLI
ECHRY
NEURO
LPNEU
BBACT
ANABA
MTUBE
BANTH
PFALC
CMERO
OSATI
ATHAL
HSALI
PHORI
ECOLI
ECHRY
NEURO
LPNEU
BBACT
ANABA
MTUBE
BANTH
PFALC
CMERO
OSATI
ATHAL
IDA----- DFYAF
LNA----- DFLAF
LDC-----DFYVF
LDC----- DFYAF
LDC----- DWFVF
LDC----- DFYAF
I DC-----DFFVF
I DC-----DWLVA
LGV-----DFAAF
LNC-----DFYAL
MKKNKSCPDILIT
IGC-----EWLVA
LGA-----DFLVA
LNA----- DFLVA
-MLGPTGIGCLYGKRHLLA-E— MEPFLYGGDMIERVSY-EDA 
GPMGPTGIGVLFISEEYFD-V— FDPPLIGGGTIEDVDL-CCY 
-LYGPTGIGILYVKEALLQ-E— MPPWEGGGSMIATVSLSEGT 
-LYGPSGIGVLYGKSELLQ-A— MPPWEGGGAMIREVSLTQGT 
-VFGPTGIGVLYGKTELLN-D— TQPWQGGGNMIQDVTF-EKT 
-MYGPTGIGVLWGKEELLN-S— MTPYQGGGEMINSVSF-EAT 
-LFGPFGFGAVYGKKEILD-Q— MPPYQGGGSMISKVTI-EKT 
-MCAPTGIGFLYGKLALLE-A— MPPFFGGGEMIAEVYL-DHS 
-MLGPNGIGVLYGRRELLA-Q— MPPFLTGGSMIETVTM-EGA 
-MCGPTGIGVLYGKKELLN-N— MEPIEFGGEMIDFVDL-QES 
-FCASLGTGFIFINKELSS-KYKFKPLLYGSNIITNVSK-YKS 
-MCGPTGIGILYGKEHVLRRE— MAPFLGGGEMIAEVFL-DHS 
-MCGPTGVGFLHGKFDLLS-S— MEPFLGGGEMIADVFQ-DKS 
-MCGPTGIGFLYGKSDLLH-S— MPPFLGGGEMISDVFL-DHS
TW-NDPPWKFEAGTPVIAQGIALAEAVDYLQDI— GMDAIRAHEEALT-------- EYAY
KL-TEPPERFEAGTPNIGGAIGLAAGIKYIEKI— GIEKIEKQERKLV-------- KRTT
TW-TKAPWRFEAGTPNTGGIIGLGAALEYVSAL— GLNNIAEYEQNLM-------- HYAL
TY-ADPPWRFEAGSPHVAGIIGLGAALDYVSAL— GVDAIQAHEGLLM-------- RYAL
AY - HGAP ARFE AGTGNIADAVGLGAAID YVERI— GLEN IS RYE HELM-------- TYAT
EY-AAIPHKFEAGTPNIAGAIGLAAAIDYIWSL— DLDAIAEYETQLL-------- NYAT
TF-NDVPTRFEAGTPHVEGAVGLHAALTFVENI— GLDKIHK YEMDLL-------- NYAT
TY-AELPHKFEAGTPAIGEAIALGAAIDYLTNI— GMEQIHAYEAELT-------- AYLY
TY-APAPQRFEAGTPMTSQWGLAAAARYLGAI— GMAAVEAHERELV-------- AAAI
TW-KELPWKFEAGTP11GNAIGLGAAIDFLEEI— GLDNIEKHEHELA-------- QYAL
KFVTSLSELLETGTQNIPGILSMGISLEFFKKI— NWNYVYQYEMYLYDLFIYYMNKYMK
TF-ADLPHKFEAGTPSIGDAVALGAAIDYLEDGLGGMKRIHQFELQLA-------- RYLY
TY-AEPPSRFEAGTPAIGEAIGLGTAIDYLSQI— GMQKIHEYENELA-------- TYLY
TY-AEPPSRFEAGTPAIGEAIALGAAVDYLSGI— GMPKIHEYEVEIG-------- KYLY
. : * :
DQLTMTDDVDVYGPPGD----------------------------------------------
EGLDELE-IPWYGPRNLD---------------------------------------------
SQLESVPDLTLYGPQ------------------------------------------------
ASLAEVPTLRLYGPV------------------------------------------------
GCLKSIAGLRLIGTAP-----------------------------------------------
KAIEAVKGYNIIGTAA-----------------------------------------------
GRLLEIPDVKIYGTSQ-----------------------------------------------
QQLEQIPQITLYGPKPDAN--------------------------- ----------------
EGLSGIDGVRILGPTSMR---------------------------------------------
ERLSEVDGVTIYGPK------------------------------------------------
NHFVQLPNLNLSYKKENINYKSHMQTHPPVHKYNDEQNFTNDHNITQSKQTKSIHSQHDT
ESLEQFQEISIYGPPLDND--------------------------------------------
E SLIAVPNVRIYGPAPCQT--------------------------------------------
EKLSSLPDVRIYGPRPSES--------------------------------------------
--------------DRGAWSFNVDGIHAHDLSSILND-YGVAIRAGDHCTQPLHD-T-LG
--------------KHAGWSFNVPPLHPHDVAAVLDE-HKIMVRSGHHCALPVMK-K-LG
--------------NRLGVIAFNLGKHHAYDVGSFLDN-YGIAVRTGHHCAMPLMA-Y-YN
--------------HRQGVIAFNLGRHHAFDVGSFLDQ-YGIAIRTGHHCAMPLMS-R-YG
--------------DKAGVLSFTLKDFSTEEVGTALNR-EGIAVRAGHHCAQPILR-R-FG
--------------NKVPIISFVHGKIHAHDIGTILDS-EGIAIRSGHHCTMPLMD-F-YD
------------- NKGAILSFNLKGAHHS DIGQILDQ-EGVAVRAGHHCTQPLMA-R-LG
----------- GEGRAALATFTTTGVHANDLSTLLD-QEGVAIRSGHHCTQPLHR-H-LG
--------------DRGSPVAFWEGVHAHDVGQVLDD-GGVAVRVGHHCALPLHR-R-FG
--------------HRAGLVTFNIEDVHPHDVATVLDV-EGIAVRAGHHCAQPLMK-W-LK
FKIYTHDTRKYGLKKIGILPLWSNTFSSFDLVTFLDF-KNICIRAGHHCASLLHK-YYLK
---------- LGLERAALCAFNVRGVHPSDLATIIDL-DGIAIRAGHHCAQPLHRDA-LG
------------ VHRAPLCSFNVENVHPTDIAEILDLQHGVAIRSGHHCAQILHR-T-LG
------------ VHRGALCSFNVEGLHPTDLATFLDQQHGVAIRSGHHCAQPLHR-Y-LG
• • . .  . .  :
HSALI VPASARAS F YLYNTRDEVDALVAAVDEARQIFAP------
PHORI INGTVRASFHVYNSVEEVEIFLGVLEDLVRKIRGAL----
ECOLI VPAMCRASLAMYNTHEEVDRLVTGLQRIHRLLG-------
ECHRY VPSMCRASLALYSCQDEIDRLVAGLHRIHRLLGE------
NEURO VESTVRPSLAFYNTYTDIDRLAAAIDRIRGKKNAF-----
LPNEU VAATSRISMSFYNTFKEIDYCMEALQRVKEVFA-------
BBACT VPGTVRASLSVYNNREDIDSMVKAWKAREMLL-------
ANABA LAATARASLSFYNTREDIDVFIKALKETIDFFAGIF----
MTUBE LAATARASFAVYNTADEVDRLVAGVRRSRHFFGRA-----
BANTH AS STARASFYLYNTKEEIDTFVESLIKTKEYFTNVI----
PFALC VPDTSRISIYFYNTPQEIKYLAQQIASTSFMLNEMKNEK—
CMERO VGGSARASVYVYN S SADIDRFIDALVDAVSVLGEKLTLRPA
OSATI INASARASLHFYNTKEEVDVFVDALKDTIDFLTSEH----
ATHAL VNASARASLYFYNTKDDVDAFIVALADTVSFFNSFK----
This edited subset of sequences was aligned and bootstrapped trees constructed by 
parsimony; and by neighbour joining and maximum likelihood. A parsimony tree is 
presented (Fig. 2.4). Plasmodium spp. SufS was distantly placed from equivalents in 
bacteria, algae and vascular plants. This grouping had strong bootstrap support 
(99/100).
2.3.4.2. SufS-like sequences in prokaryotes.
The NCBI genome databases were searched using TBLASTN with EcSufS (GenBank 
AAL79956) as a template. This search revealed SufS to be present in a large number of 
bacterial and Archeal taxa. The presence of SufS in Archaea suggests the antiquity of 
the enzyme.
23.4.3. SufS sequences in algae and vascular plants.
Algal and plant genome databases were searched using TBLASTN with AtSufS 
(GenBank AAL79956) as a template. It is important to realise that these databases offer 
a biased taxonomic sample: for economic reasons, only the major crops, in particular 
the grasses (e.g., wheat), are covered. Nevertheless, it was found that protein sequences 
were conserved (identities > 95%) with AtSufS (data not shown). Additionally, SufS 
was identified in the red alga, Cyanidioschyzon merolae. Notable vascular plant 
examples include Lycopersicon esculentum (Solanaceae), Gossypium barbadense 
(Malvaceae), Citrus sinensis (Rutaceae) and Pinus taeda (Pinaceae). In conclusion, 
SufS is probably found in all photosynthetic eukaryotes.
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FIGURE 2.4.
PHYLOGENETIC TREE OF SUFS PROTEIN SEQUENCES.
A phylogenetic tree was constructed from SufS protein sequences by parsimony. 
Bootstrap values are given (100 pseudoreplicates). Abbreviations are as follows. 
Echrysanth: E. chrysanthemi; Eschercoli: E. coli\ Bbacteriov: B. bacteriovorus; 
Nieuropaea: N. europaea; Lpneumophi: L. pneumophila; Toxogondii: T. gondii; 
Plasmvivax: P. vivax; Plchabaudi: P. chabaudi\ Pfalciparu: P. falciparum', Pgallinace: 
P. gallinaceum; Synechocys: Synechocystis sp.; Oryzsativa: O. sativa; Arthaliana: A. 
thaliana; Cyamerolae: C. merolae.
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2.3.4.4. SufS-like sequences in the Apicomplexa.
TBLASTN searching of genome databases with EcSufS revealed complete or partial 
SufS sequences in several plastid-bearing Apicomplexans. For example, P. falciparum, 
P. vivax, P. knowlesi, P. berghei, P. chabaudi chabaudi, P. yoelii and P. gallinaceum.
P. yoelii SufS (PySufS) sequence has been assembled in silico and checked by RT-PCR 
(Ellis and Clough, NIMR, unpublished observation). Additionally, P. chabaudi 
chabaudi (PC302264.00.0) and P. berghei (PB000547.03.0) SufS sequences were 
assembled by Hall, et al."  I manually assembled the sequence of P. vivax SufS 
(PvSufS) and PfSufS to supplement those assembled automatically in PlasmoDB, 
namely, PfSufS (PF07_0068), PySufS (PY06105) and PvSufS (Pv_4040.phat_55). 
However, these bioinformatic assemblies must be viewed with extreme caution as errors 
in intron boundaries and start sites have been noted in several instances (Dr. B. Clough, 
pers. comm.)
With regard to other Apicomplexan organisms, partial amino acid sequence of T. gondii 
SufS was assembled in silico from genomic read TGG_ 10447 (Sato, NIMR, 
unpublished observation). Although often classified outside the Apicomplexa, the 
oyster pathogen, Perkinsus marinus, unambiguously encodes SufS. Additionally, SufS 
hits were evident in the Babesia bovis, Eimeria tenella and Theileria annulata 
databases; but large gaps prevented reliable assembly of sequences. Notably, SufS is 
absent from Apicomplexans lacking a plastid, namely, C. hominus and C. parvum.
In an effort to quantify the high level of conservation between the Apicomplexan SufS 
sequences, 45 amino acids C-terminal of the SXGK motif were selected for estimation
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of the ratio of rates of synonymous to non-synonymous mutations (dS/dN). This 
parameter gives an indication of the force of selection upon protein-coding DNA.229 
DNA encoding the region was aligned using the T-COFFEE algorithm and refined by 
eye; dS/dN ratios were calculated as described (section 2.2.1.1). Unsurprisingly, dS/dN 
ratios were low (< 0.2), hinting at the action of purifying selection. The most 
convergent pair were those of P. falciparum and P. gallinaceum (0.0029); while the 
most divergent pair were those of P. knowlesi and P. vivax (0.1827).
2.3.5. Description of PfSufS.
A detailed description of PfSufS will now be given. Messenger RNA predicted to 
encode the enzyme is 1641 nucleotides (nt) long and would translate into a protein of 
546 amino acids (ca. 65 kDa). The gene is composed of two exons (291 nt and 1350 nt) 
divided by one intron (283 nt). The AU content of the mRNA is 76 %, typical of P. 
falciparum (the AT bias has implications for cloning and heterologous expression -  see 
chapter 5). Exon one encodes a leader sequence and a short stretch of the mature 
protein. The leader sequence is predicted to target the protein to the plastid (chapter 3). 
Exon 2 encodes the aminotransferase type V domain containing the PLP-binding and 
active site motifs (more detail is given in chapter 4).
Inspection of the alignment of PfSufS with EcSufS (Fig. 2.3) indicates regions of 
significant difference. Chief among these were two insertions: a penta-isoleucine (51) 
tract (1255-1259) and a 51-amino acid tract. With regard to the 51 tract, it is worth noting 
that similar insertions enriched for non-polar hydrophobic amino acids (IVL) were 
present in all other Apicomplexan sequences examined. Furthermore, low dS/dN ratios 
suggest that this feature is under functional constraint (i.e., purifying selection).230
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To investigate further the properties of the 51-amino acid tract, a PSI-BLASTP search 
of the NCBI database was conducted using the P. falciparum tract as a probe. Weak hits 
to rodent prion proteins (PrP) were produced. Hence, the tract was designated as the 
“PrP-like” loop. Alignment of the PrP-like loop of PfSufS with authentic PrP sequences 
is presented (Fig. 2.5).
Although insertions equivalent to the PrP-like loop were present in other Apicomplexan 
SufS sequences, amino acid composition and length was not conserved (data not 
shown). Indeed, corresponding nucleotide sequences could not be aligned; hence dS/dN 
ratios could not be calculated (data not shown). However, the edges of the loop showed 
greater sequence conservation than the central region, as has been reported for loops in 
P. falciparum and P. berghei y-glutamylcysteine synthetases.231 It is worth noting that 
insertions are common in P. falciparum proteins.232 Taken together, these data imply a 
lack of functional constraint. It is tempting to speculate on a chance insertion event after 
the divergence of Apicomplexa from the bacterial, algal and plant lineages.
2.3.6. Physical structure of PfSufS.
A hydropathy plot of PfSufS (Fig. 2.6) revealed a hydrophobic N-terminal signal 
sequence that may be involved in targeting the protein to the plastid organelle (chapter 
3). PfSufS also appeared to lack transmembrane regions. In collaboration with Dr. J. W. 
Saldanha, a molecular homology model of PfSufS was developed based on the X-ray 
crystal structure of EcSufS (PDB 1JF9). It should be noted that the first 60 amino acids 
of PfSufS and the PrP-like loop were excluded from the model.
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FIGURE 2.5.
ALIGNMENT OF PFSUFS PRP-LIKE LOOP WITH AUTHENTIC PRION 
PROTEINS.
Sequences were retrieved from the NCBI database using the PSI-BLASTP algorithm 
with a portion of the P. falciparum PrP-like loop as probe. Weak hits (E = 24-27) were 
made with PrP in three hamster taxa: Cricetulus migratorius (GenBank Q60468); C. 
griseus (GenBank Q60506); and Mesocricetus auratus (GenBank P04273). These 
sequences were aligned with the PrP-like loop of PfSufS. Also included in the 
alignment were PrP sequences from Mus musculus (GenBank P04925) and Homo 
sapiens (GenBank P04156). Abbreviations are as follows. PRIO_CRIMI: C. 
migratorius; PR10_CRIGR: C. griseus; PRIO_MESAU: M. auratus; PRIO_MOUSE: 
M. musculus; PRIO_HUMAN: H. sapiens; and SUFS_PFALC: P. falciparum.
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CLUSTAL FORMAT for T-COFFEE Version_l.41, CPU-20.42 sec, SCORE-49, Nseq-6, Len-255
PRIOCRIMI MANLSYWLLALFVATWTDVGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGTWGQP
PRIOCRIGR MANLSYWLLALFVATWTDVGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGTWGQP
PRIOMESAU MANLSYWLLALFVAMWTDVGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGTWGQP
PRIO_MOUSE MANLGYWLLALFVTMWTDVGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGG-TWGQP
PRIO_HUMAN MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQP
SUFS PFALC ------------------------------------------------------------
PRIO
PRIO"
PRIO”
PRIO”
PRIO~
SUFS"
CRIMI
CRIGR
MESAU
MOUSE
HUMAN
PFALC
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHNQWNKPNKPKTSMKHMAGAAAAGA
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHNQWNKPSKPKTNMKHVAGAAAAGA
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHNQWNKPSKPKTNMKHMAGAAAAGA
HGGGWGQPHGGSWGQPHGGSWGQPHGGGWGQGGGTHNQWNKPSKPKTNLKHVAGAAAAGA
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA
PRIOCRIMI WGGLGGYMLGSAMSRPMLHFGNDWEDRYYRENMNRYPNQVYYRPVDQYNNQNNFVHDCV
PRIO_CRIGR WGGLGGYMLGSAMSRPMLHFGNDWEDRYYRENMNRYPNQVYYRPVDQYNNQNNFVHDCV
PRIO_MESAU WGGLGGYMLGSAMSRPMMHFGNDWEDRYYRENMNRYPNQVYYRPVDQYNNQNNFVHDCV
PRIOMOUSE WGGLGGYMLGSAMSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQYSNQNNFVHDCV
PRIO_HUMAN WGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV
SUFS PFALC ----------------------------- KKENINYKS HMQTHPPVHKYNDEQNFTNDH-
PRIO_CRIMI NITIKQHTVTTTTKGENFTETDVKMMERWEQMCVTQYQKESQAYYDGRRSSA-VLFSSP
PRIO_CRIGR NITIKQHTVTTTTKGENFTETDVKMMERWEQMCVTQYQKESQAYYDGRRSSA-VLFSSP
PRIO_MESAU NITIKQHTVTTTTKGENFTETDIKIMERWEQMCTTQYQKESQAYYDGRRSSA-VLFSSP
PRIO_MOUSE NITIKQHTVTTTTKGENFTETDVKMMERWEQMCVTQYQKESQAYYDGRRSSSTVLFSSP
PRIO_HUMAN NITIKQHTVTTTTKGENFTETDVKMMERWEQMCITQYERESQAYYQ-RGSSM-VLFSSP
SUFS PFALC NITQSKQTKSIHSQHDTFKIYTHDTRKYGLKKI---------------------------
PRIO
PRIO~
PRIO"
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HUMAN
PFALC
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The first 60 amino acids approximately correspond to the plastid-targeting leader; while 
the PrP-like loop was said to be unstructured and therefore could not be modelled (Dr. 
J. W. Saldanha, pers. comm.). The molecule (Fig. 2.7) contains 276 hydrogen bonds; 20 
helices; 21 strands; 43 turns; but lacks disulphide bridges.
2.3.7. Genomic location of PfsufS
It was important to establish the presence and location of PfsufS in the malaria genome. 
This was accomplished by PFGE, followed by chromosome blotting with a 
radiolabelled probe specific for PfsufS (Fig. 2.8). Yeast DNA was used as a control to 
confirm the specificity of the PfsufS probe. PfsufS localised to the BLOB 
(chromosomes 6-9) of the P. falciparum 3D7 genome, a region that does not resolve on 
PFGE gels. This coincides with data from the genome project (chromosome I).45 PfsufS 
is also encoded by the P. falciparum CIO strain. However, in CIO, the genomic location 
cannot be precisely defined because CIO chromosomes are heavily fragmented (Dr. D. 
H. Williamson, NIMR, pers. comm.).
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FIGURE 2.7.
MOLECULAR MODEL OF PLASMODIUM FALCIPARUM SUFS.
Stereoscopic view into the active site cleft of the enzyme. Lysine-binding (yellow) and 
catalytic (red) motifs are marked. The enzyme is probably active as a dimer, but only 
the monomers are shown. Plastid-targeting leader and PrP-like loop are excluded from 
the model.
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FIGURE 2.8.
CHROMOSOMAL LOCALISATION OF PLASMODIUM FALCIPARUM SUFS.
Genomic DNA from P. falciparum 3D7 and CIO was resolved by PFGE and blotted 
onto nitrocellulose. Chromosomal localisation of PfsufS was revealed by incubation of 
the blot with a radiolabelled probe. Yeast DNA is included as a negative control (Y).
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2.3.8. Gene expression studies of PfsufS.
2.3.8.1. Transcription o f PfsufS.
Microarray data for P. falciparum are available. Bozdech, et a/.18 detected transcription 
of PfsufS (element id oPFBLOB0139) throughout the erythrocytic stage, but with an 
upregulation in trophozoites (24 h); this result has been reproduced in 3D7 and Dd2 
strains (DeRisi, UCSF, USA, unpublished observations*). In a study of P. falciparum 
HB3 developmental stages conducted by Le Roch, et a/.,83 upregulation of PfsufS 
(element id PF07_0068) was additionally demonstrated in sporozoites and gametocytes. 
Furthermore, PfsufS transcripts have been found in parasites isolated from the blood of 
an infected patient.234 In summary, PfsufS is not a pseudogene as its transcription can be 
detected in trophozoite stages as well as sexual stages of the parasite.
However, I decided it was necessary to confirm these published data. It had previously 
been shown that full-length PfsufS transcript could not be recovered by RT-PCR from 
erythrocytic stage parasites (Clough, Slatter and Wilson, NIMR, unpublished 
observations). I also made repeated attempts to amplify the entire PfsufS but was 
unsuccessful (data not shown). This suggested that PfsufS might not be expressed in 
erythrocytic stage parasites manipulated in our hands. To test this hypothesis, PfsufS 
sequence was broken in half and two sets of primers designed. Total RNA was 
recovered from mixed erythrocytic stage cultures of P. falciparum 3D7. RNA was 
prepared fresh; a typical stock concentration was 1.6 pg .pL 1. Crucially, the first set of 
primers spanned the intron boundary. Using these primers, RT-PCR was successful,
*http://plasmodb.org/restricted/gsdata/viewGlassSlideData.php?genesOnThisPage=l&g
eneID=PF07_0068
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producing products of predicted size (Fig. 2.9). This demonstrates that PfsufS transcripts 
are present in erythrocytic stage parasites.
2.3.8.2. Models o f regulation ofSUF genes.
Two mechanisms of SUF regulation may exist (chapter 1). In E. coli, correlation was 
noted between oxidative stress, iron limitation and SUF expression (chapter 1). Thus, E. 
coli SUF genes are thought to be involved in the iron starvation or oxidative stress 
responses. Recall that oxidative stress and iron status are intimately related.235 Indeed, 
Outten, et a/.178 consider the oxidative stress response of SUF genes to be ultimately due 
to iron limitation (chapter 1). However, in this study, the two conditions were 
investigated separately.
In eukaryotes and some bacteria, a different regulatory mechanism may operate to that 
found in E. coli. Specifically, the SUF system may fulfil a solely constitutive function. 
For example, in P. falciparum, the SUF system is predicted to supply [Fe-S 1 clusters 
exclusively to proteins located in the plastid organelle.236 However, upregulation of 
specific components of the SUF system could still occur in response to [Fe-S] cluster 
damage.
2.3.8.3. Design o f assay.
In an effort to distinguish between these two possible models (regulated vs. constitutive) 
in P. falciparum, it was decided to investigate PfsufS mRNA levels in response to both 
oxidative stress and iron limitation.
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FIGURE 2.9.
TRANSCRIPTION OF PLASMODIUM FALCIPARUM SUFS.
PfsufS[M] was recovered by PCR from genomic DNA (G) and cDNA (R) isolated from 
P. falciparum 3D7. Prior to RT-PCR, genomic DNA contamination was removed from 
RNA preparations by treatment with TURBO DNAse. Other abbreviations are as 
follows, bp: base pair; M: 123 bp ladder (Sigma); N: 5' end of PfsufS[M]; C: 3' end of 
PfsufS [M].
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At the commencement of this work, this was the first time such transcriptional 
responses had been measured in P. falciparum. Hence, the initial step was to establish a 
simple assay. This process is now described.
Genes can upregulate rapidly, often within minutes. Five min probably approaches the 
minimum time for upregulation of a eukaryotic gene, e.g., leu-2 of Neurospora 
crassa.231 In many gene expression studies, organisms are exposed to oxidative stress 
for short periods < 1 0  min.238 However, given the necessity for the stressor agent to 
diffuse through the multiple membranes surrounding malaria parasites in the red blood 
cell, a long exposure time (3 h) was chosen. With regard to oxidative stress in E. coli, it 
should also be noted that SUF upregulation may be associated with prolonged oxidative 
attack, as distinct from short periods of stress.146
In order to normalise loading of RNA on RNAP gels, PfactinI was used as a control. 
Initially, PfsufS and PfactinI were probed simultaneously in the same tube. However, 
this was uninformative, because degraded PfactinI fragments were of a similar size to 
(and thus indistinguishable from) PfsufS probe. Furthermore, PfactinI transcripts were 
in massive excess to PfsufS. Even after significant dilution of PfactinI probe, 
autoradiograms rapidly saturated. Therefore, it was decided to probe the two genes in 
separate tubes. Indeed, RNA level could be accurately estimated merely by inspection 
of 28S and 18S ribosomal bands on agarose gel stained with ethidium bromide (Fig. 
2.10A).
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2.3.8.4. Oxidative stress response.
Parasites were placed under oxidative stress by culturing with H20 2. Toxicity of H20 2 to 
P. falciparum is marked. For example, exposure of parasite cultures to high 
concentrations of H20 2 (> 100000 ppm) rapidly lead to cellular lysis. Frothing was also 
observed, indicating host catalase activity. Thus, low levels (10-1000 ppm) of oxidant 
were used in all assays. In spite of a weak signal, it appeared that exposure of parasites 
to H20 2 for 3 h had no influence on PfsufS transcription (Fig. 2.10A).
P. falciparum is known to be under considerable oxidative stress, notably, in the 
erythrocytic, ookinete and sporozoite stages; thus, the parasite has a highly developed 
antioxidant system.239 However, PfsufS does not appear to be part of this system.
Returning to first principles, oxidative stress must have a predominantly demetalling 
influence on [Fe-S] clusters (chapter 1). Indeed, transcription of sufS was unchanged 
under oxidative conditions in Synechocystis sp.240 Close examination of the E. coli 
microarray oxidative stress data175 indicates that EcsufA upregulated significantly (21 
x), about an order of magnitude greater than the trivial increase in EcsufS transcription 
over basal levels (3.5 x). The extent of EcsufBCDE upregulation was intermediate (8-16 
x). Therefore, in line with the hypothesis that oxidative stress preferentially damages 
the iron component of [Fe-S] clusters, it is tempting to speculate that SufA in particular 
operates in remetalling in E. coli.
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FIGURE 2.10.
TRANSCRIPTIONAL RESPONSE OF PLASMODIUM FALCIPARUM SUFS TO 
OXIDATIVE STRESS AND IRON STARVATION.
Erythrocytic stages of P. falciparum were exposed to oxidative stress by treatment with 
10, 100 and 1000 parts per million (ppm) H20 2 (A); or iron starvation by treatment with 
0 or 10 mM of BIP (B). Total RNA was extracted (RNA) and probed for PfactinI and 
PfsufS by RNAse protection assay. Ribosomal bands (28S and 18S) are marked with 
arrows.
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2.3.8.5. Iron limitation response.
To investigate the possibility that PfsufS transcription responded to iron limitation, 
cultures were treated with BIP, a lipophilic compound that chelates Fe2+, even in the 
cytosol of P. falciparum red blood cell stages.241 BIP is toxic to P. falciparum (10^-24 h 
of 27.9-37.9 pM242) and has been proposed as an adjunct to conventional antimalarial 
chemotherapy.243 The mechanism of toxicity is unknown. In my hands, BIP had a 
significant negative effect on the growth of P. falciparum (data not shown). However, 
exposure of parasites to 10 mM BIP for 3 h did not markedly influence PfsufS mRNA 
level. (Fig. 2.10B). It is worth noting that sufS transcription in A. thaliana was also 
unaffected by iron starvation.185
As observed for oxidative stress (section 2.3.8.4), reductions in intracellular iron 
concentration probably do not demand increases in the transcription of genes encoding 
cysteine desulphurases. Conversely, increase in the expression of proteins involved in 
iron transport would presumably heighten the efficiency of iron recovery from 
intracellular depots. Iron-responsive regulatory factors probably operate in P. 
falciparum244 so it would not be implausible to find iron regulation of SUF proteins.
2.3.8.6. Conclusion and future work.
With regard to the oxidative stress (section 2.3.8.4) and iron limitation (section 2.3.8.5) 
data, I found no evidence that PfsufS transcription was influenced by either of these 
environmental perturbations. This result is consistent with findings in bacteria and 
vascular plants (sections 2.3.8.4-5). However, specific attack on the sulphur component 
of [Fe-S] clusters, e.g., by NO (g), would presumably lead to upregulation of sufS
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(chapter 1). Additionally, it seems possible that oxidative stress and iron limitation 
could regulate PfsufA. In future work, it would be fruitful to investigate these ideas 
using the assay reported here. Nevertheless, until a greater understanding of 
transcriptional control in P. falciparum is developed, the value of such simple 
experiments can be challenged.
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CHAPTER 3.
EXPERIMENTS ON THE INTRACELLULAR LOCALISATION OF 
PLASMODIUM FALCIPARUM  SUES.
P. falciparum SufS is predicted to target the plastid. This chapter begins with a 
summary of current ideas on the mechanisms of plastid localisation in Apicomplexan 
cells. Prediction of the plastid localisation of PfSufS is described in detail. 
Investigations of this prediction, by transfection and immunolocalisation, are reported.
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3.1. INTRODUCTION.
3.1.1. Protein traffic to the plastid in malaria.
3.1.1.1. The need for protein import to the plastid.
As soon as the minimal size of the plastid genome of P. falciparum (35 kb)53 was 
known, it became apparent that the majority of plastid functions must be performed by 
heterochthonous proteins (c.f., plastids of vascular plants and algae): genes encoded in 
the nucleus are translated on cytosolic ribosomes; gene products are trafficked to the 
plastid where they act. The most recent bioinformatic estimate for the number of such 
genes in P. falciparum is 545 (encoding ~ 5 % of total proteome).80 Understanding the 
function of the plastid requires the identification of proteins that traffic to it; hence, 
considerable effort has been expended in dissecting the phenomenon.60,76,257
3.1.12. Complexity o f trafficking imposed by multiple membranes.
The plastid is bounded by multiple membranes. In P. falciparum, the number is either 
three or four, depending upon interpretation. For example, Hopkins, et al.59 observed 
three bounding membranes by electron microscopy (EM). Conversely, four membranes 
were observed by EM of other Apicomplexan cells, e.g., T. gondii54 and the reptile 
parasite Garnia gonadoti (Haemosporina: Garniidae).258 However, it has been pointed 
out that the fourth membrane of the T. gondii plastid could be an extension of the 
endoplasmic reticulum (ER).259 Survey of the Apicomplexan literature by Waller and 
McFadden60 apparently revealed a four-membrane plastid in Hepatozoon domerguei 
(Coccidia: Adeleidea),260 Coelotropha durchoni (Coccidia: Grelliidae)261 and Selenidium
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pendula (Sporozoa: Archigregarinida).262 Resolution of the number of membranes is 
important, as it has significant implications for the mode of plastid trafficking.
The inner two membranes of the plastid are believed to be derived from the primary 
endosymbiont (chapter 1) and hence may be termed primary inner and outer 
membranes. These membranes have, in turn, been encircled by one (or two) 
membrane(s) from secondary endosymbiosis (secondary inner and outer membranes). 
The secondary inner membrane may correspond to the cell membrane of the secondary 
endosymbiont, while a secondary outer membrane could be a vestige of the endocytic 
vesicle membrane. The compartment between the primary and secondary membrane 
layers is termed the periplastid space.
3.1.1.3. Mechanism o f intracellular trafficking to the plastid.
One experimental paradigm for plastid trafficking is acyl carrier protein (ACP) in the 
erythrocytic stages of P. falciparum (PfACP; PlasmoDB PFB0385w) and in the 
tachyzoite stages of T. gondii (TgACP; GenBank AAC63956). Experiments conducted 
with ACP indicated that nuclear-encoded proteins addressed to the plastid can be 
recognised by an N-terminal bipartite leader sequence (ACPJL]) composed of a signal 
peptide and a plastid transit peptide.76 This mode of targeting seems to apply generally 
to other parasite plastid proteins.
Fluorescent reporters (e.g., GFP) can be addressed to the plastid in vivo by genetic 
fusion to an N-terminal leader sequence. By this method, it was shown that specific 
ablation of the signal peptide led to accumulation of fluorescence in the cytosol; 
conversely, ablation of the plastid transit peptide led to accumulation of fluorescence in
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the parasitophorous vacuole.79 Hence, it was assumed that plastid-targeted proteins 
were first directed to the secretory pathway, presumably via the Golgi apparatus (at 
least in T. gondii, where a Golgi is clearly observed), before diversion to the plastid.
However, it has been claimed that proteins also pass through the parasitophorous 
vacuole en route to the plastid.263 Additionally, inhibition of Golgi trafficking by 
treatment of T. gondii with brefeldin-A, or incubation at low temperature (15 °C), did 
not abolish plastid import264 Furthermore, appending a T. gondii ER retrieval (HDEL) 
signal to the C-terminal of the GFP constructs did not influence plastid targeting.264 
These data argue against involvement of the classical secretory pathway.
Nevertheless, as a generalisation, the signal peptide is thought to be cleaved in the ER. 
Vesicles265 may convey the partially cleaved protein, possibly bound to the chaperone 
DnaK (section 3.1.2.3), and dock to components of the outermost membrane of the 
plastid. This could lead to insertion of the protein into the space underneath the 
outermost membrane. If the plastid is enveloped by four membranes (section 3.1.1.2), 
the protein would face the additional challenge of passing through a second membrane 
to reach the periplastid space. It is possible that this could be achieved via interaction 
with a duplicated Toe complex,76 but the actual mechanism is unclear.
DeRocher, et al.26* have proposed the existence of a pre-plastid compartment in which 
interaction between the C-terminal HDEL signal of the plastid-targeted protein and an 
ER retrieval receptor (e.g., Erd2) could occur (leading to re-entry of the protein into the 
secretory pathway). Presumably, for successful import to the plastid, this retrograde 
process must be out-competed by interaction between the plastid transit peptide and
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receptors on the plastid membrane. One speculation is that this pre-plastid compartment 
corresponds to the periplastid space.
Following entry into the periplastid space, the import pathway is believed to mimic that 
of the chloroplast. Specifically, a Tic/Toc translocon complex266 may mediate import 
through the two primary membranes, possibly energised by the autochthonous ATPase, 
PfClpC (GenBank S72278).236 However, it is worth noting that only a putative Tic22 
orthologue has been shown to target the plastid in P. falciparum  (Tonkin and 
McFadden, University of Melbourne, Australia, unpublished observation) and that no 
other Tics/Tocs have been identified. Cleavage of the transit peptide is probably 
achieved by endopeptidases in the plastid lumen (e.g., PfSPP; GenBank AF453250), 
releasing mature protein that can adopt a functional conformation, perhaps by the action 
of imported chaperones, e.g., Cpn60.267
3.1.1.4. Kinetics o f trafficking.
By pulse-chase experiments with PfACP[L]-GFP, van Dooren, et alT1 estimated the 
minimum time from protein synthesis, to cleavage and import into the plastid to be 30- 
40 min. This is similar to the import time for the small subunit of ribulose-15- 
bisphosphate carboxylase/oxygenase to the secondary plastid of Euglena gracilis (ca. 
40 min).268 However, it is considerably longer than for import of the L I8 ribosomal 
protein to the primary plastid of the green alga Chlamydomonas reinhardtii (< 10 
min).269 The rate-limiting step for import of proteins to the Apicomplexan plastid is thus 
assumed to be the cleavage of the plastid transit peptide.
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These kinetics give a characteristic delay signature on Western blots. When P. 
falciparum lysate is probed with antibody to plastid-targeted protein, a low abundance 
high molecular weight band (partially cleaved protein) and a high abundance low 
molecular weight band (mature protein) are seen.77,97
3.1.1.5. Comparison with trafficking to other secondary plastids.
Plastid trafficking in Apicomplexa is often modelled on the mechanisms in vascular 
plants. However, although data are sparse, it is probably more useful to look for clues in 
organisms containing secondary plastids. Important examples of cells hosting plastids 
bound by three membranes include the alga Euglenay while chromists harbour a plastid 
bounded by four membranes.265 However, based on a molecular phylogenetic study of 
duplicated GAPDH genes,62 dinoflagellates are considered the most closely related 
taxon to the Apicomplexa, with triple-membrane plastids. Nassoury, et al.210 studied 
plastid trafficking in the dinoflagellate Gonyaulax polyedra (Dinophyceae: 
Gonyaulacaceae) and revealed that a bipartite leader was required for plastid targeting, 
and that traffic passed through the Golgi apparatus (not a prominent organelle in P. 
falciparum erythrocytic stages).
3.1.2. Minimum determinants for plastid targeting in Apicomplexa.
3.1.2.1. The signal peptide.
The signal peptide portion of the leader sequence of plastid-targeted proteins is of the 
classical hydrophobic type and hence readily detected using standard algorithms, e.g.,
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SignalP. The signal peptide is probably co-translationally cleaved as the protein is 
drawn into the parasite ER, revealing the plastid transit peptide.
3.1.2.2. The plastid transit peptide.
In common with chloroplast transit peptides, the plastid transit peptide portion of the 
leader exhibits a net positive charge. However, unlike equivalents in vascular plants, it 
is enriched for asparagine and lysine and depleted in acidic residues.79 Mutation 
experiments with PfACP[L] indicated that the net positive charge was absolutely 
required for plastid-targeting.79 Besides these properties, there appears to be 
considerable functional redundancy in primary sequence.271 Thus, mutations of the 
plastid transit peptide might be expected to be under limited functional constraint and 
therefore subject to faster rates of base substitution (as compared to sequence coding for 
the mature protein). Indeed, it has been suggested that the major constraining influence 
on the amino acid composition of the plastid transit peptide is the codon bias of the 
DNA.272 All this adds up to a lack of association between primary amino acid sequence 
and plastid targeting. Thus, it has proved difficult to predict plastid transit peptides 
(section 3.1.3.1).
Considerable insight into the workings of the plastid transit peptide has been gained 
from a recent study of deletion mutants of the T. gondii ferredoxin NADP* reductase 
leader.273 Experiments were interpreted in the light of consensus motifs identified by a 
computational technique (TEIRESIAS Sequence Pattern Discovery274). Additionally, 
precise observations of intracellular protein localisation were achieved by 
deconvolution of micrographs. Hence it was possible to distinguish between targeting to
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the plastid periphery (possibly synonymous with the periplastid space) and the plastid 
lumen.
By these methods, it was shown that the transit peptide possessed a linear microdomain 
architecture: the N-terminal of the transit peptide (probable motif V[V/S]SF) mediated 
escape from the ER after co-translational cleavage of the signal peptide; whereas, the 
central microdomain controlled trafficking to the plastid periphery. However, the 
master-targeting switch appeared to be the C-terminal of the plastid transit peptide. 
Absence of the C-terminal microdomain simultaneously dispatched the protein to the 
plastid periphery; parasitophorous vacuole; and rhoptries. Perhaps the C-terminal 
microdomain “grabs” the outer primary membrane of the plastid, thereby saving the 
protein from being “washed away.”236
van Dooren, et al71 implicated PfSPP in the targeting process, and suggested proteolysis 
took place in the lumen of the plastid. Indeed, cleavage may be absolutely required for 
entry into the plastid lumen.273 It has also been suggested that multiple cleavages occur. 
Furthermore, given the apparent lack of cleavage site consensus, it is tempting to 
speculate that several endopeptidases with different specificities might be involved. One 
final curiosity is that alternative splicing allows PfSPP to share a plastid-targeting leader 
with P. falciparum porphobilinogen synthase (PfPBGS; GenBank AY064477), an 
enzyme involved in haem biosynthesis.77
3.12.3. The third factor.
While it seems that a bipartite leader is necessary and sufficient for plastid targeting, 
precedent in plants suggests that accessory factors may enhance the process. For
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example, Hsp70-like proteins can interact with chloroplast transit peptides,275 thereby 
maintaining an unfolded state appropriate for passage through the chloroplast 
membranes. Foth, et al.79 suggested the existence of a similar phenomenon in 
Apicomplexan plastid trafficking, citing the finding that DnaK-binding sites are 
abundant (> 90 % of leader sequences examined) in P. falciparum plastid transit 
peptides. Furthermore, ablation of the Hsp70-binding site of PfACP[L]-GFP directed a 
proportion of the fluorescent reporter to the parasitophorous vacuole;79 while a similar 
experiment conducted in T. gondii abolished plastid-targeting altogether.271 Further 
circumstantial evidence for DnaK involvement derives from the co-purification of an 
Hsp70-like chaperone (TgBiP) (and a subtilisin, TgSUBl) with TgL9[L]-GST fusions 
over-expressed in T. gondii.216
3.1.3. Identification of plastid-targeted proteins.
3.1.3.1. In silico techniques.
In spite of the obscure nature of the plastid transit peptide (section 3.1.2.2), ab initio 
predictions based on amino acid sequence have been made using an artificial neural- 
network (ANN) based algorithm (PATS).78 Precedent (ChloroP) suggested that this 
might be a useful approach. However, as has been noted for ChloroP,277 the problem 
with ANN-based algorithms is that it is difficult to know how they make decisions. This 
motivated the development of a rule-based algorithm (PlasmoAP) that was validated in 
vivo by selective mutation of PfACP[L].79
117
3.1.3.2. In vivo techniques.
In plants, it is possible to fractionate the chloroplast and perform a proteomic analysis. 
In spite of concerted efforts, such a technique has not yet been achieved in the 
Apicomplexan plastid. Therefore, localisation of plastid proteins relies entirely on 
immunocytochemistry (fluorescence microscopy or immunogold EM); or transient 
transfection. To my knowledge, only PfACP, PfPBGS278 and (controversially236) PfFC110 
have been localised to the plastid by antibody treatment of fixed cells. Indeed, more 
common is to fuse the leader to a fluorescent reporter, e.g., GFP or Discosoma Red 
(DsRed).267 Nevertheless, only a small number of proteins have been localised by these 
methods (Table 3.D.97’99’108’.‘o-271-278-280
3.1.4. Chapter objective and overview.
The objective of this chapter is to describe preliminary steps in work intended to reveal 
the intracellular localisation of PfSufS. After the Materials and Methods, the results 
section begins with a discussion of the bioinformatic prediction of plastid localisation 
for PfSufS. Subsequently, transfection experiments in P. falciparum using the PfSufS 
leader fused to GFP are described. Transfection experiments in T. gondii using a 
synthetic P. yoelii SufS leader fused to a fluorescent reporter are also discussed. Finally, 
I report the development and initial evaluation of peptide antibodies intended for PfSufS 
immunolocalisation experiments.
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TABLE 3.1.
PROTEINS DEMONSTRATED TO TARGET THE PLASTID IN  VIVO.
Only published observations are reported. *Validity of localisation evidence has been 
challenged by Wilson.236 Evidence codes are as follows. TF: transfection of cells with 
vector encoding a fluorescent reporter fused to the N-terminal leader sequence of the 
protein under investigation; IF: immunofluorescence with specific antibody directed 
against the protein under investigation; IG: immunogold electron microscopy with 
specific antibody directed against the protein under investigation.
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Protein Evidence Organism
Acyl carrier protein TF; IF; IG P. falciparum; T. gondii
Apicoplast dihydrolipoamide dehydrogenase TF P. falciparum
p-ketoacyl-ACP synthase III TF P. falciparum
Ferrochelatase* IG P. falciparum
Porphobilinogen synthase IG P. falciparum
Pyruvate dehydrogenase El a TF P. falciparum
Pyruvate dehydrogenase E2 TF P. falciparum
Ribosomal protein S9 TF; IF T. gondii
References
Waller, etal. [Ref. 97; 279]
McMillan, et al. [Ref. 280]
Waller, etal. [Ref. 279]
Varadharajan, et al. [Ref. 110] 
Dhanasekaran, et al. [Ref. 278]
Foth, et al. [Ref. 99]
Foth, et al. [Ref. 99]
Yung, et al.; Waller, et al. [Ref. 271; 97]
3.2. MATERIALS AND METHODS.
3.2.1. Computational techniques.
Bipartite plastid-targeting sequence was predicted using the PATS78* and PlasmoAP79f 
algorithms. Signal sequence was predicted using SignalP 3.0;289:!: while mitochondrial 
targeting sequence was predicted using PlasMit.290^  DnaK binding sites were predicted 
with the rudialg3.awk algorithm.291 § Quality of PCR primers was checked using the 
Amplify software. DNA sequences were assembled using the ABI Prism Sequencing 
Analysis software (Perkin Elmer) running on an Apple Power Mac G4. Molecular 
models were analysed with RasMol.
3.2.2. Parasite culture techniques.
P. falciparum 3D7 parasites were cultured by standard methods.252 Parasites were 
cultured in leukocyte-depleted RBCs obtained from the National Blood Service (UK); 
or in whole blood obtained from healthy human volunteers (consistent with MRC 
ethical guidelines). Briefly, ca. 10 mL whole blood was recovered by venipuncture into 
a tube containing 2.8 mL sterile anticoagulant citrate dextrose (2.45 g glucose, 2.20 g 
tri-sodium citrate and 0.89 g citric acid in 100 mL redistilled water). After gentle 
mixing, the tube was placed at 4 °C to allow the cells to separate from the serum by 
gravity. Serum was aspirated and packed cells used in transfection experiments for < 28 
d. T. gondii tachyzoites were grown in MDCK cells by standard techniques.286
* http://gecco.org.chemie.uni-frankfurt.de/pats/pats-index.php
t  http://plasmodb.org/restricted/PlasmoAPcgi.shtml 
$ http://www.cbs.dtu.dk/services/SignalP/
5 http://gecco.org.chemie.uni-frankfurt.de/plasmit/index.html
§ http://www.bijvoet-center.nl/cpc/labmembers/Stefan/DnaKbinding
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3.2.3. Nucleic acid techniques.
Nucleic acid techniques were as described (chapter 2). Primer sequences are indicated 
in Table 3.2.
3.2.4. Transfection experiments in Plasmodium falciparum,
3.2.4.1. P. falciparum transfection constructs.
Two vectors were used for transient transfection of P. falciparum: pHH2 and pSSPF2.
The pHH2 vector was created by Waller, et al.279 and encodes GFP-PfACP|Ll. The
vector also encodes mutant human dihydrofolate reductase (hDHFR), allowing selection 
with the drug WR99210. The pSSPF2 vector is a modified version of pHH2 developed 
by Sato, et al.223 Vector pHH2 was a gift from Dr. A. F. Cowman (WEHI, Melbourne, 
Australia); pSSPF2 was provided by Dr. S. Sato (NIMR).
3.2 4.2. Cloning o f P. falciparum SufS leader sequences.
Exon 1 (PfsufS(Ell) and sequence encoding the first 54 (PfsufSfL^l) and 72 
(PfsufSlLrcl) amino acids of PfSufS were separately amplified by RT-PCR from P. 
fa lciparum  3D7 cDNA. PfsufSJEl] was amplified with primers 3.1 and 3.2. 
Thermocycling conditions were: denaturation at 94 °C for 1 min; followed by 35 cycles 
of 98 °C for 10 s; 45 °C for 2 min; and 72 °C for 10 min.
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TABLE 3.2.
PCR PRIMERS USED IN CHAPTER 3.
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ID DNA sequence
3.1 5’AGATCTAATGTTAAGAGGCCCTAGATGTCrC
3.2 3'CCT AGGTT AT A A AACTCACTCATTTTCTCTAT
3.3 5'GGGAGATCT A A AATGTT A AGAGGCCCT AGATGTCTCTACAT
3.4 3'GGGCCTAGGCITTTCATCTTTTGTCAATC
3.5 3'GGGCCT AGGAAAATGTTCTCTT ACATTTTT AAAAT AATC
3.6 5'AGATCTAAGATGAACAACAAAAGTATTTGCATCTTGCTGC
3.7 5TGCTCTTCCTT AAGATT ACAGGATACT ACAGTT ACTACAT
3.8 5T AGCCCATTGAAAAAGAACATTT AT ACACACCCAATCTAC
3.9 5'AAGAGACATATCCTCAAGTTGCAAAATGAAAAACCTGAGA
3.10 5TCGACTCGAACATT ATT A ACT ACTTT AAGAACATTCGCTC
3.11 5TGATTTTCCCTTCTTTCAACAGAATAATTCACCCATCTAC
3.12 5TTTGATAATGCTGCAACTACACATAAACCTGCTTCTGTAA
3.13 3,CCTAGGTTTGATCTTTTCAATTACAGAAGCAGGTTTATGT
3.14 3'GTAGTTGCAGCATTATCAAAGTAGATGGGTGAATTATTCT
3.15 3'GTTGAAAGAAGGGAAAATCAGAGCGAATGTTCTTAAAGTA
3.16 3,GTTAATAATGTTCGAGTCGATCTCAGGTTTTTCATTTTGC
3.17 3'AACTTGAGGATATGTCTCTTGTAGATTGGGTGTGTATAAA
3.19 3TGTAATCTTAAGGAAGAGCAGCAGCAAGATGCAAATACTT
In order to amplify PfsufSfL^], primers 3.3 and 3.4 were used; equivalents for 
PfsufSfL^] were 3.3 and 3.5. Thermocycling conditions were: denaturation at 94 °C for 
1 min; followed by 35 cycles of 98 °C for 20 s; 56 °C for 30 s; and 72 °C for 1 min.
PfACP[L] was excised from the parent vector by restriction digest (Bglll and BlnY) and 
replaced with PfsufS[El], giving the plasmid pHH2:PfsufS[El]-GFP. PfsufSJEl ] was 
additionally cloned into pSSPF2 between Bglll and Blnl sites, giving rise to 
pSSPF2:PfsufS[El]-GFP. PCR products of PfsufSfL^] and PfsufSJL^l were digested 
with Bglll and Blnl and inserted between these sites in pSSPF2, giving constructs 
pSSPF2:PfsufS[L54]-GFP and pSSPF2:PfsufS[L72]-GFP, respectively. Inserts were 
confirmed by restriction digest and Sanger sequencing. pHH2:PfACP[L]-GFP and 
pSSPF2:PfiscS[L]-GFP were used as positive controls. GFP is targeted to the plastid by 
PfACP[L]279 and to the mitochondrion by PflscSfL].223
3.2.4.3. Preparation o f DNA for transfection.
To prepare DNA for transfection, INVaF cells harbouring vector were grown for 12 h 
at 37 °C in 100-500 mL Luria-Bertani broth (10 g bactotryptone, 5 g yeast extract, 10 g 
NaCl per 1 L redistilled water) with 0.2 % D-glucose and 100 //g.mL1 ampicillin. 
Plasmid DNA was purified by Wizard Plus Maxiprep (Promega) or QIAfilter Plasmid 
Maxi (Qiagen). DNA was ethanol precipitated and the concentration and purity assayed 
by 260/280 ratio and restriction digest. Immediately prior to transfection, DNA (100 pig) 
was dissolved in 50 piL of sterile TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA).
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3.2.4.4. Preparation of parasites for transfection.
Two days before electroporation, P. falciparum erythrocytic stages were synchronised 
in 10 % D-sorbitol by standard methods.292 This ensured that the culture was 
predominantly at the ring stage for electroporation.
3.2.4.5. Electroporation o f parasites.
Cells were loaded with DNA by electroporation as follows. Parasites (I % parasitaemia, 
200 pL  packed cell volume) were re-suspended in 200 pL  sterile cytomix (120 mM 
KC1, 0.15 mM CaCl2, 2 mM EGTA, 5 mM MgCl2, 10 mM K2HP04/KH2P04, 25 mM 
HEPES, pH 7.6). DNA in TE was added and the suspension mixed by gentle pipetting. 
The suspension was placed in a 0.2 cm gap electroporation cuvette (Biorad Genepulser) 
and electroporated on a BTX Electro Cell Manipulator 600 (parameters were set to 310 
V, 950 pF, 24 Q). For all electroporations, the recorded voltage was 290-300 V and the 
pulse time was 8-10 ms.
3.2.4.6. Recovery and drug selection.
Electroporated cells were transferred to 10 or 20 mL RPMI-1640 with Albumax 
(Invitrogen), 1 % glutamine and supplemented with 2 % AB+ human serum (National 
Blood Service, UK) and incubated under 5 % 0 2, 5 % C 02 in N2 at 37 °C. After 2 d 
recovery, 2.5-10 nM of the anti-folate drug WR99210 (Jacobus Pharmaceutical, 
Princeton, NJ, USA) was added in RPMI-1640. Gas, medium and drug were changed 
regularly. The health of the culture was checked by thin blood film stained with
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Giemsa’s stain. To detect fluorescent parasites, live cultures were viewed by UV 
microscopy (Zeiss).
3.2A.7. Growth assay with [8-3H]hypoxanthine.
Electroporated cells were transferred to 96-well microtitre plates. A volume (1 piL) of 
[8-3H]hypoxanthine (Amersham) was added to each well. After incubation for 48 h, 
parasites were harvested onto Wallac filtermats using a Tomtec cell harvester. 
Filtermats were soaked in 20 mL Be tap late Scint liquid scintillation cocktail (Perkin 
Elmer) and counted on a Wallac 1205 Betaplate liquid scintillation counter.
3.2.5. Toxoplasma gondii experiments.
3.2.5.1. Construction o f a synthetic SufS leader.
The approach of Jomaa, et al.lcr} was used. The first 100 amino acids of the P. yoelii 
SufS N-terminal were predicted to encode the leader sequence. The leader was back- 
translated with codon bias harmonised for T. gondii (by reference to the Codon Usage 
Database*) and flanked with restriction sites (Bglll and Blnl). Harmonised sequence 
was divided into fifteen 20-mers and codon usage further adjusted to ensure melting 
temperatures of 52-56 °C. The 20-mers were concatenated into seven overlapping 40- 
mers and complimentary sequence was generated, giving a total of 14 oligomers 
(primers 3.6-3.19) to cover synthesis of the leader.
* http://www.kazusa.or.jp/codon/
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Synthetic PySufS leader (PySufS[LJ) was assembled by recursive PCR essentially as 
described.293 Briefly, equal volumes of the 14 oligomers were combined and diluted 1/5 
into a PCR reaction mixture containing 1 x Pfu buffer (Promega), 5 mM MgS04, 1 mM 
of each dNTP and 3 U Pfu DNA polymerase (Promega). The final concentration of each 
oligomer in the reaction mixture was 180 nM. Oligomers were assembled by 
denaturation at 94 °C for 1 min followed by 24 cycles of 94 °C for 30 s, 50 °C for 30 s 
and 72 °C for 2 min. A second PCR was conducted to amplify full length product using 
the extreme 5' and 3' primers (3.6 and 3.13). Thermocycling conditions were: 94 °C for 
1 min, followed by 24 cycles of 94 °C for 45 s, 68 °C for 45 s and 72 °C for 2 min. The 
amplicon was inserted into the pCR-Script Amp SK(+) plasmid (Stratagene) by blunt 
end cloning. Insert was confirmed by restriction digest and Sanger sequencing.
3.2.5.2. T. gondii targeting constructs and transfection.
Two similar constructs were used for transient transfection of T. gondii: (1) 
pSAG 1 /CAT/TUB 1 /TgACP leader-GFP; and (2) pSAGl/CAT/TUB 1/TgACP leader- 
DsRed. These vectors were originally developed by Soldati and Boothroyd288 and 
encode T. gondii major surface antigen (SAG1), chloramphenicol acetyltransferase 
(CAT) and a-tubulin (TUB1). Additionally, the vectors encode a fluorescent marker 
[green fluorescent protein (GFP) or Discosoma red (DsRed)] in frame to the T. gondii 
acyl carrier protein leader sequence (TgACP[L]). TgACP[L] targets the fluorescent 
marker to the plastid organelle. Both vectors were a gift from Dr. S. Sato.
TgACP[L] was excised from the vectors by restriction digest {Bglll and Blnl) and 
replaced with PySufS [LJ. Insert was confirmed by restriction digest and Sanger 
sequencing. DNA was prepared for transfection as described (section 3.2.4.3).
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Immediately prior to transfection, DNA (25 pmol per transfection) was dissolved in 100 
pih of sterile cytomix. Transfections were performed by Dr. R. J. M. Wilson (NIMR), as 
described.288 To detect fluorescent parasites, live cultures were viewed under a 
fluorescence microscope (Zeiss).
3.2.6. Design, production and evaluation of peptide antibodies.
3.2.6.1. Production o f peptides and polyclonal sera.
Antibodies were prepared by Sigma-Genosys (UK). Peptides from PfSufS were 
synthesised via solid-phase Fmoc chemistry validated by mass spectrometry (MS) and 
reversed phase high performance liquid chromatography (HPLC); and conjugated to 
Keyhole limpet haemocyanin ([KLH]). Peptides were: HIKYDIKKMKKNKSC-[KLH] 
(BURN-1); and IKLHHCJKYYLKVPDTSRIS (BURN-2). Immunizations were done 
in New Zealand White rabbits according to IACUC animal welfare guidelines. The 
immunization regimen lasted 77 d and comprised one priming immunization (200 fig) 
in complete Freund’s adjuvant; followed by five boosting immunizations (100 fig) in 
incomplete Freund’s adjuvant. Serum was used for Western blotting without 
purification.
3.2.6.2. Screening o f polyclonal anti-sera.
Polyclonal anti-sera were screened by Western blotting against P. falciparum 3D7 
lysate or recombinant PfSufS proteins (chapter 4). P. falciparum 3D7 lysate was 
prepared from mixed erythrocytic stages (parasitaemia ca. 10 %; packed cell volume ca.
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2 mL) by repeated freezing in a dry ice/ethanol slush; and thawing in a 37 °C water 
bath. Lysed parasites were diluted in PBS; mixed with reducing SDS loading buffer 
(NEB); and heated to 70 °C for 10 min prior to separation through 12 % BT NuPAGE 
gel (Invitrogen). Gels were transferred to nitrocellulose membrane at 20 mA for 15 h; 
blots were blocked for 3 h in 5 % w/v BSA fraction V (Sigma), 0.1 % v/v Tween 20 
(Sigma) in PBS. Blots were immersed for 1 h in serum diluted 1:1000 in blocking 
buffer followed by incubation with 1:3000 goat anti-rabbit IgG (H+L)-HRP conjugate 
(Bio-Rad). Cross-reactive bands were revealed by ECL (Amersham) and imaged using 
Amersham Hyperfilm. Images were captured using an Epson Perfection 2480 Photo 
scanner and molecular weights of proteins estimated by comparison to Mark 12 
unstained standards (Invitrogen) using image analysis software (UVP LabWorks).
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3.3. RESULTS AND DISCUSSION.
3.3.1. Structure of the bipartite leader of Plasmodium falciparum SufS.
3.3.1.1. Plastid-targeting properties o f PfSufS[LJ.
To predict the intracellular localisation of PfSufS, the strict decision tree employed by 
Ralph, et a/.80 was applied. Submission of the PfSufS protein sequence to PATS ip = 
0.947) and PlasmoAP (5 of 5 tests positive) indicated the presence of a bipartite plastid- 
targeting signal. It is also worth noting that PfSufS is non-mitochondrial, as shown by 
PlasMit ip = 0.99).
3.3.12. Signal peptide.
Further inspection of the N-terminal portion of PfSufS was done using the SignalP 
neural network (NN) and Hidden Markov Model (HMM) algorithms. SignalP-NN 
predicted a signal peptide (5/5 tests positive) while SignalP-HMM favoured an un­
cleaved signal anchor ip = 0.501) over a signal peptide ip = 0.495). Both algorithms 
predicted signal peptidase cleavage between C22 and Y23, thus delimiting the signal 
peptide to the first 22 amino acids of PfSufS. Based on this prediction, the plastid transit 
peptide would begin at Y23.
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3.3.1.3. Plastid transit peptide.
Further analysis was conducted upon the predicted plastid transit peptide, starting at 
Y23 and predicted to end at 160. Consistent with this, alignment with bacterial SufS 
sequences (lacking intracellular targeting signals) suggested that the mature PfSufS 
enzyme started at about D62. Pair-wise comparison with the plastid transit peptide of 
PfACP indicated significant divergence at the amino acid level, although both regions 
were predicted to carry a net positive charge and were enriched for arginine (data not 
shown).
It has been suggested that binding of DnaK may be an additional determinant of plastid- 
targeting in the Apicomplexa, mimicking the situation of chloroplast transit peptides.275 
An algorithm developed for prokaryotic sequences is useful for detection of DnaK 
binding sites in P. falciparum transit peptides.79 Indeed, the algorithm revealed a 
possible DnaK binding site (AAGK = -11.44 kJ.mol'1) centred on residue Y33 of PfSufS.
3.3.1.4. Model for plastid trafficking o f PfSufS.
The predictions summarised above reasonably suggested that PfSufS targets the plastid. 
Experimental methods have been applied to verify such predictions (sections 3.3.2- 
3.3.4).
My prediction is that full-length PfSufS (65 kDa) is expressed on cytosolic ribosomes 
and then cleaved by a signal peptidase, giving an incompletely processed product of ~ 
62 kDa. Further clipping by a stromal processing peptidase (e.g., PfSPP) would occur in 
the plastid, leaving a mature enzyme of ~ 57 kDa. The predicted structure of PfSufS[L| 
is summarised in Fig. 3.1.
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FIGURE 3.1.
IMPORTANT TARGETING FEATURES OF PLASMODIUM FALCIPARUM
SUFS.
A. Major features of PfSufS protein sequence.
The signal peptide is predicted to run M1-C23, with signal peptidase (SP) cleavage 
occurring between C23 and Y24. The plastid transit peptide may stretch from Y24-I60, 
with cleavage by stromal processing peptidase (SPP) possibly occurring between 160 
and D62. As determined by alignment with EcSufS, mature PfSufS runs D62-K546. 
Peptides used for generation of peptide antibody are marked in green (Bum-1) and blue 
(Bum-2). The putative PLP-binding lysine (K291) is marked in yellow while the active 
site cysteine (C497) is marked in red. Regions excluded from the homology model are 
marked in grey, while the extremes of the modelled region are marked in orange (N- 
terminal) and purple (C-terminal). Bioinformatic methods are described in section 3.2.1.
B. Homology model of PfSufS showing position of peptides.
Peptides used for generation of peptide antibody are marked in green (Burn-1) and blue 
(Bum-2). The N-terminal is marked orange while the C-terminal is marked purple. The 
putative PLP-binding lysine (K291) is marked in yellow while the active site cysteine 
(C497) is marked in red. The molecule in the left panel is a 90° rotation in the jc-plane 
of the molecule in the right panel.
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It is tempting to speculate that cofactor (PLP) binds PfSufS apoenzyme in the plastid 
lumen. However, it is worth noting that a protein expected to be critical for this process, 
pyridoxal kinase (PfPdxK; GenBank NP_703820),281 resides in the cytosol in P. 
falciparum.™2 Dimerization of PfSufS; and complex formation with other components 
of the SUF system (e.g., PfSufBCDE) may additionally take place in the lumen of the 
plastid.
3.3.2. Transfection experiments in P. falciparum.
33.2.1. Transfection methodology.
<
To test the plastid-targeting prediction for PfSufS (section 3.3.1), transient transfection 
experiments were done in P. falciparum. Initial experiments were conducted with 
PfSufS[El]. Sequence was cloned by RT-PCR and inserted into pHH2 and pSSPF2 
vectors (Fig. 3.2). These vectors allowed the expression of PfSufS[El] to fused at the 
C-terminal to GFP. In a typical experiment, erythrocytic stage parasites were 
electroporated with vector and allowed to grow for 2 d (reaching a parasitaemia of ca. 4 
%), before treatment with the anti-folate selection drug WR99210 (2.5-20 nM).
It is worth noting that there was ca. 50 % reduction in parasite growth due to 
electroporation, as assessed by measurement of [3H]hypoxanthine uptake over the 48 h 
post shock period (Fig. 3.3). In addition, treatment with drug was rapidly parasiticidal 
and ca. 4 d after first exposure no live parasites were visible after extensive (ca. 20 min) 
searching of Giemsa-stained blood films.
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FIGURE 3.2.
RESTRICTION DIGEST OF PFSUFS[E1]-GFP CONTRUCTS.
Vector DNA of pHH2:PfsufS[El]-GFP (A) and pSSPF2:PfsufS[E1]-GFP (B) was 
isolated by maxiprep and digested with Bglll and Blnl, thus excising PfsufS [El]. 
Digests were resolved through 1 % agarose gel and viewed under ultraviolet light after 
treatment with ethidium bromide. Abbreviations are as follows. bp: base pair; M: 123 
bp ladder (Sigma); D: digest.
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FIGURE 3.3.
EFFECT OF ELECTROPORATION ON THE GROWTH OF PLASMODIUM
FALCIPARUM.
Electroporation of P. falciparum  was done with pSSPF2:PfiscS[L]-GFP or 
pSSPF2:PfsufS[El]-GFP constructs as described (section 3.2.4.5). Growth of cells for 
48 h after electroporation was monitored by uptake of [3H]hypoxanthine. Growth of 
cells without DNA and/or shock is presented for comparison. Error bars represent 
standard error of mean from ten replicates.
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Following drug selection, it was assumed that a small population of parasites would 
persist that harboured the transfection vector and thus were resistant to drug.
To encourage the expansion of this population, a healthy haematocrit (1-5 %) was 
maintained by adding fresh RBC and changing medium and drug regularly. This is 
known as the recovery period and lasted several weeks. Throughout, the culture was 
screened for the appearance of parasites.
332.2 . Experiments with vector pHH2.
Initial experiments were done with pHH2:PfsufS[E1]-GFP and pHH2:PfACP[L]-GFP 
was used as a positive control. However, in several independent experiments, 
transfectants did not arise. This indicated problems with the transfection and culturing 
technique. To investigate this, 1 adopted a systematic approach to account for the lack of 
transfectants.
First, the quality of the DNA used for the transfection was considered, as assessed by 
260/280 ratio and restriction digest. Preparations of vector DNA were performed from 
small culture volumes (100-500 mL). This is because overloading of maxi prep kits can 
contaminate the DNA with bacterial products (e.g., polysaccharides). Phenol- 
chloroform extraction was avoided during DNA preparation, because traces of phenol 
are toxic to parasites. Repeated washing in 70 % ethanol during ethanol precipitation 
steps reduced salt contamination. After taking these measures, DNA preparations were 
extremely pure. Ratios 260/280 were typically 1.8 and DNA was cleanly digested by 
restriction enzymes.
140
Second, the conditions in the electroporation cuvette were examined. To do this, 
transfections were done at various parasitaemias (0.5-2 %) and haematocrits (25-50 %). 
It was decided to leave electrical conditions unchanged for two reasons: (1) they have 
been extensively evaluated (Sato, unpublished observations) and (2) electroporation 
produced little cell lysis in my experiments.
Third, the environment inhabited by the parasites during the recovery period was 
examined. After transfection, it was assumed that parasites were exquisitely sensitive to 
environmental conditions. One key condition was the concentration of WR99210. 
Concentrations between 2.5-20 nM were tested in independent transfections. Also 
examined was the amount of physical space occupied by the cells. Cells in a confined 
area are more accessible to secreted growth factors that may facilitate recovery. Hence, 
flasks were incubated either upright (close cell packing) or on the side (loose cell 
packing). Another factor of importance may be mechanical disturbance of the cells. In 
one regimen, the flask was gassed every day and the medium and drug changed every 
other day. Therefore, to minimise disturbance, the regimen was altered to a gas, 
medium and drug change every 5 d. Other measures were taken to reduce mechanical 
stress, for example, by avoiding centrifuging the cultures.
In spite of these efforts, no transfected parasites were observed. Parasites transfected 
with pHH2 can take ^ 55 d after electroporation to appear.283 The longest time I have 
run an experiment is 30 d. This was because of significant red blood cell lysis (i.e. loss 
of > 25 % haematocrit) at > 30 d. Even with regular addition of fresh RBC, the bulk of 
the culture dates from the time of electroporation. Thirty days may approach the 
maximum survival time of RBC (value in vivo is 110 ± 40 d284).
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3.32.3. Experiments with vector pSSPF2.
Given the lack of immediate success with pHH2,1 tried pSSPF2, an improved vector 
recently developed by Dr. S. Sato. To this end, PfsufS [El] was excised from pHH2 and 
cloned into pSSPF2. The performance of two different maxiprep kits was compared for 
the preparation of this construct. In a typical experiment, the Wizard Maxiprep 
(Promega) yielded ca. 70 pg of vector per 100 mL of culture, while the QIAfilter 
Plasmid Maxi (Qiagen) kit yielded ca. 110 pg of vector per 100 mL of culture. One 
disadvantage often attributed to pHH2 (as compared to pSSPF2) is a lower yield of 
vector DNA from maxiprep. As both vectors were available containing an identical 
construct (PfsufS[E1]-GFP), this observation was tested. In a typical maxiprep, the 
yield of pHH2:PfsufS[El]-GFP was < 30 pg vector per 100 mL of culture, while for 
pSSPF2:PfsufS[El]-GFP, it was 40-110 pg  vector per 100 mL of culture. pHH2 
preparations were often contaminated with bacterial polysaccharides.
Construct pSSPF2:PfiscS[L]-GFP was successfully used in this laboratory to target GFP 
to the mitochondrion in P. falciparum223 and was thus used as a positive control. 
However, in transfection experiments with pSSPF2 constructs, no parasites appeared in 
either positive control or treatment. A parallel experiment conducted by Dr. S. Sato 
using pSSPF2:PfsufS[El]-GFP lead to no observable fluorescence in parasites. 
Although, experience of other workers (Drs. S. Sato, S. J. Lucas and M. Kadekoppala, 
NIMR, pers. comm.) indicated that repeated experiments are often necessary, I decided 
to re-engineer the construct.
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3.3.2.4. Re-engineering of the pSSPF2 construct.
It was noted that PfsufS [El] encoded a proportion of mature enzyme sequence; hence it 
probably exceeded the length of the leader. Therefore, shorter constructs encoding the 
first 54 (pSSPF2:PfsufS[L54]-GFP) and 72 (pSSPF2:PfsufS[L72]-GFP) amino acids of 
PfSufS genetically fused to GFP were generated. The first 54 and 72 amino acids were 
chosen in order to bracket the predicted leader sequence (about 60 amino acids) and for 
convenience of PCR primer design. I noted that a consensus sequence (AAAA) is 
commonly found immediately 5' to the start codon of P. falciparum ORFs.285 Hence, 
AAA was incorporated into the forward primer for both constructs. Other workers will 
continue experiments with these constructs.
3.3.3. Transfection experiments in Toxoplasma gondii.
Transient transfection experiments were also attempted in T. gondii. As compared to P. 
falciparum, T. gondii is readily transfected286 and has clear sub cellular morphology.287 
However, the T. gondii SufS leader (TgSufS[L]) could not easily be deduced from the 
incomplete ToxoDB database. Identification of TgSufSJL] by inspection of genomic 
reads was especially difficult, because T. gondii sequence often has numerous short 
introns that are difficult to recognise. Several ab initio gene models of TgSufS (e.g., 
TgTwinScan_1344, TgGlmHMM_1221 and TgTigrScan_3457) are so confused by this 
phenomenon as to be of little value. Predictably, ESTs are only available for the C- 
terminal of the protein (chapter 2).
Therefore, the strategy of Jomaa, et a lwl was adopted. Specifically, the predicted leader 
sequence of P. yoelii SufS (PySufS[LJ) was synthesised de novo by recursive PCR,
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with codon usage harmonised for T. gondii (Fig. 3.4). PySufS was chosen as the leader 
sequence is less divergent from TgSufS than PfSufS (Dr B. Clough, pers. comm.) The 
synthetic leader was cloned into the transfection vectors pSAGl/CAT/TUBl/GFP and 
pSAGl/CAT/TUBl/DsRed. Thirty separate clones were examined before correct 
sequence was identified, indicating the low success rate of recursive PCR.
Parasites were transfected and the vector pSAGl/CAT/TUBl:TgACP[L]-GFP was used 
successfully as a positive control. However, no fluorescence was detectable following 
transfection with the PysufS [LJ-GFP or PysufS[LJ-DsRed constructs.
It is possible that the PysufS[Ls] fusion proteins are ejected from the cell (where 
fluorescence would be undetectable). This is because plastid transit peptides are poorly 
conserved and the P. yoelii version is probably not recognised by T. gondii. Hence the 
first part of the synthetic leader (signal peptide) is targeting the fluorescent tag to the 
secretory pathway. It might be useful to measure CAT activity in cells transfected with 
the pSAGl/CAT/TUBl constructs, to definitively confirm vector uptake. CAT is 
encoded by the vector and enzymatic activity is considered to be a measure of 
successful transfection.288
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FIGURE 3.4.
PCR SYNTHESIS OF PYSUFS[Ls].
PysufS[LJ was assembled by recursive PCR (section 3.2.5.1). Briefly, 14 overlapping 
primers encoding PySufS[Ls] were assembled by PCR (1+). Full-length product was 
resolved in a second round of PCR directed by the extreme 5' and 3' primers (2+). 
Negative controls lacking DNA are presented (1-; 2-). Additional abbreviations are as 
follows, bp: base pair; M: 123 bp ladder (Sigma).
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3.3.4. Development of peptide antibodies against Plasmodium falciparum SufS.
3.3.4.1. Selection o f peptides.
PfSufS protein sequence was submitted to Sigma-Genosys in order to select epitopes 
that were: (1) hydrophilic; (2) antigenic; (3) suitable for Fmoc synthesis; and (4) readily 
conjugated to KLH. Only five peptides were suitable: two mapped to the leader 
sequence and were discarded immediately on the assumption that the leader was 
cleaved during entry to the plastid. Of the remaining three peptides, only two were 
deemed of suitable length (>10 residues). Both mapped to the surface of the PfSufS 
homology model (Fig. 3.1) and thus were assumed to be accessible to antibody under 
native conditions.
In order to establish the uniqueness of these two epitopes, their protein sequences were 
scrutinised against the NCB1 database using BLASTP (“short, nearly exact matches”). 
Neither peptide produced hits against E. coli proteins. As anticipated, the only strong hit 
(E = 2e-04) was against PfSufS; although weaker hits were observed against SufS from 
rodent malarias (P. yoelii, P. chabaudi and P. berghei). It is worth noting the lack of 
similarity to PflscS. I decided that every bioinformatic precaution had been taken to 
ensure antibody cross-reactive to these peptides would be specific for PfSufS. Hence, 
the two peptides were synthesised; coupled to KLH; and used to immunize to New 
Zealand white rabbits.
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3.3.42. Screening of peptide antibodies.
Serum samples were obtained from the rabbits at intervals of 5 d over the 77 d 
immunization protocol. In order to test if the sera exhibited specific cross-reactivity 
against PfSufS, Western blots were performed. The results of preliminary experiments 
will now be described. Initially, GST-PfSufS[M]x (chapter 5) was used as a target. Both 
anti-Bum-1 and anti-Bum-2 serum decorated GST-PfSufS[M]x (Fig. 3.5).
Dilutions of P. falciparum lysate were probed with anti-Bum-1 serum (Fig. 3.6). Both 
anti-Bum-1 and pre-immune sera cross-reacted with bands at 55 kDa, 44 kDa, 40 kDa 
and 31 kDa. However, anti-Burn-1 decorated one additional high molecular weight 
band (68 kDa) that could correspond to PfSufS (predicted size 65 kDa). There is 
considerable suspicion that the observed patterns on Western blots were artefactual. 
Thus, these data are of little value until confirmed. Furthermore, anti-Bum-2 needs to be 
investigated.
3.3.4.3. Future work.
In order to further investigate the cross-reactivity observed against P. falciparum lysate, 
it will be necessary to unequivocally demonstrate specificity of anti-Bum-1 serum for 
PfSufS. This will be most rapidly achieved by Western blotting against pure 
recombinant PfSufS[M]x, lacking an affinity tag. Efforts to make such protein are 
discussed in chapter 5. Furthermore, it may be useful to generate monoclonal antibodies 
against the entire protein. This could be achieved by immunization of mice with pure 
NusA-PfSufS[Mlx (chapter 5).
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FIGURE 3.5.
CROSS-REACTIVITY OF ANTI-PFSUFS SERUM AGAINST GST- 
PFSUFS[M]x.
Western blotting was used to screen antisera generated by immunisation of rabbits with 
PfSufS peptides (Bum-1 and Burn-2). The target was a recombinant GST fusion of 
PfSufS (GST-PfSufS[M]x) generated in chapter 5. Cross-reactivity of the recombinant 
protein with pre-immune serum is presented for comparison (Pre-iml; Pre-im2). 
Additional abbreviations are as follows. M: Mark 12 unstained standards; S: partially 
purified GST-PfSufS[M]x; Coom: Coomassie stained gel.
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FIGURE 3.6.
CROSS-REACTIVITY OF ANTI-PFSUFS SERUM AGAINST PLASMODIUM  
FALCIPARUM  LYSATE.
Western blotting was used to screen antisera generated by immunisation of rabbits with 
a PfSufS peptide (Bum-1). Dilutions of a lysate of P. falciparum 3D7 erythrocytic 
stages were used as targets. Molecular weights of cross-reactive bands discussed in the 
text are indicated. Cross-reactivity of lysate with pre-immune serum is presented for 
comparison (Pre-iml). Additional abbreviations are as follows. M: Markl2 unstained 
standards; 1: 1/10 dilution of P. falciparum lysate; 2: 1/100: dilution of P. falciparum 
lysate; 3: 1/250 dilution of P. falciparum lysate; 4: 1/500 dilution of P. falciparum 
lysate.
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CHAPTER 4.
DEVELOPMENT OF A COLORIMETRIC CYSTEINE DESULPHURASE
ASSAY.
Plasmodium falciparum  SufS is predicted to be a pyridoxal 5'-phosphate (PLP)- 
dependent cysteine desulphurase. Therefore, this chapter begins with a brief overview 
of PLP chemistry and PLP-dependent enzymes, followed by a detailed description of 
the reaction mechanism of E. coli SufS (EcSufS). Knowledge of bacterial cysteine 
desulphurases allowed the selection of a robust assay for cysteine desulphurase activity 
based upon the colorimetric methylene blue test for sulphide. This assay was validated 
with EcSufS and A. thaliana SufS; and used extensively to test the enzymatic activity of 
recombinant P. falciparum proteins made in chapter 5.
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4.1. INTRODUCTION.
4.1.1. Pyridoxal 5'-phosphate-dependent enzymes.
4.1.1.1. Pyridoxal 5 '-phosphate, a versatile enzyme cofactor.
Feeding experiments in rats conducted by Gyorgy (1893-1976) lead to the identification 
of vitamin B6; purification was achieved in 1938.294 In 1944, Gunsalus, et al.295 
discovered that the phosphate ester of the aldehyde form of the vitamin, pyridoxal 5'- 
phosphate (PLP), could function as an enzyme cofactor. PLP is implicated in > 140 
[Ref. different enzymatic transformations of amino acids, as well as the 
phosphorylation of glycogen and malodextrin. PLP-dependent enzymes have been 
exhaustively reviewed.296"301
4.1.1.2. PLP metabolism.
All organisms possess enzymes for the supply, trafficking and metabolism of PLP. 
Phylogenetically ubiquitous is a salvage pathway whereby vitamin B6, PLP and other 
vitamers of the B6 group (pyridoxal, pyridoxamine, PMP) are interconverted. One of the 
enzymes of the salvage pathway is PdxK, a pyridoxine/pyridoxal kinase that activates 
vitamin B6 by phosphorylation.
In addition to the salvage pathway, bacteria, fungi and plants are able to synthesise 
vitamin B6 de novo. Two synthetic pathways (PDX and SOR) are known; it seems they 
cannot co-exist in the same organism. Hence, the pyridoxine-requiring (PDX) pathway
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is restricted to certain bacteria (e.g., E. coli), while the singlet oxygen resistance (SOR) 
pathway is found in fungi, plants and some bacteria (e.g., M. tuberculosis).
The PDX machinery of E. coli is well understood and consists of PdxABCFHJ and 
GapA proteins (reviewed by Spenser and Hill302). Conversely, the SOR pathway is 
inadequately characterised, although two proteins of the pathway are known: Pdxl303 
and P dx l304
4.1.13. PLP metabolism in P. falciparum.
Recent evidence suggests that de novo vitamin B6 synthesis takes place in P. falciparum 
via the SOR pathway. For example, sequence resembling Pdxl (PlasmoDB 
MAL6P1.215) was noted in the P. falciparum genome by Ralph et al.80 Using high 
performance liquid chromatography and mass spectrometry, Cassera, et al.104 detected 
metabolites of the PLP pathway in erythrocytic stage parasites. Extending these 
findings, Wrenger, et al.782 identified Pdx2 (PlasmoDB chrl l.gen_420) and PdxK 
(GenBank NP_703820) genes in the P. falciparum genome while establishing the 
functionality of malarial Pdxl, Pdx2 and PdxK by complementation tests in yeast and 
by enzymology with purified protein. None of the SOR genes in P. falciparum possess 
an obvious mitochondrial or plastid-targeting signal, suggesting that vitamin B6 
synthesis may be cytosolic in P. falciparum.782
4.1.1.4. Chemical structure o f PLP.
PLP is composed of a pyridine ring covalently linked to an aldehyde group (CHO) at 
carbon 1 (Cl); a hydroxyl group (OH) at C2; and a phosphate group (P04) at C5'.
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Evolution has found a use for all these functional groups during PLP-dependent 
catalysis.
The over-arching chemical feature of PLP-dependent catalysis is substrate oxidation. 
This process is classically believed to be facilitated by the pyridine ring of PLP, which 
acts as an electrophile (negative charges readily delocalise through the n-orbitals). In 
order to draw electrons from the substrate by this mechanism, a covalent bond must be 
established. This task is fulfilled by the aldehyde group of PLP that forms an imine 
(Schiff base) bond with the E-group of the amino acid. Finally, molecular topology must 
be rigidly maintained during catalysis. This is the function of the OH and P04 groups 
that make hydrogen bonds with residues lining the active site of the enzyme.
4.1.1.5. PLP in enzyme catalysis.
A vast amount of information has accumulated about the mechanism of PLP-dependent 
catalysis. In part, this is due to the early realisation that certain aspects of PLP catalysis, 
such as Schiff base formation and electron flux, can be studied non-enzymatically using 
chemical models.305 This allowed meaningful experiments to be conducted even before 
large numbers of PLP-dependent enzymes had been purified.
By convention, the carbon atoms of an amino acid are labelled Ca, C|3 (and in some 
amino acids, Cy); it is the Ca that forms a Schiff base with PLP. Hence, it is the action 
of the PLP electrophile on Ca that is critical for PLP-dependent catalysis.
Withdrawal of electrons from Ca can lead in three major directions.298 These are: (1) 
deprotonation of Ca, generating a quinoid intermediate; (2) amputation of the COO"
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group (decarboxylation); or (3) amputation of the group attached to Cp (aldol cleavage 
if the group is OH). While many steps in the catalytic mechanism of PLP-dependent 
enzymes remain mysterious, this initial phase is well understood.
Dunathan306 postulated that the orientation of the substrate molecule to the PLP 
molecule controlled the direction of bond breaking (i.e. deprotonation vs. 
decarboxylation vs. aldol cleavage). This hypothesis has been confirmed by analysis of 
X-ray crystal structures of numerous PLP-dependent enzymes.297
According to the Dunathan model, the substrate bond under attack must be 
perpendicular to the plane of the pyridine ring of the PLP. This ensures intimate contact 
between “frontier” orbitals; the highest energy occupied molecular orbital (HOMO) of 
the bond under attack interacts with the lowest energy unoccupied molecular orbital 
(LUMO) of the delocalised it-system of the pyridine ring and Schiff base. Hence, the 
initial step of the reaction is guided merely by changes in molecular topology, directed 
by the residues lining the active site of the enzyme.
4.1.1.6. Disparity o f fold and function in PLP-dependent enzymes.
Metzler298 has further classified PLP-dependent enzymes into four main groups (a-d) 
based on the fate of the substrate. These are: group a (loss of a-hydrogen); group b 
(decarboxylation); group c (side chain cleavage); and the most complicated, group d 
(ketimine intermediate as electron acceptor). This mechanistic classification runs in 
parallel to a classification based on protein fold (see chapter 2). However, the two 
classifications do not correlate.297 This obviously has important implications for
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bioinformatic analysis: similarity of protein sequence does not imply similarity of 
function. This explains the need to test the catalytic activity of PfSufS (chapter 5).
4.1.2. Modelling the catalytic mechanism of cysteine desulphurases.
4.1.2.1. Nomenclature o f cysteine desulphurases.*
Cysteine desulphurases (EC 2.8.1.7) are a phylogenetically ubiquitous class of enzymes 
(chapter 2) that hydrolyse L-cysteine to L-alanine and sulphane sulphur (S0).160 They are 
all PLP-dependent and fall into the aspartate aminotransferase (AAT) category (by 
similarity of protein sequence) and the d group (by catalytic mechanism). The cellular 
role of cysteine desulphurases is described in detail in chapter 1; whereas the following 
discussion is concerned only with structure and mechanism (Fig. 4.1).
4.1.2.2. Molecular structure.
X-ray crystal structures of several prokaryotic cysteine desulphurases have been 
deposited in the Protein Data Bank (PDB).*
* Note on nomenclature. As in any rapidly advancing field, nomenclature is confused. 
For example, some authorities (e.g. Mihara and Esaki160) describe cysteine 
desulphurases as “aminotransferases [sic] class V of fold-type I” while others (e.g. 
Lima) put them in the “a-family” of PLP-dependent enzymes. For clarity, I have 
adopted the nomenclature of a recent review.307 The naming of specific proteins is also 
difficult. For example, in yeast, IscS is known as Nfslp.141 In E.coli, SufS is variously 
known as SufS,166 CsdB,308 or even NifS CsdB,251 while in Arabiopsis thaliana, SufS is 
called NFS2,198 or CpNifS.1"  Here, I exclusively use the terms IscS and SufS. 
t http://www.rcsb.org/pdb/
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FIGURE 4.1.
MODEL OF THE CYSTEINE DESULPHURASE REACTION MECHANISM.
Cysteine desulphurase enzymes catalyse the hydrolysis of L-cysteine to sulphur and L- 
alanine. The process is complex and poorly understood, but can be explained largely by 
reference to the pyridoxal 5'-phosphate (PLP) cofactor and the active site cysteine of the 
apoenzyme. A detailed description is given in the text. Transimination. The bonding 
environment of the PLP changes, allowing formation of a Schiff base with the L- 
cysteine substrate, y-elimination via ketimine. Electron flux through the substrate 
drives protonation of the ketimine intermediate. Concurrently, the active site cysteine 
(not shown) stages nucleophilic attack on the sulphur atom of the substrate (marked in 
yellow). The sulphur atom is amputated from the substrate and forms a persulphide 
bond with the active site cysteine. Cleavage of the persulphide bond liberates sulphur.
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These include: Thermatoga maritima NifS (PDB 1ECX and 1EG5309), E. coli IscS 
(PDB 1P3W310), Synechocystis sp. SufS (PDB 1T3I311) and several versions of EcSufS: 
alone (PDB ICON308 and 1JF9251); complexed with an inhibitor (L-propargylglycine) 
(PDB 1I29312); and bound to the perselenide (PDB 1KMK251) and persulphide (PDB 
1KMJ251) intermediates.
EcSufS folds into three sections, an N-terminal segment (residues 1-21), a central PLP- 
binding domain (residues 33-298) and a third small domain composed of residues 22-32 
and 299-406.308 In common with the other AAT-type enzymes, the catalytically active 
form of EcSufS is a homodimer constrained by hydrogen bonding and hydrophobic 
interactions.308 Each monomer probably binds one molecule of PLP. The interface 
between the dimers produces a deep (ca. 1.5 nm251) active site cleft along which 
substrates must diffuse to reach the active site cysteine and cofactor; histidine residues 
surrounding the active site probably coordinate the solvent (water).251 Although residues 
from one dimer contribute to the active site of the other, the two active sites of the 
enzyme operate independently.
In the remainder of this review, I will focus on EcSufS, the closest model for PfSufS. 
Hence, in the account of mechanism, numbered residues refer to those found in EcSufS; 
residues from the second monomer are marked with a star (*). All are conserved in 
AtSufS and PfSufS protein sequences (chapter 2).
4.12.3. SufS as a complex cysteine desulphurase.
In vitro, isolated EcSufS displays a marked preference for L-selenocysteine over L- 
cysteine.313 Indeed, the enzyme was initially classified as a selenocysteine lyase (EC
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4.4.1.16).165 In this context, it is worth noting the selenium starvation experienced by 
malaria parasites in the red blood cell.314 As compared to the more active IscS, the 
lethargic desulphurase activity of SufS against L-cysteine may be ascribed to the 
shortness and rigidity of the loop surrounding the active site cysteine.
It has recently been shown that accessory factors significantly enhance the cysteine 
desulphurase activity of SufS. For example, Outten, et a/.,191 demonstrated E. coli SufE 
stimulated 8-fold the activity of EcSufS against L-cysteine. Further, addition of 
SufABC proteins to the SufE-SufS complex augmented the activity 32-fold as 
compared to SufS alone.191 Using purified Erwinia chrysanthemi SUF proteins 
expressed in E. coli, Loiseau, et al.192 reported that addition of SufE to SufS stimulated 
cysteine desulphurase activity 50-fold. Hence, in vivo, SufS probably operates within a 
multi-subunit complex.
4.1.2.4. The resting enzyme.
In resting enzymes, PLP is tethered in the active site by a covalent bond (Schiff base) 
and at least seven hydrogen bonds. The Schiff base linkage is between the carbonyl 
group of the PLP and the e-amino group of the catalytic lysine (K226308). This bond is 
discussed in detail in chapter 5. Additionally, a number of active site residues (T95, 
D200, Q203, S223, H225, K226 and T278*308) form hydrogen bonds with PLP. 
Collectively, these residues maintain the cofactor within the active site after the C=N 
bond has been hydrolysed to form the enzyme-substrate complex.
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4.1.2.5. Formation of the enzyme-substrate complex by transimination.
Transimination, the necessary first step of PLP-dependent reactions, serves to make the 
cofactor available to the substrate.298 This involves the hydrolysis of the C=N bond 
between the cofactor and K226 (“internal” aldimine); and the formation of a new C=N 
bond between the cofactor and the substrate cysteine (“external” aldimine). In effect, 
the Schiff base is exchanged. In Thermatoga maritima NifS, this leads to the formation 
of a quinoid intermediate309 via the Dunathan mechanism.
Transimination can only happen because of the marked lability of the PLP-lysine Schiff 
base. Indeed, if the “internal” aldimine bond is reduced to a single bond by addition of a 
metal borohydride, commonly sodium borohydride (NaBH4), the system is locked and 
the reaction cannot proceed. Hence, NaBH4 serves as a potent irreversible inhibitor of 
PLP-dependent enzymes and thus is a valuable discriminator for Schiff base 
participation in reaction mechanisms.315
4.1.2.6. y-elimination via ketimine intermediate.
Cysteine desulphurases catalyse y-elimination reactions. The process begins with 
protonation of the C a of the quinoid intermediate, forming an electrophilic ketimine 
than can attack Cy. Polarisation of C=NH+ probably draws electrons through the 
ketimine intermediate, allowing the stripping of a proton from Cy by the action of K226.
It is probably at this stage that the active site cysteine (C364) relocates to begin 
nucleophilic attack on the intermediate,251. Briefly, the sulphur atom is confiscated from 
the substrate, and transferred to C364 where it attaches via a persulphide bond
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(persulphide intermediate). However, due to the shortness and inflexibility of the active 
site loop of SufS, this step may be severely rate-limiting in isolated enzymes.251 Kinetic 
evidence from Synechocystis sp. SufS suggests that SufE may help the process, either 
by changing the topology of the active site to facilitate nucleophilic attack by C364; or 
by attacking the substrate with a nucleophilic cysteine residue of its own.311
It is worth noting that the pivotal role of the active site cysteine has been demonstrated 
in many different cysteine desulphurase enzymes, via mutagenesis,313 crosslinking,162 
suicide inhibition316 and alkylation316 studies. However, mutation of the active site 
cysteine of Synechocystis sp. SufS (C372A) diminished but did not entirely abolish 
cysteine desulphurase activity.311 This finding may be attributed to the operation of a 
second desulphuration pathway in which additional molecules of L-cysteine diffuse into 
the active site and launch a nucleophilic attack upon the ketimine intermediate 
independent of the active site cysteine.311 Action of two distinct cysteine desulphuration 
pathways in vitro could explain the aberrant Michaelis-Menten behaviour observed with 
EcSufS.313
Finally, sulphur is abstracted from C364 onto C51 of SufE, and passed 
downstream.191,193 This event is probably helped by R359 of SufS swivelling away from 
the active site cysteine towards D28, T62* and H55*, thereby improving physical 
access.251 The second product, L-alanine, is released; transimination of PLP restores the 
Schiff base with K226. The active site has completed one catalytic cycle and is ready to 
process another molecule of L-cysteine.
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4.1.2.7. Reversible inhibition by abortive transamination.
The chemical promiscuity of PLP is such that PLP-dependent enzymes often commit 
unforced mechanistic errors.301 Hence, in spite of the majority of cysteine desulphurase 
reactions proceeding in the direction outlined above (formation of sulphur and L- 
alanine), it seems probable that the reaction will often make a wrong turn.
Abortive transamination is likely to be the predominant fault313 and probably arises via 
erroneous protonation at C4' of the quinoid intermediate (section 4.1.2.6.). 
Concomitantly, PLP is transformed into inactive pyridoxamine 5'-phosphate (PMP); the 
cysteine desulphurase becomes reversibly inhibited. Reactivity can be restored by 
addition of an excess of pyruvate (substrate for reverse transamination, i.e., PMP -*> 
PLP) or fresh PLP.313 Indeed, in vitro enzyme assays require addition of free PLP to the 
buffer in order to sustain the reaction. In vivo, abortive transamination probably makes 
the enzyme exquisitely sensitive to PLP starvation.
4.1.2.8. Kinetic model o f the reaction catalysed by SufS.
Although there is a copious general literature on cysteine desulphurases (reviewed by 
Mihara and Esaki160), to my knowledge only four SufS enzymes have been 
biochemically characterised These are: E. coli SufS,165313, Erwinia chrysanthemi 
SufS;192 Synechocystis sp. SufS;311,317 and A. thaliana SufS.198,199
Such paucity of data has limited the formulation of predictive kinetic models of SufS 
catalysis. One recent exception is Tirupati, et al.,3u who described a simple model based
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on spectroscopic data from Synechocystis sp. SufS. The model can be summarised using 
consecutive reactions constrained by rate constants kI and k2 (Eq. 4.1).318
A —^ B —^ C  (Eq. 4.1)
Mixing of substrate (A) and enzyme leads to formation (kj) of the persulphide 
intermediate (B). In isolated Synechocystis sp. SufS, k, is exceptionally slow (0.02 ± 
0.005 s 1 [Ref.311]. It is an amalgam of rapid steps (formation of the enzyme-substrate 
complex) suddenly braked by highly inefficient persulphide formation (perhaps due to 
the inflexibility of the active site loop). However, once achieved, the persulphide 
intermediate breaks down (k2), releasing sulphur (C) and L-alanine; k2 = 0.0002 mM ’.s'1 
[Ref. 311] (second order rate constant). This simple kinetic model has important practical 
implications for the study of SufS enzymes (section 4.3.2.6.).
4.1.3. Chapter objective and overview.
The objective of the work reported in this chapter was to develop a cysteine 
desulphurase activity assay suitable for screening heterologously expressed PfSufS 
(chapter 5). I describe the development of the assay and its validation with E. coli SufS 
and A. thaliana SufS enzymes.
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4.2. MATERIALS AND METHODS.
4.2.1. Preparation of enzyme controls.
4.2.1.1. Expression and purification o f E. coli SufS.
E. coli SufS (GenBank P77444) was expressed and purified essentially as described.191 
E. coli BL21 codon plus (DE3)-RIL cells (Stratagene) were transformed with the 
expression plasmid pRSET:His6-EcSufS (a gift from Dr. F. W. Outten, NIH, USA). 
Cells harbouring the plasmid were incubated for 16 h in Luria-Bertani (LB) broth (10 g 
bactotryptone, 5 g yeast extract, 10 g NaCl per 1 L redistilled water) containing 100 
/rfg.mL'1 carbenicillin. The culture was diluted 1/50 into 1 L of fresh LB broth 
containing 100 pg.m L1 ampicillin. At an OD600 of 0.4, the culture was induced for 3 h 
at 37°C with 1 mM isopropyl-6-D-thiogalactopyranoside (IPTG). Cells were harvested 
by centrifugation and resuspended in 50 mL of extraction buffer containing 50 mM 
NaH2P04, pH 8.0, 300 mM NaCl, 5 mM imidazole, 1 mM phenylmethylsulphonyl 
fluoride (PMSF) and Roche complete EDTA-free protease inhibitor cocktail set (1 
tablet per 50 mL). The cell suspension was sonicated packed in ice for 1 min in 10 s 
bursts using a Sonics and Materials Vibracell probe tip sonicator. The lysate was 
centrifuged at 150000g for 30 min at 4 °C and the supernatant was applied to a 1 mL 
HiTrap HP chelating column (Amersham) charged with Ni2+. After extensive washing, 
protein was eluted in 250 mM imidazole in extraction buffer. All steps of the 
purification were done at 4 °C at a flow rate of 1 mL.min1 using an Akta FPLC 
(Amersham). Yellow elution fractions containing the enzyme were combined. Any 
precipitate was re-dissolved by addition of 20 mM dithiothreitol332 (DTT), and dialysed
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for 16 h at 4 °C against 25 mM Tris-HCl, 100 mM NaCl, pH 7.4. Enzyme was stored at 
-20 °C in 50 % v/v glycerol.
4.2.12. Expression and purification o f A. thaliana SufS.
A. thaliana SufS (GenBank AAL79956) was expressed and purified essentially as 
described.198 E. coli BL21 cells harbouring the pET20b:AtNFS2-His6 expression 
plasmid (a gift from Dr. S. Lobreaux, INRA, Montpellier, France) were incubated for 
16 h at 30°C in 1 L LB broth containing 100 //g.mL1 ampicillin. D-glucose (1% w/v) 
was added to suppress expression from the T7 promoter. Cells were harvested by 
centrifugation and resuspended in 800 mL LB broth containing 50 //g.mL1 ampicillin 
but lacking D-glucose. Protein expression was allowed to proceed for 2 h at 30°C. The 
bacterial pellet was resuspended in 50 mL of extraction buffer containing 50 mM 
NaH2P04, 150 mM NaCl, 10 mM imidazole and Roche complete EDTA-free protease 
inhibitor cocktail set (1 tablet per 50 mL) and sonicated as described (section 4.2.1.1.). 
The lysate was centrifuged at lOOOOg for 30 min at 4 °C. The supernatant was added to 
1 mL of ProBond resin (Invitrogen) previously washed with redistilled water and 
equilibrated with extraction buffer. The mixture was incubated in a closed tube on a 
rotator for 1 h at 4 °C. The resin was.packed by gravity into a 10 mL Bio-Rad plastic 
column prior to washing with 10 mL extraction buffer containing 20 mM imidazole. 
Protein was eluted in extraction buffer containing 250 mM imidazole. Yellow elution 
fractions containing the enzyme were stored at -20°C in 50% v/v glycerol.
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4.2.1.3. Detection and quantification o f expressed proteins.
Expressed proteins were detected by denaturing polyacrylamide gel electrophoresis 
using the NuPAGE system (Invitrogen) followed by Coomassie brilliant blue staining. 
The ExPASy ProtParam tool* was used to predict molecular weights and molar 
extinction coefficients333 based on amino acid sequence. The predicted molecular weight 
of both proteins was 48 kDa. Assuming that all the cysteine residues appeared as half 
cystines, the predicted extinction coefficients at 280 nm were AtSufS-His6 (37790 M" 
‘.cm'1) and His6-EcSufS (49170 M ‘.cm ‘). Protein concentrations were determined from 
the absorbance of aromatic amino acids at 280 nm.
4.2.1.4. Assessment o f PLP content o f expressed proteins.
The PLP content of expressed proteins was assessed by inspection of absorbance 
spectra for a characteristic Schiff base peak in the yellow wavelengths. Additionally, the 
response of the PLP cofactor to L-cysteine was determined. Using a Beckman DU 640 
spectrophotometer, a spectral scan (300-600 nm) was acquired of 98 pL  of enzyme (2 
mg.mL'*) contained in a quartz-glass cuvette. A small volume (2 pL) of 25 mM L- 
cysteine (Sigma) was added to the cuvette and the mixture stirred with a pipette tip, 
giving a final L-cysteine concentration of 0.5 mM. The reaction was monitored over 
time by acquisition of spectra.
* http://www.expasy.org/tools/protparam.html
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4.2.2. Cysteine desulphurase activity by lead sulphide zymogram assay.
Cysteine desulphurase activity of purified E. coli IscS (a gift from Dr. S. Adinolfi, 
NIMR) was assessed using the lead sulphide zymogram method essentially as described 
by Borup.321 Proteins were separated by denaturing polyacrylamide gel electrophoresis 
using the NuPAGE system. Critically, protein was left unheated prior to loading on the 
gel. After the gel had been run, the enzyme was re-natured by removal of sodium 
dodecyl sulphate (SDS). This was achieved by washing gels twice in redistilled water 
and twice in 50 mM Tris-HCl, pH 7.4; both washing buffers contained 2.5% v/v Triton 
X-100. Finally, gels were washed twice in 50 mM Tris-HCl, pH 7.4 without detergent 
and incubated at 37 °C for 16 h in freshly-made developing solution containing 50 mM 
Tris, pH 7.4, 10 mM MgCl2, 10 mM L-cysteine, 0.5 mM lead nitrate (PbN03), 5 mM 
DTT and 5 mM PLP. Active bands were identified by the presence of precipitated lead 
sulphide (PbS).
4.2.3. Cysteine desulphurase activity by methylene blue assay.
4.2.3.1. Enzyme assay.
Reactions contained 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 10 piM PLP, 100 //M L- 
cysteine, 70-1000 nM of enzyme and 5 mM of reductant. Reductants used were: 8- 
mercaptoethanol (B-ME); DTT; tris(2-carboxyethyl)phosphine334 (TCEP) (Novagen); 
and tris(hydroxypropyl)phosphine (THP) (Calbiochem). Incubation was for 2-15 h in 1 
x 10 cm Pyrex glass test tubes on the open bench (ca. 20 °C). Reactions were stirred 
with a magnetic stirring flea and incubated under 1 cm depth of mineral oil (Sigma) to
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reduce the loss of H2S (g) expected after addition of the methylene blue assay 
reagents.
4.2.3.2. Determination o f sulphide concentration by methylene blue assay.
Sulphide output was measured according to the endpoint methylene blue method of 
Siegel.326 Equal volumes (100 pL) of 20 mM N,N-dimethyl-/?-phenylenediamine 
sulphate (DMPD) in 7.2 M HC1 and of 30 mM FeCl3 in 1.2 M HC1 were injected under 
the oil layer. The mixture was immediately stirred using the magnetic stirring flea. 
Escape of H2S (g) was monitored by the “bad egg” odour. After a brick-red flush, a blue 
colour (methylene blue) rapidly (< 30 min) developed, indicating the presence of 
sulphide. The mixture was centrifuged at 16000g to remove precipitated protein. 
Absorbance spectra were obtained on a Beckman DU 640 spectrophotometer. 
Absorbance at 620 nm was obtained on a Dynex Technologies MRX TCII plate reader.
4.2.3.3. Recovery o f sulphide by zinc acetate precipitation.
Sulphide was recovered using the method of Gilboa-Garber.336 Briefly, aqueous 
solutions of 2.6 % w/v zinc acetate and 6 % w/v NaOH were rapidly mixed in a ratio of 
5:1. This mixture (1 mL) was immediately added to the enzyme assay solution. The 
tube was sealed with a rubber septa stopper, shaken and centrifuged at 3000g for 10 
min. The resulting pellet (zinc sulphide) was washed with 5 mL of 1.5 M NaCl, 
followed by 5 mL of redistilled water. Both solutions had been adjusted to pH 8 with 
NaOH immediately prior to use. Finally, the pellet was resuspended in redistilled water 
and submitted to the methylene blue assay (section 4.2.3.2).
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4.23.4. Preparation of sodium sulphide standard solution.
Sodium sulphide (NajS) standard solution was prepared immediately before use. To 
remove residues of sodium sulphite (NajSC^), crystals of N a^ (Aldrich) were briefly 
washed with redistilled water (adjusted to pH 8 with NaOH). A stock solution of Na2S 
was made to a concentration of 100 mM using redistilled water adjusted to pH 8 with 
NaOH. Escape of H2S (g) was monitored by the “bad egg” odour.
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4.3. RESULTS AND DISCUSSION.
4.3.1. Preparation of enzyme controls.
43.1.1. Overexpression and purification of enzymes.
His6-tagged EcSufS and AtSufS were overexpressed in E. coli. Cells overexpressing 
EcSufS grew slowly before induction (Fig. 4.2, inset), presumably due to unregulated 
expression of active enzyme exhausting the supply of L-cysteine. EcSufS-expressing 
cell pellets were bright yellow because of the accumulation of PLP.162
Total soluble protein was extracted from the cells and His6-tagged protein was purified 
over Ni2+ resin using a simple one-step elution. A typical 280 nm elution trace for 
EcSufS is presented in Fig. 4.2A. A Coomassie-stained polyacrylamide gel of AtSufS 
purification fractions is presented in Fig. 4.3A.
Following the binding step of EcSufS purification, a bright yellow band was visible in 
the Ni2+ resin. The yellow band persisted through washing but disappeared from the 
column on elution. The band probably represented enzyme-bound PLP. Elution of 
EcSufS with 250 mM imidazole immediately caused protein precipitation. Further, the 
yellow colour of the solution diminished in brightness probably due to oxidation of the 
PLP. Eluted protein was re-dissolved (and yellow restored) by reduction with 20 mM 
DTT. It is interesting to note that another reducing agent (THP) was unable to restore 
the yellow colour (section 4.3.2.6.).
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FIGURE 4.2.
PURIFICATION AND PROPERTIES OF ESCHERICHIA COU SUFS.
A. Ultraviolet absorbance (280 nm) profile showing elution of E. coli SufS.
An N-terminal His6 fusion of E. coli SufS (EcSufS-His6) was overexpressed in bacteria. 
Soluble protein was bound to Ni2+ resin and eluted with imidazole using an Akta FPLC 
(Amersham). Inset. Pre-induction growth curve of bacteria overexpressing E. coli SufS. 
An overnight culture was diluted 1/50 into fresh medium and grown at 37 °C. 
Uninduced cells took ca. 6 h incubation to reach an OD600 of 0.4 (induction point).
B. Absorbance spectrum of E. coli SufS in the yellow regime of the spectrum.
To detect the Schiff base feature characteristic of PLP-dependent enzymes, an 
absorbance spectrum in the yellow regime was acquired for E. coli SufS (70 piM).
C. Enzymology of E. coli SufS.
E. coli SufS (700 nM) was shown to be enzymatically active using the methylene blue 
assay. Dual absorbance peaks at 667 nm and 744 nm are diagnostic of methylene blue.
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FIGURE 4.3.
PURIFICATION AND PROPERTIES OF ARABIDOPSIS THAUANA SUFS.
A. Purification of A. thaliana SufS.
A C-terminal His6 fusion of A. thaliana SufS (AtSufS-His6) was overexpressed in E. 
coli. Soluble protein was bound to Ni2+ resin and eluted with imidazole. Fractions were 
run on a NuPAGE 12% Bis-Tris gel (Invitrogen); the gel was stained with Coomassie 
brilliant blue. The major band in elution fractions 2-3 runs at an Mr of ca. 48 kDa and is 
probably A. thaliana SufS. Lanes are as follows. M: Markl2 MW Unstained Standard 
(Invitrogen); I: insoluble fraction after cell lysis; S: soluble fraction after cell lysis; FT: 
column flowthrough; W: column wash; 1-11: elution fractions 1-11.
B. Evidence for Schiff base in A. thaliana SufS.
To detect Schiff base, an absorbance spectrum of the enzyme (66 pM) was acquired. 
The peak (418 nm) is characteristic of Schiff base.
C. Enzymology of A. thaliana SufS.
A. thaliana SufS is active, as indicated by the two methylene blue peaks (667 nm and 
744 nm). Inset top. Enzyme assays were performed with a low (70 nM) and high (700 
nM) concentration of enzyme; methylene blue absorbances were taken at 670 nm. Inset 
bottom. Enzyme assays were run for 2 h, 4 h and 15 h; methylene blue absorbances 
were taken at 670 nm. The line has no mathematical significance and is intended to 
guide the eye only.
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4.3.1.2. Characterisation of purified protein.
On a Coomassie-stained acrylamide gel (Fig. 4.5A), both SufS proteins migrated with 
mobilities close to their predicted monomeric masses (48 kDa) while purity exceeded 
95%. Protein concentration in solution was determined from the absorbance at 280 nm. 
The stock concentration of EcSufS was 137 pM  (ca. 1 mg.mL'1). Several preparations 
of A. thaliana SufS were made and stock concentrations varied from 66-86 pM (ca. 3-4 
mg.mL1)
Protein solutions were yellow and exhibited absorbance maxima in the yellow region of 
the spectrum (457 nm for EcSufS; 418 nm for AtSufS). The significantly red-shifted 
peak of EcSufS (Fig. 4.2B), as compared to the reported value for the enzyme (420 
nm165), could be due to residual Ni2+ from the purification. Orange colour is associated 
with reduced nickel: DTT was added to a high concentration (20 mM) during 
preparation of EcSufS. Conversely, the AtSufS absorbance maximum (Fig. 4.3B) 
coincides with the literature198 and is diagnostic of protonated PLP Schiff base (Dr. A. J. 
Iriarte, pers. comm.).
Mixing of L-cysteine with AtSufS produced a characteristic198 red shift of the Schiff 
base peak (Fig. 4.4B). This change is probably attributable to transimination. Leon, et 
a/.198 also reported the appearance of second peak (341 nm) following addition of L- 
cysteine, perhaps due to formation of pyridoxamine 5'-phosphate (PMP) via abortive 
transamination; I did not observe this effect. However, SufS from E. coli (Fig. 4.2C) 
and A. thaliana (4.3C) were both enzymatically active, as evaluated by methylene blue 
assay (section 4.3.2.3).
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FIGURE 4.4.
EXPERIMENTS WITH PURIFIED ARABIDOPSIS THALIANA SUFS.
A. Purified E. coli SufS and A. thaliana SufS.
Purified E. coli SufS and A. thaliana SufS proteins were run on a NuPAGE 12% Bis- 
Tris gel (Invitrogen); the gel was stained with Coomassie brilliant blue. Lanes are as 
follows. M: Markl2 MW Unstained Standard (Invitrogen); Ec: E. coli SufS; At: A. 
thaliana SufS.
B. Effect of L-cysteine on the PLP Schiff base of A. thaliana SufS.
The response of the enzyme (2 mg.mL'1) to L-cysteine was determined as described.198 
L-cysteine (0.5 mM) was added and spectra taken at the outset (+ L-CYS) and 10 min 
later (+ L-CYS + 10 MIN). Inset Molecule of cysteine.
C. Effect of reducing co-substrates on the enzymatic activity of A. thaliana SufS.
Enzyme assays were set up with A. thaliana SufS (900 nM) and 5 mM of one of the 
following reductants: B-ME, DTT, TCEP or THP. After 3 h incubation, enzymatic 
reactions were subjected to the methylene blue test for sulphide.
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During storage, activity was preserved by mixing the enzyme solution 50 % v/v with 
glycerol and freezing at -20 °C. (Activity was lost if the enzyme was frozen without 
glycerol.)
4.3.2. Development of the cysteine desulphurase assay.
4.3.2.1. Detecting cysteine desulphurase activity.
Given that cysteine desulphurases hydrolyse L-cysteine to L-alanine and sulphur, 
enzyme activity can be monitored by depletion of substrate or by accumulation of 
products. However, in this study, all work focussed on sulphur measurement.
4.3.2.2. Methods for the quantification o f sulphur.
Quantification of sulphur is a common procedure in analytical chemistry (reviewed by 
Patterson Jnr and Pappenhagen319) Typically, it is the concentration of sulphide (S2 ) that 
is measured.320 In this study, a lead sulphide (PbS) zymogram method321 was initially 
attempted using extremely active E. coli IscS. The method relied on the formation of 
lead sulphide (PbS) from PbN03 and S2; the enzyme was required to re-nature in the gel 
matrix. Read-out was achieved by inspection of the gel for black bands, indicating 
precipitated PbS. However, no precipitated PbS was visible even after prolonged 
incubation at 37 °C. Re-naturation of active dimers in the gel is unlikely;322 hence, the 
technique was abandoned.
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4.3.2.3. Methylene blue method.
A second approach was adopted, the methylene blue (MB+) method. First reported by 
Fischer (1852-1919), the MB+ reaction entails the dimerization of N,N-dimethyl-p- 
phenylenediamine (DMPD) by the action of sulphide and oxidising ferric ions (Fe3+), to 
form methylene blue, a heterocyclic thiazine dye.320 The assay is probably the most 
sensitive colorimetric method for the detection of sulphide.319 However, the chemistry 
of the reaction is poorly understood, although mechanisms have been proposed (Fig. 
4.5A).323324
It is interesting to note that modem versions of the MB+ assay employ anodic oxidation 
in place of Fe3+ and thus are able to relate the concentration of sulphide to changes in 
electrical current.325 Nevertheless, colorimetric detection remains adequate. Initially, I 
demonstrated that the MB+ signal was proportional to the amount of sulphide (Beer’s 
law), using Na2S as a standard (Fig. 4.5B). It is important to note that the scatter of 
points in Fig. 4.5B indicates the escape of H2S (g).
The MB+ technique was adapted for biochemistry by Siegel326 and used for the 
measurement of cysteine desulphurase activity by Zheng, et al.162 The assay operates in 
three stages: (1) enzymatic conversion of L-cysteine to L-alanine and sulphur by the 
action of the cysteine desulphurase; (2) reduction of S° to S2' by a reducing co-substrate, 
e.g., DTT; and (3) formation of MB+ following addition of developers (DMPD, Fe3+ and 
HC1).
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FIGURE 4.5.
PHYSICAL CHEMISTRY OF THE METHYLENE BLUE TEST FOR 
SULPHIDE.
A. Model of the formation of methylene blue from N,N-dimethyl-/i- 
phenylenediamine by the action of sulphide and ferric ions.
Kuban, et a l324 envisaged a six-electron oxidation over five steps (1-5). The reaction is 
started by the rapid mixing of sulphide (S2 ) with N,N-dimethyl-p-phenylenediamine 
(DMPD), ferric ions (Fe3+), and an aggressive proton donor (HC1). DMPD is oxidised 
by Fe3+ (1). S2' enters (2) in the form of H2S, generated by the action of HC1. The cation 
radical dimerizes (3) and is oxidised by Fe3+ (4). Finally, ammonia is eliminated, giving 
methylene blue (5).
B. Methylene blue production obeys Beer’s law.
The production of methylene blue is proportional to the amount of sulphide (range 10- 
100 nmol). Scatter is due to escape of H2S (g). Neutral solutions of N a^ were prepared 
and immediately subjected to the methylene blue test, as described (section 4.2.3.2). 
Absorbances were read at 620 nm. The line is intended to guide the eye.
183
•H
• F * * ’  .H *
(1)
(2)
(3)
^Zbj&tcOx.- (4)
. jd b o ^ ^ L jC C O ^ ,  
+  +
(5)
0.8 n
0.7
0.6
0.4
0.2
60 80 100 12020 40
Amount of sodium sulphide (nmol)
• > •  o o o a o » m
Amount of Na2S (nmol) 0 10 20 30 40 50 60 70 80 90 100
Enzyme assays were commenced using E. coli and A. thaliana SufS. In my hands, the 
enzymatic reaction did not appear oxygen sensitive, as is commonly assumed (Dr. S. 
Adinolfi, pers. comm.). Indeed, scrupulous degassing and flushing of solutions with N2 
(g) was abandoned at an early stage. However, it remained essential to minimise the 
escape of H2S (g) during colour development. Thus, the reaction mixture was overlaid 
with a thick (1 cm) layer of mineral oil. After taking this precaution, no “bad egg” 
odour was detectable; the human nose can detect H2S (g) concentrations as low as 0.02 
parts per million.327
Addition of DMPD and FeCl3 to the assay solution immediately lead to a brick-red 
flush. This may be attributed to the reaction of the pyridine ring of free PLP with FeCl3 
(“Phenol test”); or to the formation of the perchlorate cation radical salt of DMPD, 
commonly known as “Wurster’s Red.”324 Nevertheless, the red reaction was rapidly out- 
competed by dimerization of the DMPD cation radical to form methylene blue.
43.2.4. Demonstration o f cysteine desulphurase activity o f E. coli lysates.
Total cellular lysate from wild type E. coli was tested for cysteine desulphurase activity. 
A strong MB+ signal was produced (could not be measured spectrophotometrically due 
to high turbidity). This was not a surprising result given the abundance of cysteine 
desulphurases (IscS, CSD, SufS) in E. coli. Nevertheless, it emphasised the need for 
rigorous purification of enzyme in order to exclude the possibility of endogenous 
enzyme activity. To confirm that sulphide was absent in prepared cellular lysates and 
that this signal was a genuine result of enzymatic action, an aliquot of lysate was 
inactivated before use in the assay by heating to 70 °C for 10 min. Treated material did 
not produce an MB+ signal, indicating that the preparation lacked sulphide.
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4.3.2.5. Assessment of assay sensitivity.
The sensitivity of the enzyme assay was examined. Assays were performed with a low 
(70 nM) and high (700 nM) concentration of AtSufS; MB+ absorbances were taken at 
670 nm. The higher concentration of enzyme produced a strong blue signal while the 
lower concentration produced a signal near background (Fig 4.3C, inset top). These data 
suggest that enzyme concentrations ~ 1 piM are required for unambiguous detection of 
SufS activity. Enzyme assays were also run for 2 h, 4 h and 15 h and MB+ absorbances 
read at 670 nm (Fig. 4.3C, inset bottom). These data indicate that the L-cysteine 
substrate is not limiting over short periods (< 4 h) while longer incubation times (15 h) 
increase the sensitivity of the assay.
4.3.2.6. Evaluation o f reducing co-substrates.
Reductants can enhance cysteine desulphurase activity. For example, experiments with 
E. coli CSD showed that inclusion of DTT in the enzyme assay raised the krat for the 
release of sulphur from 0.5 min 1 to 3 min'1.328 Recent experiments conducted by 
Behshad, et al.329 with Synechocystis sp. IscS showed that the organophosphine 
reductant TCEP further enhanced cysteine desulphurase activity (second order rate 
constant = 4.9 x 103 M '.s"1), as compared to the thiolates 6-mercaptoethanol (2.0 M'1.s'1) 
and DTT (340 M !.s ‘). This discovery was attributed to the greater capacity of TCEP to 
cleave the persulphide intermediate within the enzyme active site.
Therefore, I evaluated different reducing co-substrates for their ability to promote the 
activity of AtSufS. Critically, the enzyme had been isolated without exposure to 
reducing agents. The organophosphine THP was tested in addition to the reductants
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used by Behshad, et al.379 It is worth noting that TCEP and THP powerfully cleave 
disulphide bonds: TCEP has a reduction capacity against oxidised glutathione of 0.182 
milfiequivalents.g!; the figure for THP is 0.232 milliequivalents.g1.*
The results are reported in Fig. 4.4C. MB+ signal was detectable in the TCEP, DTT and 
6-mercaptoethanol treatments (signal strength: TCEP > DTT »  6-mercaptoethanol). 6- 
mercaptoethanol gave a persistent brick-red tinge to the MB+ solution (probably 
represented by the pronounced peak in the violet regime of the absorbance spectrum). 
The colour was likely due to a competing reaction between the mercaptan and DMPD. 
It is well known that sulphur-containing compounds (e.g., thiols) can interfere with the 
MB+ reaction.319 According to Kuban, et a l.32A the side reaction produces a sulphide- 
substituted cation radical possessing a chromophore. In order to bypass this interference 
effect, attempts were made to recover the sulphide by zinc acetate precipitation. 
However, extra manipulations inevitably lead to loss of sulphide; indeed, no MB+ signal 
was detectable following the procedure.
TCEP (Abs 667 nm = 0.50) appeared to offer only a minor enhancement of signal 
strength over DTT (Abs 667 nm = 0.46). This result apparently conflicts with the 
finding of Behshad, et a l329 for IscS.* However, my result can be readily explained by 
reference to the kinetic model (Eq. 4.1): in isolated SufS, the rate limiting step is 
nucleophilic attack (k,) upon the substrate; while in IscS, the rate limiting step is 
cleavage of the persulphide intermediate (k2). Hence, acceleration of k2 by use of TCEP 
could only have a minor impact on the activity of AtSufS because of the bottleneck 
imposed by kj.
* Calbiochem Data Sheet 598250 Rev. 22-January-04.
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In spite of its significant reducing power, THP did not produce an MB+ signal. One 
speculation is that THP is unable to cleave the persulphide intermediate due to its 
flexible side chains impairing entry to the active site. It is worth noting that THP was 
incapable of reducing the PLP cofactor resident in the active site of resting EcSufS 
(section 4.3.1.1).
4.3.3. Future work.
In conclusion, I have developed a robust cysteine desulphurase assay based on the 
methylene blue test for sulphide. Availability of active P. falciparum SufS would allow 
classical enzymological studies to be conducted, e.g. determination of maximum 
velocity (Vmax) and Michaelis constant (Km). Availability of other members of the SUF 
complex from P. falciparum (e.g. SufE) would allow stimulation experiments. 
However, Mihara, et a l313 were unable to determine the kinetic parameters of EcSufS 
because enzyme activity against L-cysteine departed markedly from Michaelis-Menten 
kinetics (determined by inspection of a Lineweaver-Burk plot).
Given the number of PLP-dependent enzymes, there are numerous examples of 
inhibitors, although the majority are.non-specific (reviewed by Eliot and Kirsch297). 
Many are potent poisons forming stable complexes with PLP (e.g., hydrazine). A few 
have been developed for clinical use, e.g., eflornithine, which attacks ornithine 
decarboxylase (EC 4.1.1.17) and is used to treat African trypanosomiasis caused by 
Trypanosoma brucei gambiense330 Hence, a screen for inhibitors of P. falciparum SufS 
might be useful. Two obvious candidates would be L-allylglycine and L-vinylglycine, 
suicide inhibitors already used to probe the cysteine desulphuration mechanism of 
Azotobacter vinelandii NifS.316 If a specific inhibitor were identified, a chemical
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knockout of SufS in living parasites could be attempted, as demonstrated with falcipain-
j  331
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CHAPTER 5.
EXPRESSION AND PURIFICATION OF RECOMBINANT PLASMODIUM
FALCIPARUM SUFS.
P. falciparum SufS (PfSufS) is predicted to be a cysteine desulphurase. In order to test 
this prediction, attempts were made to over-express recombinant PfSufS in 
heterologous hosts. This chapter briefly summarises the problems encountered with this 
technique, followed by a description of the numerous experiments conducted to obtain 
pure and active PfSufS.
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5.1. INTRODUCTION.
5.1.1. Studying enzyme activity.
In enzymology, it is vital to use an homogenous preparation so that activity can be 
unequivocally attributed to a single protein. The purpose of this brief introduction is to 
outline how P. falciparum enzymes may be obtained.
5.1.2. Isolation of authentic enzyme.
The classical method is to isolate authentic enzyme directly from the organism under 
study. Such an approach requires careful attention to the physical properties of the 
protein, notably, size, polarity and solubility, to allow purification from a complex 
mixture. Amenable to this technique are proteins expressed at high levels; or for which 
a large amount of starting material is available.337 Application to malarial enzymes was 
facilitated by the development of in vitro culture of P. falciparum erythrocytic stages.338 
For example, Chen and Zolg339 purified microgram quantities of P. falciparum 
dihydrofolate reductase-thymidylate kinase (PfDHFR-TS; PlasmoDB PFD0830w) 
through eight steps from a large number (~ 1.5 x 1011) of erythrocytic stage parasites. 
However, given the time and effort required, such techniques have fallen out of favour 
as compared to recombinant expression (section 5.1.3). To my knowledge, there are no 
reports of successful purification of plastid-targeted enzymes from P. falciparum 
lysates. It seems probable that the low levels of expression associated with these 
enzymes (chapter 1) and their imprisonment by multiple membranes (chapter 3) would 
make successful recovery challenging.
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5.1.3. Recombinant expression.
5.1.3.1. Over-expression systems.
An alternative approach is to clone the gene of interest into a vector along with an 
inducible promoter and use the resulting plasmid to programme the over-expression of 
the protein in large quantities, in vitro, or in prokaryotic340 or eukaryotic hosts.341 The 
bulk of this work done in E. coli produces enzymes that are usually considered good 
models for authentic enzyme. For example, authentic and recombinant versions of 
PfDHFR-TS (section 5.1.2) exhibited similar kinetic properties.342 Likewise, over­
expression in E. coli has been used successfully to obtain active SufS from diverse 
organisms. 165>,92«198199-311
The major advantage of the heterologous approach becomes apparent during 
purification. As the protein is already heavily enriched by over-expression, it is easier to 
separate from a complex mixture. Furthermore, genetic fusion to an affinity tag helps 
purification. For example, poly-histidine tags bind to divalent metal cations (e.g., Ni2+), 
enabling immobilised metal ion chromatography. Indeed, this approach can allow 
purification of a protein of interest, to homogeneity in one step (e.g., His6-EcSufS, 
chapter 4).
Nevertheless, the heterologous approach often fails with malarial proteins, due to 
problems of transcription, translation and protein folding arising from incompatibilities 
between P. falciparum proteins and those of the expression host. It is illustrative to note 
the small number (~ 20-30) of P. falciparum proteins that have been successfully over­
expressed in the last 20 y.343 Such anecdotal evidence is supported by high throughput
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screening, e.g., only 149 (22 %) of 672 P. falciparum proteins made by the Structural 
Genomics of Parasitic Protozoa (SGPP*) consortium are reported to be soluble (15 
April 2005).
5.1.32. Problems encountered at the level of expression.
P. falciparum  genes are characterised by a high AT content (80.6 %),45 markedly 
divergent from E. coli (49.2 % AT) and eukaryotic expression hosts (e.g., S. cerevisiae, 
61.7 % AT). Hence, expression often fails due to a lack of appropriate tRNAs. In E. 
coli, the problem can be overcome to some extent by co-transformation with helper 
plasmids encoding the required tRNAs, e.g., the RIG plasmid.344 In the case of 
eukaryotic expression systems, it is necessary to re-synthesise the P. falciparum gene 
according to the codon usage of the expression host.345 Even in E. coli, re-synthesis can 
offer significant improvements to the expression level, e.g., the ten-fold efficiency gain 
in expression of synthetic PfDHFR-TS over wild-type.346
5.1.3.3. Problems encountered at the post-translational level.
If protein is expressed, problems can still arise. Notably, the protein may be toxic to the 
host; or it may adhere to membranes, requiring extraction with detergents. However, the 
most widely publicised obstacle is protein insolubility typified by the formation of 
inclusion bodies (IB) in the cytosol or periplasm.347
IB may be crudely defined as a dense protein aggregate that partitions into the pellet 
following cellular lysis and high-speed centrifugation (e.g., 150000g). However, it is
* http://depts.washington.edu/sgpp/
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worth noting that lysis and centrifugation conditions have a marked influence on this 
partitioning; a more exact definition may be derived from recent investigations.348 IB 
was found to be an aggregate of disordered structures and 8-sheets, reminiscent of 
amyloid plaques of eukaryotic cells.
Certain physical properties of proteins are related to aggregation, e.g., cysteine fraction, 
net charge, hydrophilicity and propensity to form turns. For eukaryotic proteins, the 
ultimate cause of aggregation may be incompatibility between eukaryotic protein 
folding pathways and the alien environment of E. coli. For example, transcription and 
translation are coupled in bacteria, and the cytosol of E. coli is basic (pH 7.5-7.9), 
reducing, and lacking in eukaryotic chaperones.349
Remaining sections of this introduction focus on overcoming the IB problem in vivo 
and ex vivo. Given that a general method to ensure correct protein folding is not 
available, methodology is empirical350
5.1.4. Protein solubilisation in vivo.
5.1.4.1. Solubilisation by manipulation of expression conditions.
If a protein forms IB, attempts can be made to improve solubility during expression by 
manipulation of bacterial growth. Interventions tend to be guided by the hypothesis that 
slowing the rate of expression will allow the protein a longer time to fold. Common 
approaches include lowering the induction temperature;351 growing the bacteria in 
minimal medium; or reducing the concentration of inducing agent. Genetic methods to 
encourage solubility include the knockout of genes apparently promoting aggregation,
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e.g., GroEL,352 and co-expression with certain molecular chaperones, e.g., DnaK and 
ClpB.353 Interventions that account for the specific properties of the target protein can 
also promote correct folding. For example, expression of soluble lipoic acid synthase 
(an [Fe-S] cluster containing protein) was enhanced by co-expression of IscS.354
5.1.4.2. Solubilisation by modification o f the protein sequence.
The most common modification to aid solubility is genetic fusion with a highly soluble 
protein tag, e.g., N-utilising factor A (NusA); glutathione S-transferase (GST); or 
maltose binding protein (MBP).355 However, solubilisation may also require direct 
mutation of the target protein sequence. With the exception of certain critical regions 
(e.g., the active site), protein function is generally robust to such mutations.356 However, 
experimental progress is hampered by the lack of knowledge of the relationship 
between protein sequence and solubility. Thus, the approach relies on guesses. These 
can be informed by molecular modelling and comparison with homologous sequences 
for which expression data are available. Random mutation of the target protein makes 
fewer a priori assumptions, but is not feasible without high throughput technology to 
screen for soluble mutants. This can be done via genetic fusion to a C-terminal reporter 
tag, e.g., GFP357 or CAT,358 that will only function if the target protein is soluble.
5.1.4.3. Predicting the chance o f IB formation.
Given the often-laborious task of solubilising protein by these methods, interest has 
focussed on predicting the outcome of expression experiments in silicoy based on 
primary amino acid sequence. One prominent (but unproven) example is the Wilkinson- 
Harrison solubility model359 constructed by examination of the amino acid sequence of
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81 over-expressed proteins of known solubility. It was shown that neutrality of charge; 
and few asparagine, proline, glycine and serine residues (correlating with the propensity 
to form turns) were the major determinants of solubility. Based on these parameters, a 
statistical model was generated to predict the probability of achieving soluble protein 
during over-expression in E. coli.
5.1.5. Protein solubilisation ex vivo.
5.1.5.1. Solubilisation by denaturation.
Extraction of IB from cells is classically achieved by denaturation with aggressive 
chaotropes (guanidine hydrochloride and urea).360 Proteins extracted by these methods 
must be refolded in vitro to a functional state. Levinthal361 calculated that a protein of 
300 amino acids could adopt 10300 different folds. Achieving a native fold by refolding 
appears improbable (p = lO"300)! Nevertheless, denatured proteins can be refolded in 
vitro,362 Examination of the literature shows that refolding of proteins to an active state 
is often achieved.
Uncovering the most appropriate refolding conditions is an empirical process.363 It is 
typically done by exchange of protein into buffer lacking denaturant (by dialysis, 
dilution or rapid buffer exchange). It is important to note that while it is sometimes 
possible to refold a protein into a soluble state by these methods, it can be difficult to 
achieve a functional fold. Hence, the process is most usefully performed using a large- 
scale screen to maximise the chance of a hit, e.g., with a series of solutions containing 
different concentrations of buffer, cations and other additives. Temperature, pH and 
protein concentration are also important parameters.
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5.1.5.2. Predicting the outcome of protein refolding experiments.
It would be useful to predict the outcome of refolding experiments in silico (under a 
given set of chemical conditions) based on primary amino acid sequence alone. To my 
knowledge, only one such algorithm exists, namely, Ho and Middelberg.364 It was 
suggested that the tendency to adopt a native fold is inversely related to the rate of 
protein aggregation, and thus may be considered a function of the second virial 
coefficient (SVC). Thus, conditions that increase the SVC are likely to increase folding 
yield. Correlation between measured SVC and the molecular weight and hydropathicity 
was found; hence, hypothetical SVC may be calculated based on protein sequence. By 
this method, protein can be classed as less aggregative (SVC > 2 x 103 mL.mol.g2) or 
more aggregative (SVC < 2 x 103 mL.mol.g'2).
5.1.6. Chapter objective and overview.
The objective of the work reported in this chapter was to produce soluble and 
enzymatically active PfSufS. Following the Materials and Methods, the results section 
begins with a brief discussion of the properties of the PfSufS sequence as they relate to 
suitability for heterologous expression. A series of PfSufS expression constructs and the 
experiments conducted with them are described.
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5.2. MATERIALS AND METHODS.
5.2.1. Computational techniques.
Molecular structures were visualised using iMol while protein sequence properties were 
analysed using SeqVu. Sequences were aligned using the ClustalW algorithm249* and 
refined by eye. The ExPASy ProtParam toolt was used to predict Mr, isoelectric point 
(pi), molar extinction coefficient at 280 nm (e),333 grand average of hydropathy 
(GRAVY)233 and instability index (II).396 Wilkinson-Harrison probabilities of 
solubility359 were calculated using an Internet-based algorithm.^ Stability of proteins in 
E. coli cytosol was predicted by reference to the N-end rule.397 Second virial coefficients 
(SVC) were calculated using a Microsoft Excel spreadsheet according to the method of 
Ho and Middelberg.364 Transmembrane regions were predicted with the DAS-TMfilter 
server.398* N-linked glycosylation sites were predicted using the NetNGlyc 1.0 server.8 
O-linked glycosylation sites were predicted using the DictyOGlyc 1.1 server.399" 
Quality of PCR primers was checked with the Amplify software. DNA sequences were 
assembled using the ABI Prism Sequencing Analysis software (Perkin Elmer) running 
on an Apple Power Mac G4.
5.2.2. Nucleic acid techniques.
Nucleic acid techniques were as described (chapter 2). Primer sequences are indicated 
in Table 5.1.
* http://www.ebi.ac.uk/clustalw/
t  http://www.expasy.org/tools/protparam.html 
$ http://www.biotech.ou.edu/
* http://mendel.imp.univie.ac.at/sat/DAS/DAS.html 
8 http://www.cbs.dtu.dk/services/NetNGlyc/
I' http://www.cbs.dtu.dk/services/DictyOGlyc/
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TABLE 5.1.
PCR PRIMERS USED IN CHAPTER 5.
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ID DNA sequence
2.3 5'GAGCTCGATT ATTTTAAAAATGTAAGAGAACAT
2.4 3’CATT AGTT ATT AT ATT ACTACCAT
2.5 5’GTGCATCACTAGGTACAGGT
2.6 3'CTCGAGTTTTTCATTTTTCATTTCATTTAACAT
5.1 3'TTGTGGGCCGAGTTGAACAAAATGATTTTTCAT
5.2 5'AGGCTTGGCATATTACCATTATGGTCAAATACA
5.3 3TGGTAATATGCCAAGCCTGTTTTGTGGGCCGAGTTGAAC
5.4 5'GTTCAACrCGGCCCACAAAACAGGCTTGGCATATTACCA
5.5 5'GGGGGATCCGATTATTTTAAAAATGTAAGAGAACAT
5.6 3’GGGGAATTCTTTTTCATTTTTCATTTCATTTAACAT
5.7 5'GGGGAATTCGATTATTTTAAAAATGTAAGAGAACAT
5.8 3'GGGCrGCAGTTATTTTTCATTTTTCATTTCATTTAACAT
5.9 5'GGGGAATTCCrGGAAGTTCrGTTCCAGGGGCCCGATTATTTTAAAAATGTAAGAGAACAT
5.10 3'GGGCTGCAGTTAGTGGTGGTGGTGGTGGTGTmTCATmTCATTTCATTTAACAT
5.11 3'GGGCTGCAGTTAATGGTGGTGGTGGTGGTGGTGGTGGTGGTGGTGGTGTTTTTCATmTCATTTCATTTAACAT
5.2.3. Protein techniques.
5.2.3.1. Properties o f expression vectors.
Expression vector pTrcHis2-TOPO was obtained from Invitrogen; pET28a(+) and 
pET43.1b(+) from Novagen; pGEX-6P-l from Amersham; and pMALc2 and pMALp2 
from NEB. pET28a(+) encodes a cassette conferring resistance to kanamycin; the other 
vectors encode a 6-lactamase conferring resistance to ampicillin. Transcription from 
pTrcHis2-TOPO is programmed by the Trc promoter; whereas transcription from 
pET28a(+) and pET43.1b(+) is under the control of the T7 promoter. Expression from 
pGEX-6P-l is programmed by Ptac. In all cases, expression is regulated by the lac 
system and is therefore induced with isopropylthio-8-D-galactoside (IPTG). 
Additionally, two expression vectors for use in Saccharomyces cerevisiae (pMG and 
pMH903; Fig. 5.23A) were obtained as gifts from Dr. S. G. Sedgwick (NIMR). 
Expression from these vectors is programmed by Pgal (responsive to galactose). Fusion 
proteins expressed from all the vectors are depicted in Fig. 5.2, 5.7 and 5.11.
5.2.3.2. Expression culture.
Expression plasmids were transformed into Rosetta-gami (DE3) pLysS (Novagen) or 
BL21-CodonPlus (DE3)-RIL (Stratagene) competent E. coli cells. Rosetta-gami strains 
are deficient in glutathione reductase and thioredoxin B, thus promoting disulphide 
bond formation in the cytosol. pLysS and RIL plasmids encode rare codons thereby 
correcting for the AT bias of P. falciparum DNA. Bacteria were grown in Luria-Bertani 
broth (10 g bactotryptone, 5 g yeast extract, 10 g NaCl to 1 L in redistilled water) or 
Terrific broth (10 g tryptone, 5 g yeast extract, 10 g NaCl, 6.3 g K2HP04, 1.8 g KH2P04,
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sodium citrate 0.45 g, MgS04.7H20  0.09 g, (NH4)2S04 0.9 g, glycerol 44 g to 1 L in 
redistilled water). In addition to antibiotic (ampicillin or kanamycin) required to 
maintain the expression plasmid (section 5.2.3.1), bacteria harbouring pLysS and RIL 
plasmids were grown with chloramphenicol. Expression media were routinely enriched 
with 50 piM pyridoxal 5'-phosphate (PLP). Protein expression experiments in S. 
cerevisiae were conducted by Dr. S. G. Sedgwick.
5.2.3.3. Detection and quantification of expressed proteins.
Proteins were detected by denaturing polyacrylamide gel electrophoresis using the 
NuPAGE system (Invitrogen) followed by Coomassie brilliant blue staining or Western 
transfer. On Western blots, His fusions were detected by incubation with 1:1000 His-tag 
monoclonal antibody (Novagen) followed by 1:6000 anti-mouse IgG-HRP (Sigma). S- 
tag fusions were detected by incubation with 1:5000 S-protein HRP conjugate reagent 
(Novagen). GST fusions were detected by incubation with 1 //g.mL1 mouse anti-GST 
(Zymed) followed by 1:2000 HRP-rabbit anti-mouse IgG2b (Zymed). MBP fusions 
were detected by incubation with 1:10000 rabbit anti-MBP antisera (NEB) followed by 
1:3000 goat anti-rabbit IgG (H+L)-HRP conjugate (Bio-Rad). Cross-reactive bands 
were revealed by ECL (Amersham). Images of gels were captured using an Epson 
Perfection 2480 Photo scanner and molecular weights of proteins were estimated by 
comparison to BenchMark, Mark 12 or SeeBlue standards (Invitrogen) using image 
analysis (UVP LabWorks). N-terminal sequencing was done by Babraham Bioscience 
Technologies (UK). Protein concentrations in solution were measured by absorbance of 
aromatic amino acids at 280 nm or by BCA protein assay (Pierce) using BSA as the 
standard. Protein function was assessed by PLP binding and methylene blue (MB+) 
assay as described (chapter 4).
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5.23.4. Liquid chromatography.
Liquid chromatography was conducted on fast protein liquid chromatography (FPLC) 
apparatus: Akta Prime or Akta FPLC (Amersham). Operation of the Akta FPLC was 
controlled by the UNICORN software (Amersham) running on a Compaq DESKPRO 
PC. Buffers intended for use in the high-pressure system of the FPLC were filtered 
through a polyethersulfone membrane of 0.2 pm  pore size.
5.2.4. Engineering of expression constructs.
5.2.4.1. Recovery o f mature P. falciparum sufS.
P. falciparum sufS (PlasmoDB PF07_0068) predicted to encode the mature enzyme 
(PfSufS[MJ; D62-K546) was recovered from cDNA using the splicing by overlap 
extension (SOE)-PCR technique of Horton, et a /.400 Briefly, PfsufS[M] was split into 
two overlapping segments. Primers flanked with complementary sequence were 
designed to amplify each segment such that the two segments could be joined in a 
second round of PCR. This approach was necessary owing to the failure to recover 
PfsufS[M] in one PCR reaction (chapter 2).
In the first round of PCR, the 5' segment was amplified with primers 2.3 and 2.4; while 
the 3' segment was amplified with primers 2.5 and 2.6. Thermocycling conditions were: 
denaturation at 94 °C for 1 min; followed by 35 cycles of 98 °C for 20 s; 45 °C for 30 s; 
and 72 °C for 1 min. PCR products were gel purified and assembled with a second 
round of PCR directed by the extreme 5' and 3' primers (2.3 and 2.6). Thermocycling 
conditions were identical to the first round except for a higher annealing temperature
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(65 °C). After gel purification, 5' overhangs were generated by heating the DNA at 72 
°C for 10 min with dNTPs (2.5 mM each), 1 x PCR buffer I (Perkin Elmer) and 1 U 
AmpliTaq (Roche). Final product was extracted in phenol-chloroform and ligated into 
pCRII (Invitrogen) by TA cloning. Insert was checked by restriction digest and Sanger 
sequencing. The construct was termed pCRII:PfsufS[M].
5.2.4.2. Construction ofchimaeric P. falciparum sujS.
A chimaeric version of PfsufS[M] (PfsufS[M]x) was also generated. In this construct, 
sequence encoding the PrP-like loop was replaced with a cassette 
(GGCCCACAAAACAGGCTT; GPQNRLG) modelled to ease folding and derived 
from the EcSufS sequence (referred to as the E. coli bridge). SOE-PCR was employed 
to generate PfsufSfM]/ in three distinct rounds of PCR.
In the first step, sequence encoding PfSufS[M] was split into three segments that were 
amplified in three separate PCR reactions from a cDNA template. The segment 5' distal 
to the PrP-like loop (N-terminal region) was amplified with primers 2.3 and 2.4. The 
segment 5' proximal to the PrP-like loop (middle region) was amplified with primers
2.5 and 5.1. The segment 3' to the PrP-like loop (C-terminal region) was amplified with 
primers 5.2 and 2.6. Thermocycling conditions were as described (section 5.2.4.1) with 
an annealing temperature of 45 °C. PCR products were gel purified.
In order to insert the E. coli bridge, products encoding the middle and C-terminal 
regions were used as targets for a second round of PCR in two distinct reactions. In the 
first reaction, the middle region was joined to the E. coli bridge using primers 2.5 and
5.3. In the second reaction, the C-terminal region was joined to the E. coli bridge using
204
primers 5.4 and 2.6. Touchdown thermocycling conditions for both reactions were: 
denaturation at 94 °C for 1 min; followed by five cycles of 98 °C for 20 s; 45 °C for 30 
s; and 72 °C for 30 s; followed by 30 cycles of 98 °C for 20 s; 60 °C for 30 s; and 72 °C 
for 1 min.
Products were gel purified before a third round of PCR to join sequence encoding the 
N-terminal region (made in the first round of PCR) to the E. coli bridged middle and C- 
terminal regions (made in the second round of PCR). This final reaction was directed by 
the extreme 5' and 3' primers (2.3 and 2.6), thus giving PfsufS[M]x* Thermocycling 
conditions were as described (section 5.2.4.1), with the exception of the annealing step 
conducted at 64 °C. Product was screened for the presence of the E. coli bridge by 
sizing on 2 % Metaphor agarose gel (FMC Bioproducts) before insertion into pCRII as 
described (section 5.2.4.1). Clones were checked for insert by restriction digest and 
Sanger sequencing. The resulting construct was termed pCRII:PfsufS[M]x-
5.2.4.3. Cloning into expression vectors.
An expression construct encoding exon 2 of P. falciparum SufS (PfsufS[E2]; K98- 
K546), known as pTrcHis2-TOPO:PfsufS[E2], was obtained from Mr. A. Slatter and 
Dr. B. Clough. PfsufS[M] and PfsufS[M]x were recovered by digestion (Sacl and Xhol) 
from pCRII:PfsufS[M] and pCRII:PfsufS[Mlx, respectively, and inserted into the 
corresponding sites in pET43.1b(+), generating pET43.1b(+):PfsufS[M] and 
pET43.1b(+):PfsufS[M]x, respectively. PfsufS[M] was additionally cloned into the 
same restriction sites in pET28a(+), giving pET28a(+):PfsufS[MJ. PfsufS[M]x was 
recovered from pCRII:PfsufS[M]x by PCR using primer sets flanked with the 
appropriate restriction sites for cloning into plasmids pGEX-6P-l, pMALc2, pMALp2,
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pMH903 and pMG, generating pGEX-6P-l:PfsufS[M]x, pMALc2:PfsufS[M]/, 
pMALp2:PfsufS[M]x, pMH903:PfsufS[M]x and pMG:PfsufS[M]x, respectively. 
Primers flanked with appropriate restriction sites (BamUl and EcoRl) for insertion into 
pGEX-6P-l, pMH903 and pMG were 5.5 and 5.6; equivalents flanked with restriction 
sites (EcoRl and Pstl) for insertion into pMALc2 and pMALp2 were 5.7 and 5.8. 
Thermocycling conditions were as described (section 5.2.4.1), with the exception of the 
annealing step conducted at 57 °C. PCR products were digested with appropriate 
restriction enzymes and inserted directly into target vectors. Inserts were confirmed by 
restriction digest and Sanger sequencing.
Additional editing was performed on pMALc2:PfsufS[M]x to insert a human rhinovirus 
3C protease (3Cpro) recognition site (LEVLFQGP401) between cMBP and PfSufS[MJx; 
and His6 or His12 affinity tags at the C-terminus of the fusion protein, generating 
pMALc2:3Cpro-PfsufS[M]x-His6 and pMALc2:3Cpro-PfsufS[M]x-His12, respectively. 
Briefly, PfsufS[M]x was recovered by PCR from pMALc2:PfsufS[M]x using primers 
flanked with sequence coding for the insertions, i.e., primer 5.9 was combined with 
either primer 5.10 or 5.11. Thermocycling conditions were as described (section
5.2.4.1), with the exception of the annealing step at 52 °C. PCR products were digested 
(ZscoRI and Pstl) and ligated into fresh pMALc2 vector. Sequences were confirmed by 
restriction digest and Sanger sequencing.
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5.2.5. Experiments with pTrcHis2-TOPO:PfsufS[E2].
5.2.5.1. Protein expression.
BL21-CodonPlus (DE3)-RIL cells harbouring pTrcHis2-TOPO:PfsufS[E2] were 
incubated for 16 h in Luria-Bertani broth containing 100 //g.mL1 ampicillin. The 
culture was diluted 1/50 into fresh Luria-Bertani broth containing 50 //g.mL1 ampicillin 
and grown until the optical density at 600 nm (OD600) reached 0.6. Cultures were 
induced with 1 mM IPTG at 37 °C, 23 °C or 18 °C. Pilot experiments were done in 100 
mL of culture medium; while preparative experiments were done in 3 L of culture 
medium.
5.2.52. Protein purification.
For soluble protein preparations, all steps were performed at 4 °C; while for insoluble 
preparations, steps were performed at room temperature and buffers were supplemented 
with 6 M urea. Bacterial pellets were recovered by centrifugation and re-suspended in 
binding buffer (20 mM phosphate, 0.5 M NaCl, 10 mM imidazole, pH 7.6) containing 
Roche complete EDTA-free protease inhibitor cocktail tablets (1 tablet per 50 mL of 
suspension). The cell suspension was sonicated on ice with a Sonics and Materials 
Vibracell probe tip sonicator. Sonicate was centrifuged at 150000# for 1 h at 4 °C. The 
supernatant was applied to an Amersham HiTrap Chelating HP 1 mL column with a 
Pharmacia LKB Pump PI. Previously the column had been charged with 0.5 mL 0.1 M 
NiS04 and equilibrated by flushing with 10 mL binding buffer. Protein was eluted from 
the column with a linear gradient limited by 1 M imidazole using an Akta FPLC. Urea
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was removed by dialysis for 24 h against buffer containing 50 mM Tris, 100 mM KC1,2 
mM MgCl2, 1 mM DTT.
5.2.6. Experiments with pET28a(+):PfsufS[M].
Cells harbouring pET28a(+):PfsufS[M] were incubated for 16 h in Luria-Bertani broth 
containing 100 pig.mL'1 kanamycin and 34 /<g.mL1 chloramphenicol. The culture was 
diluted 1/50 into fresh Terrific broth containing 50 pig.mL'x kanamycin, 34 pig.m L1 
chloramphenicol and 50 piM PLP. At an OD600 of 1.0, the culture was induced for 5 h 
at 37 °C with 1 mM IPTG. Pilot experiments were done in 100 mL of batch culture.
5.2.7. Experiments with pET43.1b(+):PfsufS[M] and pET43.lb(+):PfsufS[M]x-
5.2.7.1. Protein expression.
Cells harbouring pET43.1b(+):PfsufS[M] and pET43.1b(+):PfsufS[M]x were cultured 
as described (section 5.2.6). Pilot experiments were done in 1 L of batch culture. 
Conversely, preparative experiments required a culture volume of 40 L and were 
conducted in a biostat (Large Scale laboratory, NIMR). Cells were harvested by 
centrifugation and lysed in PBS containing Roche complete EDTA-free protease 
inhibitor cocktail set (1 tablet per 50 mL) by sonication or passage through a French 
pressure cell.
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5.2.7.2. Protein purification.
Inclusion bodies were prepared essentially as described.402 Briefly, lysate (section
5.2.7.1) was centrifuged at 12000# to recover IB. Pelleted IB was washed repeatedly in 
PBS and recovered by centrifugation at 12000#; prior to a final differential 
centrifugation at 960# to partition the protein component of IB into the supernatant. 
Supernatant was transferred to another receptacle and IB recovered by centrifugation at 
12000#. IB was dissolved by gentle stirring for 1 h at 25 °C in 50 mL of buffer 
containing 20 mM phosphate, pH 7.4, 0.5 M NaCl, 10 mM imidazole, 8 M urea. 
Ethylenediamine (25 mM) was included in all urea buffers to prevent cyanate 
accumulation.403,404 Protein solutions were centrifuged at 150000# for 20 min at 4 °C 
and the supernatant was applied to a 1 mL or 5 mL HisTrap HP column (Amersham) 
using an Atka Prime. Protein was eluted by linear gradient limited by 250 mM 
imidazole.
52.7.3. Cleavage experiments.
Fractions containing NusA-PfSufS[M]x were pooled and concentrated through an 
Amicon membrane (molecular weight cut-off 10 kDa). Concentrated protein was 
dialysed for 80 h at 4 °C against 1 L EKMax reaction buffer (50 mM Tris, pH 8.0, 1 
mM CaCl2, 0.1 % v/v Tween-20) supplemented with 1 M urea. Protein was centrifuged 
at 150000# to remove precipitate. Soluble protein was digested for 20 h at 4 °C or 37 °C 
with differing amounts (0.001-4 U) of EnterokinaseMax (Invitrogen).
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5.2.7.4. Refolding screen.
NusA-PfSufS[M]x was submitted to the Foldlt refolding screen (Hampton Research) 
according to the instructions of the manufacturer. Briefly, fractions containing NusA- 
PfSufS[M]x were pooled and dialysed for 16 h at 4 °C against 1 L of buffer containing 
100 mM Tris, pH 7.6, 100 mM NaCl, 1 mM DTT, 4 M urea. No precipitation of protein 
was evident in 4 M urea. Therefore, dialysate was diluted 20-fold into 16 different 
refolding buffers with addition of PLP in a selection of buffers (Table 5.2). Mixtures 
were incubated on a rocking platform for 12 h at 4 °C before dialysis in mini dialysis 
units (molecular weight cut-off 10 kDa) for 4 h at 4 °C (one change of buffer) against 1 
L of buffer containing 50 mM NaH2P04, pH 8.0, 150 mM NaCl, in a common 
container. Dialysate was centrifuged at 150000g for 20 min at 4 °C and the supernatants 
analysed for protein by Western blotting.
5.2.7.5. Preparative refolding.
Concentrated NusA-PfSufS[M]x (lmL) dissolved in 8 M urea (section 5.2.7.2) was 
dialysed against 1 L of freshly made refolding buffer (section 5.2.7.4) for 16 h at 4 °C. 
Refolding buffer was exchanged for 50 mM NaH2P04, pH 8.0, 150 mM NaCl by either 
a second dialysis for 1 h at 4 °C; or a rapid buffer exchange through a 5 mL HiTrap 
Desalting column using an Akta Prime. Soluble protein was recovered by centrifugation 
at 150000g for 20 min at 4 °C.
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TABLE 5.2.
COMPOSITION OF BUFFERS IN THE FACTORIAL REFOLDING SCREEN.
NusA-PfSufS[M]x was submitted to a factorial refolding screen comprising 16 buffers 
of stated composition. Abbreviations are as follows. PEG 3350: polyethylene glycol 
3350; GuHCl: guanidine hydrochloride; GSH: reduced glutathione; GSSG: oxidised 
glutathione.
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Foldlt reagent Buffer Salts PEG 3350 GuHCl Divalent cation/chelator Polar/non-polar additives DTT Lauryl maltoside GSH GSSG PLP Solubility
1 50 mM Tris pH 8.2 241 m M  NaCl, lOmM KC1 0.05% 0 1.0 mMEDTA 0 0.% mM 0 0 0 0.48 mM _
2 50 m M  MES pH 6.5 9.65 m M  NaCl, 0.40 m M  KC1 0 502 mM 2.0 m M  MgCl2,2.0 m M  CaCl2 0 0 0.29 mM 0.96 m M 0.0% mM 0 -
3 50 m M  MES pH 6.5 9.65 m M  NaCl, 0.40 mM KC1 0.05% 502 mM 1.0 m M  EDTA 402 m M  Sucrose, 502 m M  L-Arginine 0 0 0.96 m M 0.0% mM 0.48 mM -
4 50 mM Tris pH 8.2 241 m M  NaCl, lOmM KC1 0 0 2.0 m M  MgCl2,2.0 mM  CaCl2 402 m M  Sucrose, 502 m M  L-Arginine 0.96 mM 0.29 mM 0 0 0 +
5 50 mM  MES pH 6.5 241 m M  NaCl, lOmM KC1 0 0 2.0 m M  MgCl2,2.0 mM  CaCl2 402 mM  Sucrose 0 0 0.96 m M 0.0% mM 0.48 mM -
6 50 mM Tris pH 8.2 9.65 m M  NaCl, 0.40 mM KC1 0.05% 502 mM 1.0 m M  EDTA 402 m M  Sucrose 0.96 mM 0.29 m M 0 0 0 +
7 50 mM Tris pH 8.2 9.65 m M  NaCl, 0.40 mM  KC1 0 502 mM 2.0 m M  MgCl2,2.0 mM CaCl2 502 m M  L-Arginine 0.96 mM 0 0 0 0.48 mM -
8 50 mM  MES pH 6.5 241 m M  NaCl, lOmM KC1 0.05% 0 1.0 m M  EDTA 502 m M  L-Arginine 0 0.29 mM 0.96 m M 0.0% m M 0 +
9 50 mM MES pH 6.5 241 m M  NaCl, lOmM KC1 0.05% 502 mM 2.0 m M  MgCl2, 2.0 mM  CaCl2 402 mM Sucrose 0.96 mM 0 0 0 0 -
10 50 m M  Tris pH 8.2 9.65 m M  NaCl, 0.40 m M  KC1 0 0 1.0mMEDTA 402m M  Sucrose 0 0.29 mM 0.96 m M 0.0% mM 0.48 mM +
11 50 mM  Tris pH 8.2 9.65 m M  NaCl, 0.40 mM KC1 0.05% 0 2.0 m M  MgCl2,2.0 mM  CaCl2 502 m M  L-Arginine 0 0 0.96 m M 0.0% m M 0 -
12 50 m M  MES pH 6.5 241 m M  NaCl, lOmM KC1 0 502 mM 1.0 m M  EDTA 502 mM L-Arginine 0.96 mM 0.29 mM 0 0 0.48 mM +
13 50 m M  Tris pH 8.2 241 m M  NaCl, lOmM KC1 0 502 mM 1.0 mMEDTA 0 0 0 0.96 m M 0.0% m M 0 -
14 50 m M  MES pH 6.5 9.65 m M  NaCl, 0.40 mM KC1 0.05% 0 2.0 m M  MgCl2,2.0 mM  CaCl2 0 0.96 mM 0.29 m M 0 0 0.48 mM -
15 50 m M  MES pH 6.5 9.65 m M  NaCl, 0.40 m M  KC1 0 0 1.0 m M  EDTA 402 m M  Sucrose, 502 m M  L-Arginine 0.96 mM 0 0 0 0 -
16 50 mM  Tris pH 8.2 241 m M  NaCl, lOmM KC1 0.05% 502 mM 2.0 m M  MgCl2,2.0 mM  CaCl2 402 m M  Sucrose, 502 m M  L-Arginine 0 0.29 mM 0.96 m M 0.0% mM 0.48 mM +
5.2.8. Experiments with pGEX-6P-l:PfsufS[M]x.
5.2.8.1. Protein expression.
Cells harbouring pGEX-6P-1:PfsufS[M \% were cultured as described (section 5.2.6). 
Preparative expressions were done in 3-6 L of culture medium in a batch format.
5.2.8.2. Protein solubilisation with N-laurylsarcosine.
Protein was solubilised with N-laurylsarcosine essentially as described.383 Bacterial 
pellets were washed in cold STE (10 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA) 
prior to re-suspension in STE containing 100 //g.mL1 chicken egg white lysozyme 
(Sigma) and Roche complete EDTA-free protease inhibitor cocktail set (2 tablets per 50 
mL). The suspension was incubated on ice for 15 min before addition of DTT to a final 
concentration of 5 mM and N-laurylsarcosine to a final concentration of 2 % w/v. For 
small volumes (500 //L), the suspension was sonicated for 1 min in 10 s bursts 
immersed in an ice-water mix in an Ultrawave water bath sonicator. For large volumes 
(25 mL), the suspension was sonicated packed in ice for 1 min in 10 s bursts using a 
Sonics and Materials Vibracell probe tip sonicator. To recover soluble protein, lysate 
was centrifuged at 150000g for 30 min at 4 °C. Supernatant was neutralised to a final 
concentration of 2 % v/v Triton X-100 before further processing.
5.2.8.3. Pilot scale purification over glutathione-agarose
Lyophilised glutathione-agarose (Sigma) was swollen in redistilled water (200 mL.g!), 
washed repeatedly with PBS and equilibrated in PBS containing 2 % v/v Triton X-100.
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Supernatant containing the protein (section 5.2.8.2) was added to the glutathione- 
agarose gel and the mixture incubated on a rotator for 1 h at 4 °C. For batch 
purifications, washing and elution was done by repeated re-suspension of gel and 
centrifugation (500g for 1 min). For small scale purifications, gel was packed by gravity 
into a 10 mL Bio-Rad plastic column prior to gravity flow washing and elution. 
Washing buffer was PBS containing 2% v/v Triton X-100 while eluting buffer 
contained 10 mM reduced L-glutathione, 75 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM 
DTT and either 2% v/v Triton X-100 or 2% w/v N-octyl-B-D-glucopyranoside.
5.2.8.4. Purification by liquid chromatography.
Preparative purifications were done by FPLC at 4 °C. Supernatant containing protein 
(section 5.2.8.2) was applied to a 1 mL GSTrap HP column (Amersham) at a flow rate 
of 0.2 mL.min 1 using an Akta FPLC. The column was washed at a flow rate of 1 
mL-min'1 in three steps. The first and third washes were done with 10 mL PBS 
containing 2% v/v Triton X-100; while the second wash was done with 20 mL washing 
buffer. Protein was eluted at a flow rate of 1 mL.min1 along a linear gradient (0-10 mM 
L-glutathione reduced) in buffer containing 75 mM HEPES, pH 7.4, 150 mM NaCl, 5 
mM DTT and either 2% v/v Triton X-100 or 2% w/v N-octyl-B-D-glucopyranoside.
5.2.8.5. Cleavage experiments.
Fractions containing GST-PfSufS[MJx were pooled and buffer exchanged with 
PreScission cleavage buffer (50 mM Tris, pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM 
DTT) by passage through a HiTrap Desalting column using an Akta Prime. Protein was 
treated with 160 U of a GST-tagged version of 3Cpro (Amersham PreScission Protease)
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and digestion allowed to proceed for 24 h at 4 °C; samples were taken at regular 
intervals and snap frozen in N2 (1).
5.2.9. Experiments with pMALc2:PfsufS[M]x and pMALp2:PfsufS[M]x.
5.2.9.1. Protein expression.
Cells harbouring pMALc2:PfsufS[M]/ and pMALp2:PfsufS[M]x were cultured as 
described (section 5.2.6), except that D-glucose (0.2% w/v) was added to suppress 
amylase expression; and cultures were induced for 16 h at 14 °C with 0.3 mM IPTG. 
Preparative expressions were done in 3-6 L of culture medium in a batch format.
5.2.9.2. Pilot scale purification.
Bacterial pellets were re-suspended in “BugBuster” protein extraction reagent 
containing 25 U.mL'1 Benzonase nuclease, 1 KU.mL'1 chicken egg white lysozyme, 1 
mM DTT, ImM EDTA and Roche EDTA-free protease inhibitor cocktail set (2 tablets 
per 50 mL). The suspension was incubated at 25°C for 20 min on a rocking platform 
before centrifugation at 16000# for 20 min at 4°C. Supernatant was mixed with pre­
swollen amylose resin (NEB) that had been repeatedly washed with 20 mM Tris, pH
7.4, 0.2 M NaCl, 1 mM DTT, 1 mM EDTA. The mixture was incubated on a rotator for 
20 h at 4°C before the resin was packed by gravity into a 10 mL Bio-Rad plastic 
column. The column was washed with 10 mL washing buffer and eluted with washing 
buffer containing 10 mM maltose. Elution was also attempted by cleavage with Factor 
Xa. After protein application and washing, resin was mixed with 400 /<g.mL1 Factor Xa 
on a rotator for 80 h at 4 °C.
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5.2.9.3. Purification by affinity chromatography.
Protein was purified using an Akta FPLC through an Omni 10 mm column packed by 
gravity with 1 mL of amylose resin (NEB). All steps of the purification were done at 4 
°C. Bacterial pellets were re-suspended in column buffer containing 20 mM Tris, pH
7.4, 0.2 M NaCl. Roche EDTA-free protease inhibitor cocktail set was added (2 tablets 
per 50 mL). The suspension was spiked with 1 KU.mL1 chicken egg white lysozyme 
prior to incubation on ice for 20 min; sonication; and centrifugation at 150000g for 30 
min at 4 °C. Supernatant was diluted 1/5 with fresh column buffer and applied to the 
amylose at a flow rate of 0.2 mL.min \  The resin was washed at 1 mL.min'1 with 
column buffer. Protein was eluted at a flow rate of 1 mL.min1 in column buffer with a 
linear gradient limited by 10 mM maltose. Care was taken to minimise degradation of 
the amylose column due to amylases in the bacterial lysate. Therefore, a maximum of 
50 mL of sample was injected each time. Elutions were chased with 0.1 % v/v SDS 
followed by redistilled water. After five elutions, the column was re-packed with fresh 
amylose resin.
5.2.10. Experiments with pMALc2:3Cpro-PfsufS[M]x-His12.
Soluble 3Cpro-PfSufS[M]x-His12 protein was expressed and extracted as described 
(sections 5.2.6 and 5.2.9.3) but with some modifications. Critically, protease inhibitors 
were not used. Exploiting the C-terminal His-tag, soluble protein was purified through a 
1 mL HiTrap chelating column (Amersham) charged with Ni2+. Supernatant containing 
protein (section 5.2.9.2) was applied to the column at a flow rate of 1 mL.min1 using an 
Akta Prime. The column was washed at a flow rate of 1 mL.min 1 with binding buffer. 
PreScission Protease (160 U) in a carrier volume of 5 mL binding buffer was injected
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into the column at a rate of 0.2 mL.min'1. To allow digestion, the column was sealed 
and incubated for 20 h at 5 °C. The column was washed extensively in binding buffer 
and protein was eluted at a flow rate of 1 mL.min'1 along a linear gradient limited by 1 
M imidazole.
5.2.11. Experiments with pMH903:PfsufS[M]x.
Vector pMH903:PfsufS[M]x was transformed into S. cerevisiae and protein was 
expressed using proprietary methods developed Dr. S. G. Sedgwick.
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5.3. RESULTS AND DISCUSSION.
5.3.1. Sequence analysis of P. falciparum SufS.
5.3.1.1. Codon bias.
A major determinant of low protein expression level in heterologous hosts is the high 
AT content of Plasmodium spp. DNA (review in Withers-Martinez, et a/.345). At the 
start of this project, only PfsufS (77 % AT) and PysufS (76 % AT) sequences were 
available in the database. I used the P. falciparum gene for my expression experiments, 
relying on the availability of helper plasmids to supply rare codons. However, other 
sufS constructs already expressed in E. coli in a soluble form have a more equitable AT 
bias, e.g., EcsufS (GenBank AB055108) (45 % AT) and AtsufS (GenBank AY078068) 
(55 % AT). Apicomplexan sufS sequences recently deposited in the database include 
PvsufS (49 % AT); and TgsufS (48 % AT). These might constitute useful future starting 
points for over-expression.
5.3.1.2. Protein stability.
Protein stability is essential for accumulation of expressed protein. The N-end rule 
indicates that proteins are stable in the E. coli cytosol (Table 5.3). Stability in vitro is 
also important, allowing the protein to be manipulated at the bench. By reference to the 
instability index (II), PfSufS was predicted to be unstable (II > 40). However, addition 
of fusion partners greatly improved the predicted in vitro stability (Table 5.3).
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TABLE 5.3.
BIOINFORMATIC SUMMARY OF SUFS PROTEINS.
The properties of SufS proteins described in this thesis were determined in silico. 
Briefly, the ExPASy ProtParam tool was used to predict Mr, isoelectric point (pi), molar 
extinction coefficient at 280 nm (e), grand average of hydropathy (GRAVY) and 
instability index (II). The Wilkinson-Harrison score for each protein was determined 
and reported as a chance of obtaining soluble protein during over-expression in E. coli. 
Stability of proteins in E. coli cytosol (t1/2) was predicted by reference to the N-terminal 
amino acid (N-end). Second virial coefficients (SVC) were calculated using a Microsoft 
Excel spreadsheet.
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Protein Mr (kDa) pi e(M  .cm ) GRAVY N-end tm
PfSufS 65
PfSufS [E2] 53
PfSufS [E2]-cMyc 57
PfSufS [M] 57
NusA-PfSufS[M] 119
Hi s6-Pf Suf S [M] -Hi s6 62
PfSufS [M]x 49
NusA-PfSufS[M]x 111
GST-PfSufS[M]x 78
cMBP-PfSufS[M]x 92
cMBP-SC^-PfSufStMlx-His, 94 
cMBP-SC^-PfSufStMJx-His^ 95 
pMBP-PfSufS[M]x 95
His6-EcSufS 48
AtSufS-His6 48
9.44 67590 -0.44 M >10 h
9.4 59670 -0.482 K 2 min
9.24 60950 -0.505 M >10 h
.9.35 62350 -0.486 D >10 h
6.05 92910 -0.437 M >10 h
9.32 62350 -0.54 M >10 h
9.31 55950 -0.328 D >10 h
5.77 86510 -0.366 M >10 h
8.91 96870 -0.356 M >10 h
8.65 120670 -0.364 M >10 h
8.59 120670 -0.374 M >10 h
8.59 120670 -0.395 M >10 h
8.8 120670 -0.324 M >10 h
5.97 49170 -0.16 M >10 h
6.09 37790 -0.052 M >10 h
II Chance of solubility (%) SVC (mL.mol.g'z) x HP
44.15 24.2 0.36
44.34 21.3 0.94
42.79 16.5 0.95
44.89 20.2 0.83
39.47 50.9 -1.27
43.17 15.4 0.96
46.18 18.5 0.24
39.67 55.5 -1.41
42.34 17.9 -0.46
34.12 17.3 -0.86
33.47 18.4 -0.86
33.3 18.8 -0.77
33.19 16.4 -1.14
33.86 45 -0.60
30.34 46.4 -1.16
5.3.1,3. Protein solubility.
Attempts to over-express P. falciparum proteins in E. coli in an active form may also 
fail due to aggregation. PfSufS protein sequence lacks obvious trans-membrane regions 
(chapter 2), suggesting that soluble PfSufS might be produced. However, the 
Wilkinson-Harrison score was low (24.2 %), suggesting that the protein would be 
insoluble. This contrasts with the higher Wilkinson-Harrison scores of EcSufS (45 %) 
and AtSufS (46.4 %).
Given such potential for insolubility, PfSufS protein sequence was modified to promote 
solubility. For example, expression of soluble AtSufS was achieved without the 
chloroplast-targeting signal. Hence, the bipartite plastid-targeting signal of PfSufS (Ml- 
161; chapter 3) was absent in all my expression constructs. In some constructs, further 
modifications were introduced (section 5.3.5) and solubilising fusion partners were 
used. Major features of PfSufS discussed in this chapter are indicated schematically in 
Fig. 5.1.
However, it is important to realise that none of these interventions produced a 
significant impact on the Wilkinson-Harrison score, with the exception of the NusA 
fusion (Table 5.3). Finally, it is worth noting the aggregative SVC values were 
exhibited by all the constructs, suggesting a tendency to precipitate in vitro. (Table 5.3).
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FIGURE 5.1.
SCHEMATIC REPRESENTATION OF P. FALCIPARUM  SUFS SHOWING 
MAJOR FEATURES DISCUSSED IN CHAPTER 5.
Amino acids corresponding to indicated regions are reported in the one letter code.
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5.3.2. Experiments with pT rcHis2-TOPO: PfsufS [E2].
53.2.1. Properties o f the expression construct.
Vector pTrcHis2-TOPO:PfsufS[E2], encoding PfSufS[E2]-cMyc included PLP-binding 
and active sites of the mature PfSufS enzyme, but lacked the leader sequence and a 
region of homology with EcSufS (exon 1). Expressed protein contained cMyc and His6 
tags at the C-terminal of the fusion, giving a predicted molecular weight of 57 kDa (Fig. 
5.2).
5.3.22. Protein expression.
Over-expressed PfSufS[E2] was insoluble at 37 °C; peak of expression was achieved 3 
h after induction (Slatter, Clough and Wilson, unpublished observations). In order to 
promote solubility, bacteria expressing PfSufS [E2]-cMyc were grown at 23 °C and 18 
°C. Soluble protein was fractionated from lysate by centrifuging at 150000#. It was 
found that protein remained insoluble at 23 °C but was soluble at 18 °C (Fig. 5.3). I 
noted a peak of accumulation at 4 h (23 °C) and 7 h (18 °C) followed by sudden (1-2 h) 
degradation (Fig. 5.3).
224
FIGURE 5.2.
SCHEMATIC OF PFSUFS[E2] FUSION PROTEIN.
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FIGURE 5.3.
EXPRESSION OF PFSUFS[E2]-cMYC AT LOW TEMPERATURE PROBED BY 
WESTERN BLOT.
E. coli cells harbouring pTrcHis2-TOPO:PfsufS[E2] were induced with 1 mM IPTG at 
23 °C and 18 °C. Samples were taken at intervals following induction. Protein was 
extracted with “BugBuster” reagent (Novagen) and the lysate centrifuged (150000g) to 
separate soluble (supernatant) and insoluble (pellet) protein. Protein was resolved 
through NuPage 12 % BT gels and detected with anti-His monoclonal antibody by 
Western blot. Evidence for soluble expression of the fusion protein after 6-7 h induction 
at 18 °C is indicated with an arrow. Abbreviations are as follows. M: Markl2 unstained 
standards (Invitrogen); 2 ,4 ,6,7  and 8: 2 ,4 ,6,7  and 8 h post-induction.
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5.3.2.3. Affinity purification.
Attempts were made to purify soluble PfSufS [E2]-cMyc produced from 3 L of culture 
induced for 7 h at 18 °C. Affinity purification over Ni2+ was done with a linear 
imidazole gradient using FPLC (Fig. 5.4). However, purification did not significantly 
enrich for PfSufS [E2]-cMyc, probably due to the low level of expression of soluble 
protein. It is important to realise that protein could not be enriched during culture due to 
instability after 7 h of induction (section 5.3.2.2). Hence I decided to abandon low 
temperature methods and instead focus on insoluble PfSufS [E2]-cMyc expressed at 37 
°C.
To this end, insoluble PfSufS[E2]-cMyc was extracted into 6 M urea and purified over 
Ni2+ by FPLC using a two-step linear imidazole gradient (step 1: 10 -> 100 mM; step 2: 
100 mM 1 M). Reasonable purity was achieved with protein eluting at ca. 20 mM 
imidazole (Fig. 5.5). However, the protein was smaller than expected (c.f., predicted Mr 
of 57 kDa). Nevertheless, fractions enriched for the protein were pooled and dialysed 
for 48 h against buffer lacking urea. Dialysis produced a visible white precipitate, 
possibly representing PfSufS[E2]-cMyc. Further diminution in the size of the protein 
was noted, suggesting truncation or degradation. Therefore, I performed Western 
blotting using commercially available anti-cMyc; and anti-cMyc monoclonal antibody 
generated in-house by Dr. M. J. Blackman (NIMR). This technique indicated significant 
truncation of the fusion protein (Fig. 5.6).
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FIGURE 5.4.
PURIFICATION OF SOLUBLE PFSUFS[E2]-cMYC.
E. coli cells harbouring pTrcHis2-TOPO:PfsufS[E2] were induced with 1 mM IPTG for 
7 h at 18 °C. Soluble protein was extracted with “BugBuster” reagent (Novagen). 
Soluble PfSufS [E2]-cMyc was purified over Ni2+ by FPLC with a two-step linear 
gradient limited by 1 M imidazole. A typical 280 nm elution profile is shown (A). The 
UV absorbance trace is marked with an arrow. Elution fractions were resolved through 
NuPage 12 % BT gel (B) and detected with His-tag monoclonal antibody (Novagen) on 
Western blot (C). Evidence of the fusion protein in elution fractions 30-32 is presented 
(C). Abbreviations are as follows. M: Markl2 unstained standards (Invitrogen); FT: 
column flow-through; 9, 10, 12, 14, 16, 18. 20, 22, 24, 26, 28, 30 and 32: elution 
fractions as numbered.
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FIGURE 5.5.
PURIFICATION OF INSOLUBLE PFSUFS[E2]-cMYC.
E. coli cells harbouring pTrcHis2-TOPO:PfsufS[E2] were induced with 1 mM IPTG for 
3 h at 37 °C. Total protein was extracted with 6 M urea. Insoluble PfSufS[E2]-cMyc 
was purified over Ni2+ by FPLC with a two-step linear gradient limited by 1 M 
imidazole. A typical 280 nm elution profile is shown (A). The UV absorbance trace is 
marked with an arrow. Elution fractions were resolved through NuPage 12 % BT gel 
(B). Evidence of the fusion protein in elution fractions 7-8 is presented. Abbreviations 
are as follows. M: SeeBlue markers (Invitrogen); UI: uninduced; FT: column flow­
through; 1, 2,4, 5 ,6,7 , 8, 11, 12, 14 and 16: elution fractions as numbered.
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FIGURE 5.6.
IMMUNO-REACTIVITY OF PFSUFS[E2]-cMYC.
Elution fractions (7-8) from purification of insoluble PfSufS[E2]-cMyc (Fig. 5.5) were 
refolded by dialysis against buffer containing 50 mM Tris, 100 mM KC1, 2 mM MgCl2, 
1 mM DTT. Dialysed protein was centrifuged (150000g) to fractionate dissolved 
(supernatant) and precipitated (pellet) protein. Protein was resolved through NuPage 12 
% BT gel (panel 1). Protein on Western blots was detected with anti-His monoclonal 
antibody developed in-house by Dr. M. J. Blackman (MJB; panel 2) and a commercially 
available equivalent (Novagen; panel 3). Truncated and precipitated PfSufS[E2]-cMyc 
is indicated by an arrow. Abbreviations are as follows. M: SeeBlue markers; S: 
supernatant; P: pellet.
234
1 2 3
Coomassie MJB Novagen
M (kDa) M S P M S P C  M S P C  
191
64
51
39 «  •  ^ ______  p34
28 AWKXKP
19
14
6
3
To further investigate the cause of this phenomenon, pTrcHis2TOPO:PfsufS[E2] 
plasmids were isolated directly from expression culture to be digested and re­
sequenced. These data confirmed the integrity of the insert. However, given that the 
cMyc epitope tag was at the C-terminal of the fusion protein, the possibility existed of 
degradation; or transcriptional starts at internal sites, leading to expression of protein 
lacking a complete N-terminal. To test this hypothesis, N-terminal sequencing was 
conducted. However, the N-terminal motif (AVVKXKP) did not correspond to any part 
of PfSufS[E2]-cMyc. Therefore, sequence was searched against the NCBI database 
using the BLASTP algorithm (“short, nearly exact matches”). Closest in similarity (E = 
6375) were ribosomal proteins. Hence, the major protein within the band was likely to 
be bacterial; apparent cross-reactivity with anti-cMyc could be explained by co­
migration with truncated PfSufS[E2]-cMyc.
5.3.3. Experiments with pET28(a):PfsufS[M] and pET43.1b(+):PfsufS[M].
5.3.3.1. Design o f expression construct.
Alignment of SufS protein sequences revealed that PfSufS [M] likely encompassed ca. 
36 amino acids (D62-E97) encoded by exon 1 (additional to amino acids encoded by 
exon 2). Hence, original PfSufS[E2] constructs (section 5.3.2) may have lacked the 
potential to be enzymatically active. Therefore, the strategy of cloning only exon 2 was 
modified to include the homologous region of exon 1.
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5.3.3.2. Engineering of expression constructs.
PfsufS[M] was successfully constructed using the SOE-PCR technique and ligated into 
pET28a(+) and pET43.1b(+) vectors.
5.3.3.3. Properties o f the fusion proteins.
Protein expressed from the pET28a(+) construct lacks solubility tags, possessing only N 
and C-terminal His6 tags. Conversely, protein expressed from pET43.1b(+) is designed 
to contain a large N-terminal extension composed of the highly soluble N-utilising 
factor A (NusA: GenBank AAC76203); a His6-tag; an S-tag; and recognition sites for 
thrombin I and enterokinase; a second His6-tag is C-terminal to the insert. Schematic 
representations of fusion proteins are provided (Fig. 5.7).
It is useful to consider the solubilising properties of NusA, an E. coli transcriptional 
anti-terminator protein.365 Davis, et al.366 suggested that NusA was the most likely E. 
coli protein to promote solubility, as identified from genome-wide screen of E. coli 
proteins using a modified version of the Wilkinson-Harrison solubility model. As 
expected, NusA markedly increased the Wilkinson-Harrison score (20.2 -*> 50.9 %) of 
the PfSufS[M] construct. The tag has since been used to solubilise numerous bacterial, 
animal and plant proteins over-expressed in E. coli.361 The S-tag additionally permits 
detection of the fusion protein by interaction with HRP-conjugated S-protein.368
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FIGURE 5.7.
SCHEMATICS OF PFSUFS[M] FUSION PROTEINS.
PfSufS[M] fusions expressed from pET43. lb(+):PfsufS[M ] (A) and 
pET28a(+):PfsufS[M] (B). Thrombin and enterokinase sites are indicated. 
Abbreviations are as follows. NusA: N-utilising substance A.
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5.33.4. Protein expression.
Experiments done with these constructs revealed a lack of convincing evidence for 
induction from pET28a(+):PfSufS[M]; while protein produced from 
pET43.1b(+):PfSufS[M] was truncated (Fig. 5.8). Therefore, I conducted no further 
experiments with these constructs.
5.3.4. Design and construction of PfsufS[M]x.
Further examination of the SufS protein sequence alignment (Fig. 2.3) revealed two 
major features unique to PfSufS, namely, the poly-isoleucine tract (1255-1259); and PrP- 
like loop (E405-L462). Comparable features are present in other Apicomplexan SufS 
sequences; but not in bacterial, algal or vascular plant sequences. The poly-isoleucine 
tract was deemed unlikely to cause insolubility given that it was modelled inside the 
molecule. However, likeness between the amyloid inclusions of eukaryotic cells and IB 
was noted.348 Although protein sequence similarity between PrP and the PrP-like loop of 
PfSufS (Fig. 2.5) falls outside the putative fibrillogenic domain (PrP 106-126),369 the 
PrP-like loop could be involved in aggregation.
To circumvent potential insolubility due to the PrP-like loop, a deletion strategy was 
adopted. A structure-based alignment of several representative SufS sequences was 
done by Dr. J. W. Saldanha (Fig. 5.9). The loop was revealed to be longer (66 amino 
acids; L398-K463) than originally indicated (Fig. 2.3), constituting 12 % of the entire 
PfSufS ORF.
240
FIGURE 5.8.
EXPRESSION OF PFSUFS[M].
E. coli cells harbouring pET28a(+):PfsufS[M] and pET43.1b(+):PfsufS[M] were 
induced with 1 mM IPTG at 37 °C for 3 h. Expressed protein was resolved through 
NuPage 4-12 % BT gel (panel 1) and detected with anti-His antibody on Western blot 
(panel 2). Expression of NusA-PfSufS[M] was additionally probed with S-protein HRP 
(panel 3). NusA-PfSufS[M] was expressed in a truncated form (ca. 92 kDa). There was 
no convincing evidence for induction of protein from pET28a(+). Abbreviations are as 
follows. M: Mark 12 unstained standards (Invitrogen); UI: uninduced control; I: 
induced; 28: pET28a(+):PfsufS[M]; 43: pET43.1b(+):PfsufS[M].
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FIGURE 5.9.
STRUCTURE-BASED ALIGNMENT OF SUFS PROTEIN SEQUENCES.
In order to delineate the PrP-like loop of PfSufS, a rigorous structure-based alignment 
of SufS protein sequences was done by Dr. J. W. Saldanha. Alignment between the 
conserved lysine binding (SXHK) and active site (GXHCX) motifs is presented. The 
PrP-like loop of PfSufS is underlined. Abbreviations are as follows. ECOLI: EcSufS; 
STYPH: Salmonella typhimurium SufS; YPEST: Yersinia pestis SufS; ECHRY: E. 
chrysanthemi SufS; ATHAL: AtSufS; MTUBE: M. tuberculosis SufS; PFALC: PfSufS; 
PKNOW: PkSufS; PYOEL: PySufS; TGOND: TgSufS.
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ECOLI SGHKLYGPTGIGILYVKEALLQEMP— PWEGGGSMIATVSLSEGTTWTKAPWRFEAGTPNTGGIIGLGAALEYVSALG--- LNNIAEYEQNLMHYALSQLES-VPDLTLYGPQ------
STYPH SGHKMLGPNGIGVLYGRRELLAQMP— PFLTGGSMIETVTM-EGATYAPAPQRFEAGTPMTSQWGLAAAARYLGAIG--- MAAVEAHERELVAAAIEGLSG-IDGVRILGPTS-----
YPEST SGHKLYGPSGIGILYGKSALLQQMP— PWEGGGAMIKTVSLTQGTTFADAPWRFEAGSPNTAGIMGLGAAIDYVTELG--- LLPIQQYEQSLMHYALAQLSQ-IKSLTLYGPT------
ECHRY SGHKLYGPTGIGILYVKEALLQEMP— PWEGGGSMISTVSLTQGTTWAKAPWRFEAGTPNTGGIIGLGAAIDYVTSLG--- LDKIGDYEQMLMRYALEQLAQ-VPDITLYGPA------
MTUBE SGHKLYGPSGIGVLYGKSELLQAMP— PWEGGGAMIREVSLTQGTTYADPPWRFEAGSPHVAGIIGLGAALDYVSALG----VDAIQAHEGLLMRYALASLAE-VPTLRLYGPV------
ATHAL SSHKMCGPTGIGFLYGKSDLLHSMP— PFLGGGEMISDVFL-DHSTYAEPPSRFEAGTPAIGEAIALGAAVDYLSGIG----MPKIHEYEVEIGKYLYEKLSS-LPDVRIYGPRP-----
PFALC SGHKFCASLGTGFIFINKELSSKYKFKPLLYGSNIITNVSKYKSKFVTSLSELLETGTONIPGILSMGISLEFFKKINWN-YVYOYEMYLYDLFIYYMNKYMK-NHFVQLPNLNLSYKKE
PKNOW SGHKFCAPFGSGFVYIKKKITHASKTNPFLYGSNIITDVNKYRSKFVSS-PHIFETGTQNISAILAMGEAIKYLQKINDEGNAYKYEMYLYDLFLFYLRSFLT-HHLVELPNIPTKLD—
PYOEL SGHKFCAPLGCGFIYIKNTLTCSYKFKPLLYGSNMITTVGKYKSEFVSS-PHLFETGTQNIAGVISMGVALDFLEKIDKN-LLCRYEMYLYDVLIYYLTKHLQ-RGLVQLPGG-------
TGOND SGHKMYGPTGVGFLYGKYELLRNMP— PWKGGGEMIEFVDL-CESTYANPPARFEAGTPPFLQVIGLGAAVDFIEEVG----WPAIYSHDARLQRALHEVLASRFPELRLFCPPSAGTAY
ECOLI ----------------------------------------------------------- NRLGVIAFNLGKHHAYDVGSFLDNY-GIAVRTGHHCA
STYPH --------------------------------------------------------- MRDRGSPVAFWEGVHAHDVGQVLDDG-GVAVRVGHHCA
YPEST ----------------------------------------------------------- ERAGVIAFNLGQHHAYDVGSFLDQY-GIAIRTGHHCA
ECHRY ----------------------------------------------------------- QRLGVIAFNLGKHHAYDVGSFLDNY-GIAVRTGHHCA
MTUBE ----------------------------------------------------------- HRQGVIAFNLGRHHAFDVGSFLDQY-GIAIRTGHHCA
ATHAL ------------------------------------------------------- SESVHRGALCSFNVEGLHPTDLATFLDQQHGVAIRSGHHCA
PFALC NINYKSHMQTHPPVHKYNDEQNFTNDHNITQSK--QTKSIHSQHDTFKIYTHDTRKYGLKKIGILPLWSNTFSSFDLVTFLDFK-NICIRAGHHCA
PKNOW ------------EMHTSXQIRNNKVDDTYTHSE----- IQNEDNDYLKIFVHNTRKDNKKKIGILPLWSLNFTSFDLVTFLDFK-NICIRSGHHCA
PYOEL ------------- VKG-DMMNEKEDTTLGRS----------SENDQCRLYIHNSRMVKGKKVPILPLWSDQFTSYDLVTFLDFK-NVCIRSGHHCA
TGOND APELLSDAFDFSKVKQHRWVQSDQSDGRSAVTANAVHRSAVAGATDEARNGAFASGIERIPSIPLISFAHPEIHAHDIAVFLDVCGGVCVRSGHHCC
SOE-PCR (Fig. 5.10) was used to generate PfSufS [M]x, with the PrP-like loop excised 
and replaced with a six amino acid bridge copied from the EcSufS sequence (intended 
to ease folding). Homology modelling suggested that the chimaeric protein would be 
able to adopt a native conformation. PfsufS[M]x was cloned into several vectors for 
expression in E. coli and S. cerevisiae. Experiments with these vectors are now 
described. Schematic representations of PfSufS[M]x fusion proteins are given in Fig. 
5.11.
5.3.5. Expression and purification experiments with pET43.1b(+):PfsufS[M]x.
5.3.5.1. Properties o f the fusion protein.
Properties of the fusion partners in pET43.1b(+) constructs are discussed in section
5.3.3.3. NusA fusion again produced a significant increase in the Wilkinson-Harrison 
score of PfSufS[M]x (18.5 — 55.5 %).
5.3.5.2. Protein expression.
Induction of cells at 37 °C led to the accumulation of protein with a functional S-tag 
(Fig. 5.12A). Image analysis of Coomassie-stained poly-acrylamide gels indicated the 
Mr to be 114 kDa; close to the predicted value of 111 kDa. However, the NusA- 
PfSufS[M]x fusion apparently offered no solubilising benefit (Fig. 5.12B).
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FIGURE 5.10.
CONSTRUCTION OF PFSUFS[M ]x BY SPLICING BY OVERLAP 
EXTENSION-PCR.
PfsufS[M]x was assembled in three distinct steps by splicing by overlap extension 
(SOE)-PCR. In the first step, sequence encoding the N-terminal (N), middle (M) and C- 
terminal (C) of PfsufS [M] was recovered by RT-PCR (panel 1). A second step was 
required to assemble M and C regions with a short stretch of E. coli sequence (E. coli 
bridge), giving M+x and C+x, respectively (panel 2). Products of the first two PCR 
steps were assembled (As) in a final step, giving PfSufS [M]x(panel 3). Additional 
abbreviations are as follows, bp: base pair; M: 123 bp ladder (Sigma).
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FIGURE 5.11.
SCHEMATICS OF PFSUFS[M]x FUSION PROTEINS.
Thrombin, enterokinase, rhinovirus 3C protease (3Cpro) and Factor Xa sites are 
indicated. Abbreviations are as follows. NusA: N-utilising substance A; GST: 
glutathione S-transferase; cMBP: cytosolic maltose binding protein.
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FIGURE 5.12.
EXPRESSION OF NUSA-PFSUFS[M]x.
E. coli cells harbouring pET43.1b(+):PfsufS[M]x were induced with 1 mM IPTG at 37 
°C for 3 h (A). Protein was extracted with “BugBuster” reagent (Novagen) and the 
lysate centrifuged (150000#) to separate soluble (supernatant) and insoluble (pellet) 
protein (B). Protein was resolved through NuPage 4-12 % BT gel (A panel 1) and 
detected with S-protein HRP on a Western blot (A panel 2; and B). Expression of 
insoluble NusA-PfSufS[M]x is marked with an arrow. Abbreviations are as follows. M: 
Mark 12 unstained standards (Invitrogen); UI: uninduced control; I: induced.
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5.3.5.3. Specific stimulation of protein expression by PLP.
To enhance expression, I enriched the bacterial growth medium with 50 pM  PLP.* PLP 
was chosen for trivial reasons of availability; any of the B6 vitamers could be 
satisfactorily absorbed by bacteria.370 Notably in vitamin B6 auxotrophs, PLP is only 
acceptable to cells growing in a rich medium (e.g., Terrific broth) as the cofactor is de- 
phosphorylated during import and re-phosphorylated in the cytosol (an energy 
demanding process).370
PLP significantly enhanced the expression level of NusA-PfSufS[M]x (Fig. 5.13A). 
Indeed, from inspection of the relative intensity of bands in the gel, this stimulation 
appeared specific for the fusion protein (rather than a general increase in protein level 
due to faster bacterial growth). Consideration of the nature of the fusion protein 
indicated that PLP could be interacting with NusA or PfSufS[M]%. While, to my 
knowledge, there is no published evidence suggesting that PLP interacts with NusA, it 
should be understood that several prokaryotic transcription factors are PLP-dependent, 
e.g., Bacillus subtillis GabR.371
In order to further associate PLP stimulation with the PfSufS[M]x component of the 
fusion, 50 pM  PLP was added to the medium of bacteria expressing GST-PfSufS[M]x 
(section 5.3.9); or cMBP-PfSufS[M]x (section 5.3.11). Critically, all constructs were 
expressed against the same bacterial background (BL21 CodonPlus(DE3)-RIL). 
Limited enhancement of expression was observed for GST-PfSufS[M]x and cMBP- 
PfSufS[M]x (Fig. 5.13B).
* PLP addition is advocated by Dr. R. Lill (Philipps-Universitat Marburg, Germany) and 
(the late) Dr. G. Kispal.
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FIGURE 5.13.
PFSUFS[M]x EXPRESSION WITH PYRIDOXAL 5'-PHOSPHATE.
E. coli cells harbouring pET43.1b(+):PfsufS[M]x, pGEX-6-P l:PfsufS[M]x and 
pMALc2:PfsufS[M]x were induced with 1 mM IPTG at 37 °C for 3-5 h in medium 
enriched with 50 yM  PLP. Protein was resolved through NuPage 4-12 % BT gel. 
Expression of NusA-PfSufS[M]x (A), GST-PfSufS[M]x (B) and cMBP-PfSufS[M]x 
(B) was enhanced by PLP. Abbreviations are as follows. M: SeeBlue (A) or Mark 12 
unstained standards (B); 2, 4, 5: 2, 4, and 5 h post-induction; UI: uninduced control; I: 
induced; -P: PLP absent; +P: 50 yM  PLP.
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Therefore, the possibility exists that PLP-stimulation is specific to PfSufS [M]x, 
independent of fusion partner. Therefore, I speculate that PLP is stabilising folding 
intermediates of PfSufS [M|x, thus abrogating degradation. Hence, PfSufS[M]x fusion 
proteins could be binding PLP in E. coli cultures. Several caveats need to be inserted. 
Notably, promoters were different for each construct (T7 for pET43.1b(+) and 
pMALc2; Ptac for pGEX-6-Pl). Additionally, PLP can interact with GST, as shown by 
inactivation of human placental GSTji (GenBank P09211) in vitro by treatment with 8 
mM PLP.372
5.3.5.4. Affinity purification.
In a typical preparative purification of NusA-PfSufS[M]x, cells were broken via 
passage through a French pressure cell. However, ca. 10 L of culture («ca. 50 g wet 
weight of bacteria) was required to give sufficient protein for three experiments; this 
highlights the typically low yield achieved with heterologously expressed P. falciparum 
proteins. Inclusion bodies were recovered by repeated washing and centrifugation and 
finally dissolved in 8 M urea; purification was done over Ni2+ using an Akta Prime. 
NusA-PfSufSJMlx eluted at ca. 150 mM imidazole on the shoulder of a larger peak 
composed of irrelevant protein (Fig. 5.14). Changes to the slope of the gradient did not 
greatly improve purity (data not shown). Fractions of highest purity {ca. 80 %) assessed 
by inspection of a Coomassie-stained poly-acrylamide gel were pooled and 
concentrated for further processing. In a typical preparation, protein concentration was 
~ 150 //g.mL1 (1.4 //M), as assessed by BCA assay.
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FIGURE 5.14.
PURIFICATION OF INSOLUBLE NUSA-PFSUFS[M]x.
E. coli cells harbouring pET43.1b(+): PfsufS [M]x were induced with 1 mM IPTG for 5 
h at 37 °C. Inclusion bodies were dissolved with 8 M urea. Insoluble NusA-PfSufS[M]x 
was purified over Ni2+ by FPLC with a linear gradient limited by 250 mM imidazole. A 
typical 280 nm elution profile is shown (A). Elution fractions were resolved through 
NuPage 4-12 % BT gel (B). Evidence of the fusion protein in elution fractions > 18 is 
marked with an arrow. Abbreviations are as follows. M: Mark 12 unstained standards 
(Invitrogen); D: dissolved inclusion bodies; FT: column flow-through; 17-28: elution 
fractions 17-28.
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5.3.6. Pyridoxal 5'-phosphate.
5.3.6.1. PLP-lysine Schiffbase.
It is worth recapitulating the chemical properties of PLP, given the significance of this 
cofactor in refolding experiments (section 5.3.7). Covalent attachment of the cofactor to 
the active site lysine of the cysteine desulphurase, via Schiff base (C=N) linkage, is 
assumed to be critical for enzyme activity. Notably, all native cysteine desulphurases 
studied so far have been isolated with PLP already bound. For example, the PLP content 
of EcSufS was equimolar;165 the value for Synechocystis sp. SufS was 0.58 
equivalents311 (estimated by different methods). Based on a priori mechanistic 
assumptions, it seems reasonable to expect 1 molecule of PLP per monomer in an active 
enzyme.
PLP content of proteins described in this study was probed using visible spectroscopy. 
At neutral pH, free PLP is bright yellow, exhibiting a Xmax of 325 nm; the peak shifts 
downward in acidic environments (295 nm) and upward in basic environments (388 
nm).373 Another type of absorbance spectrum develops when free PLP reacts with 
primary amines (e.g., amino acids), forming Schiff bases. Specifically, 7^^ shifts to ca. 
415 nm (neutral pH).374 As such, a of ca. 415 nm may be considered diagnostic of a 
Schiff base (Dr. A. J. Iriarte, University of Missouri-Kansas City, USA, pers. comm.) 
Prolonged incubation leads to a gradual drop in the amplitude of the PLP peak 
concomitant with the appearance of a second peak (ca. 330 nm), probably indicating 
transamination (PLP -*• pyridoxamine 5'-phosphate). I observed this classical effect by 
adding super-stoichiometric L-cysteine to a solution of PLP (Fig. 5.15).
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FIGURE 5.15.
ABIOTIC FORMATION OF SCHIFF BASE BETWEEN PYRIDOXAL 5'- 
PHOSPHATE AND L-CYSTEINE.
PLP (100 fiM) in aqueous buffer (PBS) was mixed with super-stoichiometric L-cysteine 
(500 fiM) at 25 °C in a quartz-glass cuvette; absorbance spectra were acquired. 
Instantaneous transition from a single peak of free PLP (A) to a red-shifted peak of 
lower amplitude (Schiff base, B) upon addition of L-cysteine (L-cys) is observed. A 
pyridoxamine 5'-phosphate (PMP) peak appears in the lower energy regime of the 
spectrum after 10 min incubation (C).
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Formation of a Schiff base by condensation of an aldehyde (PLP) with a primary amine 
does not require aggressive conditions.375 Indeed, Schiff base linkages are readily 
formed with amino acids, most stably with lysine (by attack upon the e group). 
However, reaction of PLP with polypeptides is a more challenging reaction. PLP is inert 
towards polypeptides with the important exception of random coils of poly-lysine.376 
Hence, in refolding experiments, adventitious binding to amino acids other than lysine 
may be excluded on chemical grounds. However, NusA-PfSufS[M]x possesses 78 
lysine residues. Any lysines exposed to solvent might be accessible to electrophilic 
attack by PLP. However, the Schiff base formed with the catalytic lysine probably 
exhibits greatest stability because the phosphate group of the PLP makes additional 
hydrogen bonding contacts with the active site cleft.
5.3.62. PLP in protein refolding.
It is unknown if PLP binding is an essential feature of the folding pathway of SufS. 
Classical studies have been conducted on the role of PLP in the in vitro folding of 
enzymes of the aminotransferase class, notably, aspartate aminotransferase (AAT; EC 
2.6.1.1). For example, Reyes, et al.,377 found that a greater amount of active rat 
mitochondrial AAT was recovered after refolding in the presence than in the absence of 
PLP; DTT was also vital.
However, it was evident that PLP binding was not absolutely necessary for acquisition 
of a native fold. Indeed, yields of functional E. coli AAT were high even if PLP was 
absent from the refolding buffer.378 Nevertheless, once the native fold is achieved, PLP 
is probably an important determinant of structural stability.379
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5.3.7. Refolding experiments with NusA-PfSufS[M]x*
5.3.7.1. Refolding screen.
Purified NusA-PfSufS[M]x was subjected to a commercially available factorial 
refolding screen; 8 buffers were randomly supplemented with PLP. Protein solubility 
was assessed by partition into the supernatant after centrifugation at 150000g, as 
indicated by Western blot (Fig. 5.16). Six of the 16 refolding buffers (4 ,6, 8, 10, 12 and 
16) solubilised NusA-PfSufS[M]x- However, no common factor was apparent.
5.3.72. Preparative refolding.
The first four solubilising buffers (4, 6, 8 and 10) were arbitrarily chosen for initial 
scale-up experiments, with the object of testing refolded protein for enzymatic activity. 
Preparative refolding (Fig. 5.17) gave qualitatively similar results to the refolding 
screen (section 5.3.7.1). After extensive concentration of refolded soluble protein, 
typical concentrations estimated by absorbance at 280 nm were 7-14 pM (ca. 0.8-1.5 
mg.mL'). PLP was added to a high concentration (0.5 mM) in refolding buffers to 
mitigate any effects of dephosphorylation.
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FIGURE 5.16.
REFOLDING SCREEN OF NUSA-PFSUFS[M]x.
Insoluble NusA-PfSufS[M]x dissolved in 8 M urea (Fig. 5.14) was subjected to a 
factorial refolding screen comprising 16 different buffers (compositions stated in Table 
5.2). Refolded protein was centrifuged (150000g) to fractionate dissolved (supernatant) 
and precipitated (pellet) protein. Dissolved protein was resolved through NuPage 4-12 
% BT gel and detected by Western blot using S-protein HRP conjugate (Novagen) 
Abbreviations are as follows. M: Markl2 unstained standards (Invitrogen); 1-16: 
soluble protein refolded in buffers 1-16.
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FIGURE 5.17.
PREPARATIVE REFOLDING OF NUSA-PFSUFS[M]x.
Pooled fractions of insoluble NusA-PfSufS[M]x dissolved in 8 M urea (Fig. 5.14) were 
concentrated and refolded by dialysis against buffer 4, 6, 8 and 10 (compositions stated 
in Table 5.2). Refolded soluble protein was resolved through NuPage 4-12 % BT gel. 
Abbreviations are as follows. M: Markl2 unstained standards (Invitrogen); P: pooled 
fractions of insoluble NusA-PfSufS[M]x; C: 5 x concentrated P; 4, 6, 8 and 10: soluble 
protein refolded in buffers 4, 6, 8 and 10.
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Protein refolded in Foldlt buffer 10 exhibited a X^cofactor (395 nm) suggestive of free 
PLP (Fig. 5.18D). Conversely, the higher values of X^cofactor for protein refolded in 
Foldlt buffers 4 (416 nm), 6 (410 nm) and 8 (416 nm) were robustly indicative of Schiff 
base rather than free PLP (Fig. 5.18ABC). Slight differences probably reflect cofactor 
protonation: buffers 4 and 8 were held at pH 8.2; while buffer 6 was held at pH 6.5. 
Mihara, et a l313 reported little significant difference in the X^cofactor of EcSufS in the 
range pH 6-8. Given some evidence for the presence of PLP Schiff base, NusA- 
PfSufS[M]x refolded in buffer 4, 6 and 8 was tested for enzyme activity by MB+ assay. 
Protein was diluted 1/10 into the assay, giving a concentration of ca. 700 nM (matches 
protein concentration used in control assays in chapter 4). However, refolded proteins 
were not obviously active. Even after prolonged incubation (12 h), MB+ signals 
remained below background (Abs 670 < 0.17). Lack of enzymatic activity in the 
presence of cofactor could be associated with adventitious binding of PLP to the 
refolded protein. However, a more likely explanation for inactivity was the inability of 
the enzyme to dimerize due to the bulky NusA fusion partner. Therefore, refolding 
experiments with the fusion protein were discontinued in favour of preliminary 
investigations of PLP binding (section 5.3.7.3) and protein cleavage (section 5.3.8).
5.3.73. Adventitious PLP binding to NusA-PfSufS[M]%.
In order to investigate further the phenomenon of PLP interaction with NusA- 
PfSufS[M]x, a crude estimate of PLP binding, the ratio of X .^^280 to X,maxcofactor, was 
taken. Ratios obtained for Foldlt 4 (0.44), 6 (0.27) and 8 (0.83) were variable; no 
correlation between the two values was evident.
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FIGURE 5.18.
ABSORBANCE SPECTRA OF REFOLDED NUSA-PFSUFS[M]x.
Absorbance spectra of soluble NusA-PfSufS[M]x (Fig. 5.17) refolded in buffer 4 (A), 6 
(B), 8 (C) and 10 (D) were acquired. Schiff base peaks are apparent from protein 
refolded in buffers 4, 6 and 8. Conversely, the peak at 395 nm exhibited by protein 
refolded in buffer 10 suggests free PLP.
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Therefore, it seemed that binding efficiency varied between refolding conditions; or that 
adventitious (non-stoichiometric) binding was occurring. Indeed, it has recently been 
noted that dialysis is a poor method for removal of adventitiously bound PLP and that 
gel filtration is preferable (Dr. A. J. Iriarte, pers. comm.).
5.3.8. Cleavage experiments with NusA-PfSufS[M]x.
Given the possibility that the large NusA tag was interfering with dimerization or 
folding, attempts were made to cleave NusA from PfSufS [M]x via digestion with 
EnterokinaseMax (Fig. 5.19). To this end, protein dissolved in 8 M urea was partially 
re-natured by dialysis for 40 h against buffer containing 1 M urea. Following dialysis, 
aliquots of protein were digested for 20 h under various conditions, namely, high (37 
°C) and low (4 °C) temperature; and differing amounts of EnterokinaseMax (0.001-4 U 
per reaction). Inefficient cleavage of the fusion protein into 58 kDa and 55 kDa 
fragments was detectable following digestion at 4 °C with the largest amount of 
protease (4 U). Conversely, protein was completely degraded by 1 U EnterokinaseMax 
at 37 °C. Taken together, these data indicate that NusA-PfSufSlMlx can be cleaved. 
Conversely, in the absence of protease, the fusion protein was stable for long periods at 
37 °C (data not shown).
270
FIGURE 5.19.
ENTEROKINASE CLEAVAGE OF NUSA-PFSUFS[MJx.
Purified NusA-PfSufS[M]x (Fig. 5.14) was cleaved by incubation with enterokinase at 
37 °C and 4 °C. Abbreviations are as follows. M: Markl2 unstained standards 
(Invitrogen); 0,0.001,0.01,0.1, 1 and 4: 0,0.001,0.01,0.1,1 and 4 U enterokinase.
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5.3.9. Experiments with pGEX-6P-l:PfsufS[M]x.
5.3.9.1. Properties o f the fusion protein.
The pGEX-6P-l vector allows the expression of PfSufS[M]x N-terminal fused to the 26 
kDa C-terminus of Schistosoma japonicum glutathione 5-transferase (GST; GenBank 
AAB37346).380 GST can be used to purify the fusion by specific interaction with 
glutathione immobilised to a resin. The two fusion partners are separated by an 11- 
amino acid linker containing a recognition site for the protease 3Cpro. Hence, the GST 
tag may be cleaved from PfSufS [M]x by specific proteolytic digestion. A GST-tagged 
version of 3Cpro is available commercially (Amersham PreScission Protease) and can 
cleave a variety of fusion proteins with high specificity and at low temperature.381
5.3.9.2. Protein expression.
Expression of GST-PfSufS[M]x at 37 °C gave high levels of protein (Fig. 5.20). 
However, large amounts of protein were present in the uninduced control, indicating 
that expression was unregulated. As determined by image analysis of Coomassie- 
stained gels, the Mr of the protein was 71 kDa. This approximates the predicted value 
(78 kDa).
Soluble protein was recovered from cells by extraction in detergents and subjected to 
immunoblot with anti-GST antibody (Fig. 5.21). Cross-reactivity was demonstrated, 
suggesting that GST-PfSufS[M]x was expressed.
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FIGURE 5.20.
EXPRESSION OF GST-PFSUFS[M]x.
E. coli cells harbouring pGEX-6P-l:PfsufS[M]x were induced with 1 mM IPTG at 37 
°C. Samples were taken at 3, 4, and 5 h post-induction. Additionally, an uninduced 
culture was grown and a sample taken after 5 h of growth. Protein was resolved through 
NuPage 12 % BT gel. Evidence for expression of fusion protein (GST-PfSufS[M]x) is 
marked with an arrow. Abbreviations are as follows. M: Mark 12 unstained standards 
(Invitrogen); 3, 4 and 5: samples taken 3, 4 and 5 h post-induction; UI: uninduced 
sample taken at 5 h.
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FIGURE 5.21.
DETERGENT SCREEN OF GST-PFSUFS[M]x-
E. coli cells harbouring pGEX-6P-l:PfsufS[M]x were induced with 1 mM IPTG at 37 
°C for 5 h. Protein was extracted in Triton X-100 (1.0 % v/v) or N-lauryl sarcosine 
(0.25 and 0.5 % w/v). Soluble (supernatant) protein was fractionated from insoluble 
(pellet) protein by centrifugation (150000g) and resolved through NuPage 12 % BT gel 
(A). Western blotting was done with anti-GST (B). B is a replicate blot of A. Evidence 
for expression of fusion protein is marked with an arrow. Abbreviations are as follows. 
M: Markl2 unstained standards (Invitrogen); L: total lysate; P: pellet; S: supernatant.
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However, a large amount of truncated protein was present as indicated by long smear of 
immunoreactivity. Additionally, I noted that protein was solubilised in ^ 0.25 % w/v 
N-laurylsarcosine but not in 1 % v/v Triton X-100. Although N-laurylsarcosine is an 
anionic detergent, it is non-denaturing:382 hence enzymatic activity may be retained.383 
The solubilising properties of N-laurylsarcosine can be attributed to the ability of the 
detergent to disrupt only the cytoplasmic and inner membranes of the bacterium while 
keeping the outer membrane intact.384 Components of the outer membrane (protein, 
phospholipid and lipopolysaccharide) might otherwise co-aggregate with GST- 
PfSufS[M]x during cellular lysis.382 Conversely, Triton X-100 disrupts cytoplasmic, 
inner and outer membranes (although addition of Mg2+ may offer some protection to the 
outer membrane). Thus, it is possible that GST-PfSufS[M]x was expressed in a soluble 
form but was rendered insoluble by interaction with outer membrane components 
during lysis with Triton X-100.
5.3.9.3. Affinity purification.
Protein purification was done essentially as indicated by Frangioni and Neel.383 N- 
laurylsarcosine inhibits binding to glutathione. Therefore, the detergent was sequestered 
by addition of a large excess (2 % v/v) of Triton X-100. Protein was applied to 
glutathione agarose in a batch format; or to a glutathione sepharose column by FPLC. 
Affinity resin was washed in buffer containing Triton X-100 prior to elution with 
reduced glutathione. A typical FPLC run is summarised in Fig. 5.22. Baseline deflection 
is due to Triton X-100, which exhibits a of 275 nm.
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FIGURE 5.22.
PURIFICATION OF GST-PFSUFS[M]x.
E. coli cells harbouring pGEX-6P-l:PfsufS[M]x were induced with 1 mM IPTG at 37 
°C for 5 h. Protein was extracted in N-lauryl sarcosine (0.5 % w/v). Soluble protein was 
purified through a GSTrap column (Amersham) by FPLC and eluted with 10 mM 
reduced glutathione (GSH). A typical 280 nm elution profile is shown (A). Elution 
fractions were resolved through NuPage 4-12 % BT gel (B panel 1). Western blotting 
was done with anti-GST (B panel 2). Evidence of the fusion protein in elution fraction 3 
is presented. Abbreviations are as follows. M: Mark 12 unstained standards (Invitrogen); 
L: lysed bacteria; FT: column flow-through; 1, 3, 5, 7, 10, 20, 21 and 22: elution 
fractions 1, 3, 5,7, 10, 20, 21 and 22.
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53.9.4. Enzymology.
Preparations were submitted to MB+ assay. However, no signal was detected, indicating 
the absence of active cysteine desulphurase. I noted the presence of residual Triton X- 
100 (indicated by frothing of the buffer during stirring). Triton X-100 is difficult to 
remove from preparations, due to a low critical micellar concentration (2.5 x 104 M). 
Detergent may have reduced the sensitivity of the MB+ assay by emulsification of the 
oil overlay, thus allowing the escape of H2S during colour development. Indeed, loss of 
the essential oil layer was consistently observed in spite of efforts to reduce the Triton 
X-100 concentration (data not shown).
It is known that an extraneous 70-kDa E. coli protein (GroEL: GenBank AAA97042) 
can co-purify with GST. Therefore, the strong band assumed to comprise GST- 
PfSufS[M]x (71 kDa) could also contain an irrelevant protein, lowering the effective 
concentration of GST-PfSufS[M]x in the enzyme assays. Suggestion of a co-mi grating 
protein was derived from cleavage experiments conducted using PreScission Protease. 
No sign of degradation was apparent on a Coomassie-stained poly-acrylamide gel 
despite a large amount of protease (160 U per reaction) and long incubation time (24 h) 
(data not shown). Removal of GroEL may be achieved by spiking lysates with ATP and 
GroES;385 this might be an appropriate experiment in future work.
5.3.10. Experiments with pMH903:PfsufS[M]x*
PfSufS[Mlx was cloned into two novel vectors (pMG and pMH903; Fig. 5.23A) 
developed by Dr. S. G. Sedgwick for heterologous protein expression in S. cerevisiae. 
Protein expressed from both vectors was fused at the N-terminal to GST.
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FIGURE 5.23.
GST-PFSUFS[M]x EXPRESSION IN SACCHAROMYCES CEREVISIAE.
PfSufSfM ]/ was cloned into a yeast expression vector (pMH903; A). Insert was 
confirmed by restriction digest (B) and Sanger sequencing. Total protein from induced 
yeast cells harbouring the vector was extracted and resolved through NuPage 12 % BT 
gel. Western blotting using anti-GST indicated that GST-PfSufS[M]x was not 
expressed (C). Function of the Western blotting system was confirmed by cross- 
reactivity against GST-containing irrelevant controls. Abbreviations are as follows. L: 
123 bp ladder (Sigma); M: Mark 12 unstained standards (Invitrogen); PF: 
pMH903:PfsufS[M]x; II and 12: irrelevant GST-containing controls.
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The two vectors were distinct only in the presence of a 3Cpro site between GST and the 
insert in pMH903. No protein was detectably expressed from pMH903, as evaluated by 
Western blot of total protein using anti-GST (Fig. 5.23C). (Given this negative result, 
pMG:PfsufS[M]x was not evaluated.) Functionality of anti-GST was confirmed by 
blotting against irrelevant GST fusions (a gift from Mr. B. Y. S. Yim Lim), while the 
integrity of the insert was checked by restriction digest (Fig. 5.23B) and Sanger 
sequencing. Obvious factors that might have contributed to lack of expression include 
divergent codon usage between P. falciparum and S. cerevisiae; and the presence of 
potential glycosylation sites in PfSufS[M]x- Although protein glycosylation probably 
does not occur at a significant level in P. falciparumf86 malarial proteins contain 
potential sites that interfere with expression in heterologous eukaryotic hosts. Indeed, 
six potential N-linked glycosylation sites were detected in PfSufS[M]x-
5.3.11. Experiments with pMALc2:PfsufS[M]x and pMALp2:PfsufS[M]x.
5.3.11.1. Properties o f the fusion protein.
From the pMALc2 and pMALp2 vectors, protein is expressed fused to the E. coli MBP 
encoded by the malE  gene.387 In the cMALc2 vector, MBP lacks the periplasmic 
targeting sequence (pMBP) and hence remains in the cytosol (cMBP). PfSufS|M]x 
contains eight cysteines but is not predicted to require formation of disulphide bridges 
to give a functional fold (Dr. J. W. Saldanha, pers. comm.); thus the reducing 
environment of the cytoplasm is not expected to present a barrier to folding.
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5.3.11.2. Protein expression.
Expression of protein was induced by addition of IPTG to cells growing at 37 °C for 5 h 
(Fig. 5.24). Cross-reactivity with anti-MBP antibody was marked (Fig. 5.25). 
Furthermore, soluble protein was present after induction for 18-20 h at 14 °C; protein 
accumulation was greatest in the BL21-CodonPlus (DE3)-RIL host cells (Fig. 5.25). As 
determined by image analysis of Coomassie-stained poly-acrylamide gels, the Mr of the 
cross-reactive protein was 90 kDa; this approximates the predicted size (92 kDa). 
Therefore, I concluded that soluble cMBP-PfSufS[M]x was expressed. Conversely, 
pMBP-PfSufS[MJx did not appear to be expressed (data not shown); thus, I decided to 
discontinue experiments with this construct.
5.3.11.3. Affinity purification in a batch format.
Protein cMBP-PfSufS[M]x was purified over an amylose resin in a batch format by 
washing and centrifugation (Fig. 5.26). The fusion protein eluted with low specificity. 
Indeed, poor binding to amylose is associated with the use of MBP as fusion partner.388 
There are also numerous truncation or degradation products.
5.3.11.4. Cleavage experiments.
Efforts were made to cleave cMBP from PfSufS[M]x by binding protein to amylose 
resin, prior to incubation with Factor Xa for a prolonged period (78 h). However, 
evidence for cleavage to yield a PfSufS[M]x product of ca. 50 kDa was unconvincing 
as viewed on a Coomassie-stained poly-acrylamide gel (Fig. 5.27).
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FIGURE 5.24.
EXPRESSION OF cMBP-PFSUFS[M]x
E. coli cells harbouring pMALc2:PfsufS[M]x were induced with 0.3 mM IPTG at 37 
°C. Samples were taken at 3, 4, and 5 h post-induction. Additionally, an uninduced 
culture was grown and a sample taken after 5 h of growth. Protein was resolved through 
NuPage 4-12 % BT gel. Evidence for expression of fusion protein is marked with an 
arrow. Abbreviations are as follows. M: Markl2 unstained standards (Invitrogen); 3, 4 
and 5: samples taken 3 ,4  and 5 h post-induction; UI: uninduced sample taken at 5 h.
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FIGURE 5.25.
EXPRESSION OF cMBP-PFSUFS[M]x AT LOW TEMPERATURE.
Rosetta-gami (DE3) pLysS (Novagen) or BL21-CodonPlus (DE3)-RIL (Stratagene) E. 
coli cells harbouring pMALc2:PfsufS[M]x were induced with 0.3 mM IPTG at 37 °C 
for 3 h or 14 °C for 16 h. Protein was extracted in “BugBuster” reagent (Novagen). 
Soluble protein (supernatant) was fractionated from insoluble protein (pellet) by 
centrifugation (16000g) and resolved through NuPage 12 % BT gel (panel 1). Western 
blotting was performed using anti-MBP (panel 2). Evidence for expression of soluble 
cMBP-PfSufS[M]x is marked with an arrow. Abbreviations are as follows. BL21: 
BL21-CodonPlus (DE3)-RIL; Rosetta: Rosetta-gami (DE3) pLysS; M: Markl2 
unstained standards (Invitrogen); UI: uninduced control; IP: induced pellet; IS: induced 
supernatant.
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FIGURE 5.26.
PURIFICATION OF cMBP-PFSUFS[M]x.
E. coli cells harbouring pMALc2:PfsufS[M]x were induced with 0.3 mM IPTG at 14 °C 
for 16 h. Soluble protein was extracted from the bacterial sonicate by centrifugation 
(9000g). Supernatant was diluted 1/5 and incubated with amylose resin for 18 h at 4 °C. 
Protein was eluted in a batch format with 10 mM maltose. Fractions were resolved 
through NuPage 4-12 % BT gel. Evidence of cMBP-PfSufS[M]x in elution fraction 1 is 
marked with an arrow. Abbreviations are as follows. M: Mark 12 unstained standards 
(Invitrogen); P: bacterial pellet; S: bacterial sonicate; 9P: 9000g pellet; 9S: 9000g 
supernatant; 9D: 9000g supernatant diluted 1/5; On: supernatant and resin after binding 
for 18 h at 4 °C; FT: flow-through; W: wash; 1, 3, 5 and 7: elution fractions 1, 3, 5 and 
7; St: flow-through after stripping resin with 0.1 % v/v SDS; SR: stripped resin.
290
Mr (kDa) stSR
200
116.3 
97.4
66.3
55.4
• cMBP-PfSuf S[M]x
FIGURE 5.27.
FACTOR Xa CLEAVAGE OF cMBP-PFSUFS[M]x.
E. coli cells harbouring pMALc2:PfsufS[M]x were induced with 0.3 mM IPTG at 14 °C 
for 16 h. Soluble protein was bound to amylose resin for 2 h at 4 °C. Effort was made to 
elute the protein by incubation with Factor Xa for 78 h at 4 °C. Remaining protein was 
eluted with 10 mM maltose followed by 0.1 % v/v SDS. Fractions were resolved 
through NuPage 4-12 % BT gel. Evidence for cleavage of cMBP-PfSufS[M]x was 
unconvincing given the estimated Mr value of cleaved PfSufS[M]x (50 kDa). 
Abbreviations are as follows. M: Mark 12 unstained standards (Invitrogen); L: soluble 
protein; FT: flow-through; Wl-3: wash 1-3; Xa: flow-through after Factor Xa 
treatment; Mai: flow-through after maltose; S: flow-through after stripping resin with 
SDS.
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5.3.11.5. Enzymology.
Elution fractions containing cMBP-PfSufS[M]x were pooled and concentrated five-fold 
using a spin concentrator (Fig. 5.28A). Scanning of concentrated protein gave a low 
(0.26) peak at 408 nm; possibly indicative of Schiff base (Fig. 5.28B). By comparison, 
an equivalent fraction of AtSufS-His6 gave a significantly higher peak (0.91) at 419 nm 
(see chapter 4). All preparations were blanked against redistilled water, ensuring that 
absorbance data are directly comparable. Therefore, if the amount of Schiff base linkage 
is used as a crude method of active site titration, it would seem reasonable to predict a 
four-fold lower activity of cMBP-PfSufS[M]x than AtSufS-His6. Concentrated cMBP- 
PfSufS[M]x was submitted to the MB+ assay. Prolonged Incubation (20 h) indicated the 
presence of sulphide at a higher level that in a control containing only elution buffer 
(Fig. 5.28C). Thus, active cysteine desulphurase was present. Activity of fractions 
containing cMBP-PfSufS[M]x (Abs 667 nm = 0.3) was six-fold less than AtSufS-His6 
(Abs 667 nm » 1.8). Given the imprecision of these estimates, this is a reasonable match 
to the four-fold difference predicted from PLP binding. Such a low level of activity 
might be due to the presence of a large fusion partner (cMBP) that could impair 
dimerization. Reciprocal inhibition might be expected, given the interference by 
PfSufSfM lx with the function of cMBP (section 5.3.11.6). Furthermore, optimal 
conditions for activity of PfSufS[M]x are unknown.
Before proceeding further, it was necessary to investigate numerous potentially 
confounding factors. The first possibility was that the MB+ signal was due to sulphides 
present in the isolate; or to abiotic desulphurase activity of free PLP over prolonged 
incubation.
294
FIGURE 5.28.
ENZYMATIC CHARACTERISATION OF cMBP-PFSUFS[M]x.
cMBP-PfSufS[M]x (Fig. 5.26) was concentrated 5-fold and resolved through NuPage 4- 
12 % BT gel (A, panel 1) before Western blotting was done with anti-MBP (A, panel 
2). A spectral scan was acquired, suggestive of PLP Schiff base (B). A scan of AtSufS- 
His6 (chapter 5) is presented for comparison. Cysteine desulphurase activity of the 
preparation was demonstrated by the MB+ assay, as compared to a control lacking 
protein (C).
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However, this possibility can probably be discounted because heat inactivation of the 
preparation ablated the activity (absorbance spectrum could not be acquired due to high 
turbidity). Another consideration was that the cMBP component of the fusion was an 
active cysteine desulphurase. In order to test this hypothesis, cMBP alone (isolated in 
section 5.3.11.6) was submitted to the enzyme assay. Indeed, no activity was detected 
with cMBP alone (data not shown).
However, the major confounder in the assay was the low purity of cMBP-PfSufS[M]x. 
Crude bacterial lysates exhibit pronounced cysteine desulphurase activity owing to 
endogenous cysteine desulphurases (IscS, SufS and CSD) (chapter 4). Indeed, lysate 
from a strain containing an empty pMALc2 vector (expressing cMBP alone) was 
identical to a strain expressing cMBP-PfSufS[M]x (data not shown). It is salutary to 
note conflicting reports with E. coli biotin synthase. Ollagnier-de-Choudens, et al.389>39° 
demonstrated PLP-binding and cysteine desulphurase activity for the enzyme whereas 
Cosper, et al,391 and Tse Sum Bui, et al.392 did not. One explanation for the difference is 
that PLP-binding and cysteine desulphurase activity may be attributed to endogenous 
cysteine desulphurase contamination of the preparation.393
Hence, to associate cysteine desulphurase activity specifically with cMBP-PfSufS(M]x, 
it was necessary to manipulate the purification to allow isolation of a homogenous 
preparation. The remainder of this discussion focuses on this process.
5.3.11.6. Affinity purification by FPLC.
In an effort to improve the homogeneity of the preparation, purification was done by 
FPLC (Fig. 5.29).
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FIGURE 5.29.
FPLC PURIFICATION OF cMBP-PFSUFS[M]x
E. coli cells harbouring pMALc2:PfsufS[M]x were induced with 0.3 mM IPTG at 14 °C 
for 16 h. Soluble protein was extracted from bacterial sonicate, diluted 1/5, and passed 
through an amylose resin column by FPLC. Protein was eluted with a linear gradient 
limited by 10 mM maltose. A typical 280 nm elution profile is presented (A). Fractions 
were resolved through NuPage 4-12 % BT gel (B). Evidence of the fusion protein in 
elution fraction 2 is marked with an arrow. Abbreviations are as follows. M: Markl2 
unstained standards (Invitrogen); L: lysed bacteria; FT: column flow-through; 1-7 and 
12: elution fractions 1-7 and 12; S: flow-through after stripping column with 0.1 % v/v 
SDS.
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However, the fusion protein again appeared to bind the column weakly and eluted in the 
dead volume of the apparatus regardless of the gradient used (data not shown). By 
contrast, cMBP alone bound the column strongly and eluted at a high concentration of 
limiting buffer (8.3 mM maltose) (Fig. 5.30). Therefore, it appears that the PfSufS[M]x 
interacts with cMBP, reducing its affinity.
5.3.12. Experiments with pMALc2:3Cpro-PfsufS[M]x-His12.
5.3.12.1. Design o f constructs.
In order to better exploit the high solubility of cMBP-PfSufS[M]x, I re-engineered the 
expression construct to facilitate easy purification of full length protein and to increase 
the chance of a successful proteolytic cleavage.394 The location of the catalytic cysteine 
of PfSufS means that a small C-terminal truncation (50 amino acids; 6 kDa) will destroy 
the activity of the enzyme. Hence, in a bespoke design, a C-terminal affinity tag was 
introduced to select full-length products during purification. Furthermore, a 3Cpm 
recognition site was inserted between cMBP and PfSufSJMJx, given the specificity of 
3Cpro even at low temperature. PCR was used to introduce these modifications. It has 
been shown that a C-terminal His-tag can markedly reduce the solubility of an MBP 
fusion.395 Therefore, to decrease the chance of producing an insoluble construct, two 
fusions were made (His6 and His12)
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FIGURE 5.30.
FPLC PURIFICATION OF cMBP.
E. coli cells harbouring empty pMALc2 were induced with 0.3 mM IPTG at 14 °C for 
16 h. Soluble protein was extracted from bacterial sonicate, diluted 1/5, and passed 
through an amylose resin column by FPLC. Protein was eluted with a linear gradient 
limited by 10 mM maltose. A typical 280 nm elution profile is presented (A). Fractions 
were resolved through NuPage 4-12 % BT gel (B). Evidence of the protein in elution 
fractions 9-10 is marked with an arrow. Abbreviations are as follows. M: Markl2 
unstained standards (Invitrogen); L: lysed bacteria; FT: column flow-through; 1-2, 4, 6 
and 8-11: elution fractions 1-2, 4, 6 and 8-11; S: flow-through after stripping column 
with 0.1 % v/v SDS.
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5.3.12.2. Protein expression.
Modified construct (pMALc2:3Cpro-PfSufS[M]x-His12) was transformed into E. coli and 
expression experiments conducted. Induced protein was soluble, migrated near the 
predicted size of 95 kDa (Fig. 5.3IB) and was cross-reactive with anti-His and anti- 
MBP (Fig. 5.32).
5.3.12.3. Protein purification.
Soluble extract was applied to a Ni2+ column and cleaved on the column by incubation 
with 3Cpro. Cut protein was successfully eluted through a linear gradient limited by 1 M 
imidazole (Fig. 5.31 A). This experiment suggested recovery of protein to be imperfect. 
However, there was evidence for column binding and protease cleavage. Furthermore, 
high imidazole (1 M) was required for elution; a result consistent with tight binding 
conferred by the His12-tag.
Western blotting with anti-His and anti-MBP antibodies (Fig. 5.32) revealed successful 
cleavage of the fusion protein: products ran near the predicted sizes (cMBP: 44 kDa; 
PfSufS(M]x-His12: 51 kDa) and gave the appropriate cross-reactivity. These data 
warrant further investigation, as digestion conditions were clearly sub-optimal. For 
example, the presence of cleaved cMBP in the elution fraction suggests the need for 
more extensive washing.
The persistence of full-length cMBP-PfSufS[M]x-His12 in elution fractions may be 
explained by incomplete proteolytic cleavage.
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FIGURE 5.31.
FPLC PURIFICATION OF cMBP-3Cpro-PFSUFS[M]x-HIS12.
E. coli cells harbouring pMALc2:3Cpro-PfsufS[M]x-His12 were induced with 0.3 mM 
IPTG at 14 °C for 16 h. Soluble protein was extracted from bacterial sonicate and 
passed over Ni2+ by FPLC. 3Cpro (160 U) was injected and the column was incubated at 
4 °C for 20 h. Protein was eluted with a linear gradient limited by 1 M imidazole. A 
typical 280 nm elution profile is presented (A). Fractions were resolved through 
NuPage 4-12 % BT gel (B). Evidence of the fusion protein in elution fractions 16-18 is 
presented. Abbreviations are as follows. M: Mark 12 unstained standards (Invitrogen); 
UI: uninduced bacteria; I: induced bacteria; S: soluble lysate; FT: column flow-through; 
Wl: wash before protease; P: flow-through during protease injection; W2: wash after 
protease; 11-14 and 16-18: elution fractions 11-14 and 16-18.
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FIGURE 5.32.
IMMUNO-REACTIVITY OF cMBP-3Cpro-PFSUFS[M]x-fflS12.
Purification fractions (Fig. 5.31) were probed with anti-His (A) and anti-MBP (B) 
antibody on Western blots. Full-length cMBP-3Cpro-PfSufS[M]x-His12 and digestion 
products (cMBP and PfSufS[M]x-His12) are indicated. Abbreviations are as follows. UI: 
uninduced bacteria; I: induced bacteria; S: soluble lysate; FT: column flow-through; 
Wl: wash before protease; P: flow-through during protease injection; W2: wash after 
protease; 13 and 17: elution fractions 13 and 17.
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This phenomenon is probably due to low effective protease concentration in the 
column, given the inability of 3Cpro to adhere to the Ni2+ resin. A more efficient fusion 
protease would be 6His-3Cpro (Ref.381), as it could be immobilised in the resin. It is also 
worth noting the co-elution of a significant amount of an unidentified protein of ca. 60 
kDa and lacking cross-reactivity to anti-His12 and anti-MBP antibodies. On the basis of 
size, amount and elution profile (high imidazole), it is reasonable to exclude this being 
the PreScission protease (46 kDa).
Elution fractions containing cMBP-PfSufS[M]x-His12 were scanned for PLP binding 
and submitted to MB+ assays. A weak (0.09) Schiff base signal at 416 nm was noted 
(Fig. 5.33). However, a colorimetric MB+ signal failed to appear after 15 h of incubation 
at 37 °C (data not shown). Although this experiment needs further refinement, I 
tentatively suggest that the cMBP-PfSufS[M]x-His12 is enzymatically inactive and that 
the initial activity described (section 5.3.12.5) was due to contaminants. However, 
cleavage of PfSufS[MJx (away from cMBP) might render the enzyme able to dimerize 
and become active.
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FIGURE 5.33.
ABSORBANCE SPECTRUM OF cMBP-3Cpro-PFSUFS[M]x-HIS12.
An absorbance spectrum of elution fraction 17 (Fig. 5.31) was acquired. A weak (0.09) 
Schiff base peak is apparent at 416 nm.
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5.3.13. Future approach.
Expression of soluble P. falciparum protein in a heterologous host cell is known to be 
difficult, e.g., recent work conducted in this laboratory failed to produce active P. 
falciparum  SufA, SufB, SufC and PBGS (Rangachari, Clough, Thakrar and Wilson, 
NIMR, unpublished observations). However, by consideration of the nature of the 
PfSufS sequence; coupled to simple experiments with solubility tags, it has been 
possible to obtain soluble protein (cMBP-PfSufS[M]x). Furthermore, by bespoke re­
engineering of this construct, a soluble fusion amenable to cleavage and facile 
purification (cMBP-PfSufS[M]x-His12) was produced. A promising route is now open 
to evaluate the enzymatic activity of PfSufS.
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GENERAL CONCLUSION.
The objective of this project was to investigate a sufS gene in P. falciparum. In order to 
achieve this, a number of difficult techniques have been applied and progress towards 
this objective has been made. Using a combination of simple bioinformatic and in vitro 
methods, the existence of the gene and its transcription has been demonstrated in P. 
falciparum. A start has been made on investigation of PfSufS localisation using 
transfection and immunocytochemistry. The major focus of this project was the 
production of active recombinant PfSufS to allow a full description of enzymatic 
properties. A robust colorimetric cysteine desulphurase assay based on methylene blue 
has been developed and significant progress has been made towards the production of 
recombinant enzyme. This work may have a practical purpose as large amounts of 
enzyme and a rapid assay would be required for high throughput in vitro screening of 
inhibitors. Future efforts will capitalise on these achievements, as we move towards a 
complete characterisation of the intracellular localisation and enzymatic properties of 
PfSufS.
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